BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Whiteside TL. The tumor microenvironment and its role in promoting tumor growth. Oncogene. 2008;27:5904-5912. [PMID: 18836471 DOI: 10.1038/onc.2008.271] [Cited by in Crossref: 1026] [Cited by in F6Publishing: 1014] [Article Influence: 73.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Q, Zhang X, Zhang L, Li W, Wu H, Yuan X, Mao F, Wang M, Zhu W, Qian H, Xu W. The IL-6-STAT3 axis mediates a reciprocal crosstalk between cancer-derived mesenchymal stem cells and neutrophils to synergistically prompt gastric cancer progression. Cell Death Dis. 2014;5:e1295. [PMID: 24946088 DOI: 10.1038/cddis.2014.263] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 8.0] [Reference Citation Analysis]
2 Patidar A, Selvaraj S, Sarode A, Chauhan P, Chattopadhyay D, Saha B. DAMP-TLR-cytokine axis dictates the fate of tumor. Cytokine 2018;104:114-23. [PMID: 29032985 DOI: 10.1016/j.cyto.2017.10.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
3 Zhu J, Yang X, Wang Y, Zhang H, Guo Z. Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer. Oncol Lett 2019;17:5094-102. [PMID: 31186721 DOI: 10.3892/ol.2019.10208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
4 Azuma T, Matayoshi Y, Odani K, Sato Y, Sato Y, Nagase Y, Oshi M. Preoperative Neutrophil-Lymphocyte Ratio as an Independent Prognostic Marker for Patients With Upper Urinary Tract Urothelial Carcinoma. Clinical Genitourinary Cancer 2013;11:337-41. [DOI: 10.1016/j.clgc.2013.04.003] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 5.0] [Reference Citation Analysis]
5 Khalilnezhad A, Mahmoudian E, Mosaffa N, Mohsenifar J, Amani D. Spontaneous mouse mammary tumor cell lysates induce IgG production in spleen mononuclear cells of healthy and tumor-bearing mice. Journal of Immunoassay and Immunochemistry 2016;38:333-42. [DOI: 10.1080/15321819.2016.1266499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Markus RP, Fernandes PA, Kinker GS, da Silveira Cruz-Machado S, Marçola M. Immune-pineal axis - acute inflammatory responses coordinate melatonin synthesis by pinealocytes and phagocytes. Br J Pharmacol 2018;175:3239-50. [PMID: 29105727 DOI: 10.1111/bph.14083] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
7 Ruud J, Bäckhed F, Engblom D, Blomqvist A. Deletion of the gene encoding MyD88 protects from anorexia in a mouse tumor model. Brain Behav Immun 2010;24:554-7. [PMID: 20093176 DOI: 10.1016/j.bbi.2010.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
8 Ding SZ, Zheng PY. Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges. Gut Pathog. 2012;4:18. [PMID: 23217022 DOI: 10.1186/1757-4749-4-18] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
9 Safarzadeh E, Hashemzadeh S, Duijf PH, Mansoori B, Khaze V, Mohammadi A, Kazemi T, Yousefi M, Asadi M, Mohammadi H, Babaie F, Baradaran B. Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer. J Cell Physiol 2019;234:3515-25. [DOI: 10.1002/jcp.26896] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
10 Kapalatiya H, Madav Y, Tambe VS, Wairkar S. Enzyme-responsive smart nanocarriers for targeted chemotherapy: an overview. Drug Deliv Transl Res 2021. [PMID: 34251612 DOI: 10.1007/s13346-021-01020-6] [Reference Citation Analysis]
11 Shetty SS, Padam KSR, Hunter KD, Kudva A, Radhakrishnan R. Biological implications of the immune factors in the tumour microenvironment of oral cancer. Arch Oral Biol 2021;133:105294. [PMID: 34735925 DOI: 10.1016/j.archoralbio.2021.105294] [Reference Citation Analysis]
12 Attaran S, Bissell MJ. The Role of Tumor Microenvironment and Exosomes in Dormancy and Relapse. Semin Cancer Biol 2021:S1044-579X(21)00232-7. [PMID: 34757184 DOI: 10.1016/j.semcancer.2021.09.008] [Reference Citation Analysis]
13 Chen K, Liu Q, Tsang LL, Ye Q, Chan HC, Sun Y, Jiang X. Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway. Cell Death Dis 2017;8:e2819. [PMID: 28542126 DOI: 10.1038/cddis.2017.138] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
14 Cui X, Qin T, Zhao Z, Yang G, Sanches JGP, Zhang Q, Fan S, Cao L, Hu X. Pentraxin-3 inhibits milky spots metastasis of gastric cancer by inhibiting M2 macrophage polarization. J Cancer 2021;12:4686-97. [PMID: 34149932 DOI: 10.7150/jca.58698] [Reference Citation Analysis]
15 Whiteside TL. Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer Immunol Immunother. 2014;63:67-72. [PMID: 24213679 DOI: 10.1007/s00262-013-1490-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 114] [Article Influence: 12.2] [Reference Citation Analysis]
16 Albrecht T, Goeppert B, Brinkmann F, Charbel A, Zhang Q, Schreck J, Wilhelm N, Singer S, Köhler BC, Springfeld C, Mehrabi A, Schirmacher P, Kühl AA, Vogel MN, Jansen H, Utku N, Roessler S. The Transmembrane Receptor TIRC7 Identifies a Distinct Subset of Immune Cells with Prognostic Implications in Cholangiocarcinoma. Cancers 2021;13:6272. [DOI: 10.3390/cancers13246272] [Reference Citation Analysis]
17 Chaudhary B, Elkord E. Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel) 2016;4:E28. [PMID: 27509527 DOI: 10.3390/vaccines4030028] [Cited by in Crossref: 213] [Cited by in F6Publishing: 216] [Article Influence: 35.5] [Reference Citation Analysis]
18 Sahu A, Choi WI, Tae G. Recent Progress in the Design of Hypoxia-Specific Nano Drug Delivery Systems for Cancer Therapy. Adv Therap 2018;1:1800026. [DOI: 10.1002/adtp.201800026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
19 Gomceli I, Demiriz B, Tez M. Gastric carcinogenesis. World J Gastroenterol 2012; 18(37): 5164-5170 [PMID: 23066309 DOI: 10.3748/wjg.v18.i37.5164] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
20 Laytragoon Lewin N, Lewin F, Andersson BÅ, Löfgren S, Rutqvist LE. The use of rapid and cost-effective blood-based biomarkers in combination with tumour TNM stage for individual head and neck cancer patient treatment selection. Med Oncol 2017;34:63. [PMID: 28316053 DOI: 10.1007/s12032-017-0912-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
21 Mittendorf EA, Sharma P. Mechanisms of T-cell inhibition: implications for cancer immunotherapy. Expert Review of Vaccines 2014;9:89-105. [DOI: 10.1586/erv.09.144] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
22 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell 2014;5:673-91. [PMID: 24916440 DOI: 10.1007/s13238-014-0065-9] [Cited by in Crossref: 80] [Cited by in F6Publishing: 87] [Article Influence: 10.0] [Reference Citation Analysis]
23 Huo J, Wu L, Zang Y, Dong H, Liu X, He F, Zhang X. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma. BMC Cancer 2021;21:31. [PMID: 33413205 DOI: 10.1186/s12885-020-07734-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
24 Liu D, Chen B, Mo Y, Wang Z, Qi T, Zhang Q, Wang Y. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway. Nano Lett 2019;19:6964-76. [PMID: 31518149 DOI: 10.1021/acs.nanolett.9b02306] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 20.3] [Reference Citation Analysis]
25 Yin S, Song G, Yang Y, Zhao Y, Wang P, Zhu L, Yin X, Zhang X. Persistent Regulation of Tumor Microenvironment via Circulating Catalysis of MnFe 2 O 4 @Metal–Organic Frameworks for Enhanced Photodynamic Therapy. Adv Funct Mater 2019;29:1901417. [DOI: 10.1002/adfm.201901417] [Cited by in Crossref: 99] [Cited by in F6Publishing: 67] [Article Influence: 33.0] [Reference Citation Analysis]
26 Liu GY, Liu KH, Li Y, Pan C, Su JQ, Liao HF, Yv RX, Li ZH, Yuan L, Zhang HJ, Tzeng CM, Xiong B. Novel cancerization marker, TP53, and its role in distinguishing normal tissue adjacent to cancerous tissue from normal tissue adjacent to benign tissue. World J Surg Oncol 2012;10:252. [PMID: 23170979 DOI: 10.1186/1477-7819-10-252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Li C, Cheung MKH, Han S, Zhang Z, Chen L, Chen J, Zeng H, Qiu J. Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. Biosci Rep 2019;39:BSR20182417. [PMID: 30979829 DOI: 10.1042/BSR20182417] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 8.3] [Reference Citation Analysis]
28 Sánchez-Reyes K, Pedraza-Brindis EJ, Hernández-Flores G, Bravo-Cuellar A, López-López BA, Rosas-González VC, Ortiz-Lazareno PC. The supernatant of cervical carcinoma cells lines induces a decrease in phosphorylation of STAT-1 and NF-κB transcription factors associated with changes in profiles of cytokines and growth factors in macrophages derived from U937 cells. Innate Immun 2019;25:344-55. [PMID: 31099286 DOI: 10.1177/1753425919848841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Lodestijn SC, van Neerven SM, Vermeulen L, Bijlsma MF. Stem Cells in the Exocrine Pancreas during Homeostasis, Injury, and Cancer. Cancers (Basel) 2021;13:3295. [PMID: 34209288 DOI: 10.3390/cancers13133295] [Reference Citation Analysis]
30 Iesato A, Li S, Roti G, Hacker MR, Fischer AH, Nucera C. Lenvatinib targets PDGFR-β pericytes and inhibits synergy with thyroid carcinoma cells: novel translational insights. J Clin Endocrinol Metab 2021:dgab552. [PMID: 34302727 DOI: 10.1210/clinem/dgab552] [Reference Citation Analysis]
31 Acharya UH, Walter RB. Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML). Cancers (Basel) 2020;12:E3617. [PMID: 33287224 DOI: 10.3390/cancers12123617] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Feizi A, Banaei-Esfahani A, Nielsen J. HCSD: the human cancer secretome database. Database (Oxford) 2015;2015:bav051. [PMID: 26078477 DOI: 10.1093/database/bav051] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
33 Behrens C, Feng L, Kadara H, Kim HJ, Lee JJ, Mehran R, Hong WK, Lotan R, Wistuba II. Expression of interleukin-1 receptor-associated kinase-1 in non-small cell lung carcinoma and preneoplastic lesions. Clin Cancer Res 2010;16:34-44. [PMID: 20028769 DOI: 10.1158/1078-0432.CCR-09-0650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
34 Orel VE, Ashykhmin A, Golovko T, Rykhalskyi O, Orel VB. Texture Analysis of Tumor and Peritumoral Tissues Based on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Hybrid Imaging in Patients With Rectal Cancer. J Comput Assist Tomogr 2021;45:820-8. [PMID: 34469907 DOI: 10.1097/RCT.0000000000001218] [Reference Citation Analysis]
35 Furlan F, Eden G, Archinti M, Arnaudova R, Andreotti G, Citro V, Cubellis MV, Motta A, Degryse B. D2A-Ala peptide derived from the urokinase receptor exerts anti-tumoural effects in vitro and in vivo. Peptides 2018;101:17-24. [PMID: 29273518 DOI: 10.1016/j.peptides.2017.12.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
36 Tao L, Huang G, Wang R, Pan Y, He Z, Chu X, Song H, Chen L. Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway. Sci Rep 2016;6:38408. [PMID: 27922075 DOI: 10.1038/srep38408] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 10.0] [Reference Citation Analysis]
37 Fang W, Shi C, Wang Y, Song J, Zhang L. microRNA-128-3p inhibits CD4+ regulatory T cells enrichment by targeting interleukin 16 in gastric cancer. Bioengineered 2022;13:1025-38. [PMID: 34968167 DOI: 10.1080/21655979.2021.2017566] [Reference Citation Analysis]
38 Arnold SA, Brekken RA. SPARC: a matricellular regulator of tumorigenesis. J Cell Commun Signal. 2009;3:255-273. [PMID: 19809893 DOI: 10.1007/s12079-009-0072-4] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 8.2] [Reference Citation Analysis]
39 Long S, Guang ZY, Bao JG, Wei X, Yan YH, YingLi W, Yang Z, Li HL. Shikonin derivatives protect immune organs from damage and promote immune responses in vivo in tumour-bearing mice. Phytother Res. 2012;26:26-33. [PMID: 21538626 DOI: 10.1002/ptr.3503] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
40 Arias JI, Aller MA, Prieto I, Arias A, de Julian Z, Yang H, Arias J. The Amazing Power of Cancer Cells to Recapitulate Extraembryonic Functions: The Cuckoo’s Tricks. J Oncol. 2012;2012:521284. [PMID: 21969829 DOI: 10.1155/2012/521284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
41 de la Torre P, Pérez-Lorenzo MJ, Alcázar-Garrido Á, Flores AI. Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments. Molecules 2020;25:E715. [PMID: 32046010 DOI: 10.3390/molecules25030715] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
42 Carmi Y, Rinott G, Dotan S, Elkabets M, Rider P, Voronov E, Apte RN. Microenvironment-derived IL-1 and IL-17 interact in the control of lung metastasis. J Immunol 2011;186:3462-71. [PMID: 21300825 DOI: 10.4049/jimmunol.1002901] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
43 Lin J, Jiang L, Wang X, Wei W, Song C, Cui Y, Wu X, Qiu G. P4HA2 Promotes Epithelial-to-Mesenchymal Transition and Glioma Malignancy through the Collagen-Dependent PI3K/AKT Pathway. J Oncol 2021;2021:1406853. [PMID: 34434233 DOI: 10.1155/2021/1406853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Peng H, Wang JH, Guo F, Zhu FF, Wen ZJ, Zhong HJ, Liang DS. Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy. Colloids Surf B Biointerfaces 2021;197:111442. [PMID: 33166937 DOI: 10.1016/j.colsurfb.2020.111442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
45 Singer K, Gottfried E, Kreutz M, Mackensen A. Suppression of T-cell responses by tumor metabolites. Cancer Immunol Immunother 2011;60:425-31. [DOI: 10.1007/s00262-010-0967-1] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
46 Maimela NR, Liu S, Zhang Y. Fates of CD8+ T cells in Tumor Microenvironment. Comput Struct Biotechnol J 2019;17:1-13. [PMID: 30581539 DOI: 10.1016/j.csbj.2018.11.004] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 27.5] [Reference Citation Analysis]
47 Lee S, Kim JE, Hong SH, Lee AY, Park EJ, Seo HW, Chae C, Doble P, Bishop D, Cho MH. High Inorganic Phosphate Intake Promotes Tumorigenesis at Early Stages in a Mouse Model of Lung Cancer. PLoS One 2015;10:e0135582. [PMID: 26285136 DOI: 10.1371/journal.pone.0135582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
48 Aydin O, Chandran P, Lorsung RR, Cohen G, Burks SR, Frank JA. The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models. Ultrasound Med Biol 2019;45:3232-45. [PMID: 31530419 DOI: 10.1016/j.ultrasmedbio.2019.08.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Gadd AJR, Greco F, Cobb AJA, Edwards AD. Targeted Activation of Toll-Like Receptors: Conjugation of a Toll-Like Receptor 7 Agonist to a Monoclonal Antibody Maintains Antigen Binding and Specificity. Bioconjugate Chem 2015;26:1743-52. [DOI: 10.1021/acs.bioconjchem.5b00302] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
50 Castro F, Martins C, Silveira MJ, Moura RP, Pereira CL, Sarmento B. Advances on erythrocyte-mimicking nanovehicles to overcome barriers in biological microenvironments. Adv Drug Deliv Rev 2021;170:312-39. [PMID: 32946921 DOI: 10.1016/j.addr.2020.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
51 Chen RJ, Kuo HC, Cheng LH, Lee YH, Chang WT, Wang BJ, Wang YJ, Cheng HC. Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer. Int J Mol Sci 2018;19:E287. [PMID: 29346311 DOI: 10.3390/ijms19010287] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
52 Lin CS, de Oliveira Santos AB, Silva ELE, de Matos LL, Moyses RA, Kulcsar MAV, Pinto FR, Brandão LG, Cernea CR. Tumor volume as an independent predictive factor of worse survival in patients with oral cavity squamous cell carcinoma: Tumor volume as predictive of survival in patients with oral cavity SCC. Head Neck 2017;39:960-4. [DOI: 10.1002/hed.24714] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
53 Cantoni C, Grauwet K, Pietra G, Parodi M, Mingari MC, Maria AD, Favoreel H, Vitale M. Role of NK cells in immunotherapy and virotherapy of solid tumors. Immunotherapy 2015;7:861-82. [PMID: 26314197 DOI: 10.2217/imt.15.53] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
54 Li G, Sun B, Li Y, Luo C, He Z, Sun J. Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery. Small 2021;:e2101460. [PMID: 34342126 DOI: 10.1002/smll.202101460] [Reference Citation Analysis]
55 Li Z, Zhu Q, Chen H, Hu L, Negi H, Zheng Y, Ahmed Y, Wu Z, Li D. Binding of anterior gradient 2 and estrogen receptor-α: Dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer. Cancer Lett 2016;377:32-43. [PMID: 27063095 DOI: 10.1016/j.canlet.2016.04.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
56 Maman S, Edry-Botzer L, Sagi-Assif O, Meshel T, Yuan W, Lu W, Witz IP. The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis. Int J Cancer 2013;133:2296-306. [PMID: 23649556 DOI: 10.1002/ijc.28255] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
57 Bali P, Lozano-Pope I, Pachow C, Obonyo M. Early detection of tumor cells in bone marrow and peripheral blood in a fast‑progressing gastric cancer model. Int J Oncol 2021;58:388-96. [PMID: 33469673 DOI: 10.3892/ijo.2021.5171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Chen PC, Cheng HC, Wang J, Wang SW, Tai HC, Lin CW, Tang CH. Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment. Oncotarget 2014;5:1595-608. [PMID: 24721786 DOI: 10.18632/oncotarget.1570] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
59 Rehman AU, Olof Olsson P, Khan N, Khan K. Identification of Human Secretome and Membrane Proteome-Based Cancer Biomarkers Utilizing Bioinformatics. J Membr Biol 2020;253:257-70. [PMID: 32415382 DOI: 10.1007/s00232-020-00122-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Cen S, Liu K, Zheng Y, Shan J, Jing C, Gao J, Pan H, Bai Z, Liu Z. BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer. Front Cell Dev Biol 2021;9:705060. [PMID: 34381786 DOI: 10.3389/fcell.2021.705060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Lotfi R, Kaltenmeier C, Lotze MT, Bergmann C. Until Death Do Us Part: Necrosis and Oxidation Promote the Tumor Microenvironment. Transfus Med Hemother 2016;43:120-32. [PMID: 27226794 DOI: 10.1159/000444941] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
62 Balajam NZ, Shabani M, Aghaei M, Haghighi M, Kompani F. Study of T-cell immunoglobulin and mucin domain-3 expression profile in peripheral blood and bone marrow of human acute lymphoblastic leukemia patients. J Res Med Sci 2020;25:69. [PMID: 33088306 DOI: 10.4103/jrms.JRMS_759_19] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Di Gaetano R, Gasparetto V, Padoan A, Callegari B, Candiotto L, Sanzari MC, Scapinello A, Tagariello G. Flow cytometry CD4+CD26−CD38+ lymphocyte subset in the microenvironment of Hodgkin lymphoma-affected lymph nodes. Ann Hematol 2014;93:1319-26. [DOI: 10.1007/s00277-014-2044-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
64 Qiao YM, Zhang Y. Immunotherapy for esophageal cancer: Current studies and future perspectives. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4739-4751 [DOI: 10.11569/wcjd.v24.i36.4739] [Reference Citation Analysis]
65 Yokoyama S, Cai Y, Murata M, Tomita T, Yoneda M, Xu L, Pilon AL, Cachau RE, Kimura S. A novel pathway of LPS uptake through syndecan-1 leading to pyroptotic cell death. Elife 2018;7:e37854. [PMID: 30526845 DOI: 10.7554/eLife.37854] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
66 Sha Z, Yang S, Fu L, Geng M, Gu J, Liu X, Li S, Zhou X, He C. Manganese-doped gold core mesoporous silica particles as a nanoplatform for dual-modality imaging and chemo-chemodynamic combination osteosarcoma therapy. Nanoscale 2021;13:5077-93. [DOI: 10.1039/d0nr09220g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Clifton GT, Gall V, Peoples GE, Mittendorf EA. Clinical Development of the E75 Vaccine in Breast Cancer. Breast Care (Basel) 2016;11:116-21. [PMID: 27239173 DOI: 10.1159/000446097] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
68 Rijal G. Understanding the Role of Fibroblasts following a 3D Tumoroid Implantation for Breast Tumor Formation. Bioengineering (Basel) 2021;8:163. [PMID: 34821729 DOI: 10.3390/bioengineering8110163] [Reference Citation Analysis]
69 Polverino F, Laucho-Contreras M, Rojas Quintero J, Divo M, Pinto-Plata V, Sholl L, de-Torres JP, Celli BR, Owen CA. Increased expression of A Proliferation-inducing Ligand (APRIL) in lung leukocytes and alveolar epithelial cells in COPD patients with non small cell lung cancer: a possible link between COPD and lung cancer? Multidiscip Respir Med 2016;11:17. [PMID: 27047662 DOI: 10.1186/s40248-016-0051-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
70 Sabzpoushan SH. A System Biology-Based Approach for Designing Combination Therapy in Cancer Precision Medicine. Biomed Res Int 2020;2020:5072697. [PMID: 32908895 DOI: 10.1155/2020/5072697] [Reference Citation Analysis]
71 Dudek RM, Chuang Y, Leonard JN. Engineered cell-based therapies: a vanguard of design-driven medicine. Adv Exp Med Biol 2014;844:369-91. [PMID: 25480651 DOI: 10.1007/978-1-4939-2095-2_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
72 Yuge R, Kitadai Y, Shinagawa K, Onoyama M, Tanaka S, Yasui W, Chayama K. mTOR and PDGF pathway blockade inhibits liver metastasis of colorectal cancer by modulating the tumor microenvironment. Am J Pathol. 2015;185:399-408. [PMID: 25478811 DOI: 10.1016/j.ajpath.2014.10.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
73 Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009;285:116-26. [PMID: 19464788 DOI: 10.1016/j.canlet.2009.04.031] [Cited by in Crossref: 289] [Cited by in F6Publishing: 280] [Article Influence: 22.2] [Reference Citation Analysis]
74 Tian H, Liu J, Chen J, Gatza ML, Blobe GC. Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment. Oncogene 2015;34:5635-47. [PMID: 25823021 DOI: 10.1038/onc.2015.13] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
75 Pachva MC, Lai H, Jia A, Rouleau M, Sorensen PH. Extracellular Vesicles in Reprogramming of the Ewing Sarcoma Tumor Microenvironment. Front Cell Dev Biol 2021;9:726205. [PMID: 34604225 DOI: 10.3389/fcell.2021.726205] [Reference Citation Analysis]
76 He X, Zhou T, Yang Y, Hong S, Zhan J, Hu Z, Fang W, Qin T, Ma Y, Zhao Y, Cheng Z, Huang Y, Zhao H, Yang G, Zhang L. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer. Clin Lung Cancer 2015;16:e165-71. [PMID: 25922292 DOI: 10.1016/j.cllc.2015.03.005] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
77 Kotler BP, Brown JS. Cancer Community Ecology. Cancer Control 2020;27:1073274820951776. [PMID: 32942911 DOI: 10.1177/1073274820951776] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
78 Ma SR, Deng WW, Liu JF, Mao L, Yu GT, Bu LL, Kulkarni AB, Zhang WF, Sun ZJ. Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma. Mol Cancer 2017;16:99. [PMID: 28592285 DOI: 10.1186/s12943-017-0665-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 11.4] [Reference Citation Analysis]
79 Fang WY, Chen YW, Hsiao JR, Liu CS, Kuo YZ, Wang YC, Chang KC, Tsai ST, Chang MZ, Lin SH, Wu LW. Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production. Oncotarget 2015;6:28401-24. [PMID: 26315114 DOI: 10.18632/oncotarget.4951] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
80 Leibovici J, Itzhaki O, Huszar M, Sinai J. Targeting the tumor microenvironment by immunotherapy: part 2. Immunotherapy 2011;3:1385-408. [DOI: 10.2217/imt.11.112] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
81 Kim H, Khanna V, Kucaba TA, Zhang W, Ferguson DM, Griffith TS, Panyam J. Combination of Sunitinib and PD-L1 Blockade Enhances Anticancer Efficacy of TLR7/8 Agonist-Based Nanovaccine. Mol Pharm 2019;16:1200-10. [PMID: 30620878 DOI: 10.1021/acs.molpharmaceut.8b01165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
82 Liu XJ, Zheng YB, Li Y, Wu SY, Zhen YS. A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice. PLoS One 2014;9:e115790. [PMID: 25531414 DOI: 10.1371/journal.pone.0115790] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
83 Xu F, Cui W, Zhao Z, Gong W, Wei Y, Liu J, Li M, Li Q, Yan C, Qiu J, Liu B, Dong J. Targeting Tumor Microenvironment: Effects of Chinese Herbal Formulae on Macrophage-Mediated Lung Cancer in Mice. Evid Based Complement Alternat Med 2017;2017:7187168. [PMID: 28630636 DOI: 10.1155/2017/7187168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
84 Lee BM, Chung SY, Chang JS, Lee KJ, Seong J. The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy. Gut Liver 2018;12:342-52. [PMID: 29409306 DOI: 10.5009/gnl17216] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
85 Lourenço BN, Springer NL, Ferreira D, Oliveira C, Granja PL, Fischbach C. CD44v6 increases gastric cancer malignant phenotype by modulating adipose stromal cell-mediated ECM remodeling. Integr Biol (Camb) 2018;10:145-58. [PMID: 29450424 DOI: 10.1039/c7ib00179g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
86 Harris AR, Perez MJ, Munson JM. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression. BMC Cancer 2018;18:718. [PMID: 29976154 DOI: 10.1186/s12885-018-4619-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
87 Ludwig N, Whiteside TL. Potential roles of tumor-derived exosomes in angiogenesis. Expert Opin Ther Targets 2018;22:409-17. [PMID: 29634426 DOI: 10.1080/14728222.2018.1464141] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
88 Sambi M, Qorri B, Harless W, Szewczuk MR. Therapeutic Options for Metastatic Breast Cancer. Adv Exp Med Biol 2019;1152:131-72. [PMID: 31456183 DOI: 10.1007/978-3-030-20301-6_8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
89 Oh IR, Raymundo B, Kim M, Kim CW. Mesenchymal stem cells co-cultured with colorectal cancer cells showed increased invasive and proliferative abilities due to its altered p53/TGF-β1 levels. Biosci Biotechnol Biochem 2020;84:256-67. [PMID: 31601153 DOI: 10.1080/09168451.2019.1676692] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
90 Lin L, Lin JM. Development of cell metabolite analysis on microfluidic platform. J Pharm Anal 2015;5:337-47. [PMID: 29403948 DOI: 10.1016/j.jpha.2015.09.003] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
91 Iqbal J, Naushad H, Bi C, Yu J, Bouska A, Rohr J, Chao W, Fu K, Chan WC, Vose JM. Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis? Blood Reviews 2016;30:73-88. [DOI: 10.1016/j.blre.2015.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
92 Xu P, Liang F. Nanomaterial-Based Tumor Photothermal Immunotherapy. Int J Nanomedicine 2020;15:9159-80. [PMID: 33244232 DOI: 10.2147/IJN.S249252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
93 Zhang Q, Li Y, Miao C, Wang Y, Xu Y, Dong R, Zhang Z, Griffin BB, Yuan C, Yan S, Yang X, Liu Z, Kong B. Anti-angiogenesis effect of Neferine via regulating autophagy and polarization of tumor-associated macrophages in high-grade serous ovarian carcinoma. Cancer Lett 2018;432:144-55. [PMID: 29879497 DOI: 10.1016/j.canlet.2018.05.049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
94 Zhang L, Zhang X, Liu Y, Zhang T, Wang Z, Gu M, Li Y, Wang DD, Li W, Lin PP. PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients. Cancer Letters 2020;469:355-66. [DOI: 10.1016/j.canlet.2019.10.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
95 Klein B, Schuppe HC, Bergmann M, Hedger MP, Loveland BE, Loveland KL. An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment. Andrology 2017;5:763-70. [PMID: 28544640 DOI: 10.1111/andr.12365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
96 Hanna A, Balko JM. Breast cancer resistance mechanisms: challenges to immunotherapy. Breast Cancer Res Treat 2021. [PMID: 34322780 DOI: 10.1007/s10549-021-06337-x] [Reference Citation Analysis]
97 Mansoori B, Mohammadi A, Shirjang S, Baradaran B. MicroRNAs in the Diagnosis and Treatment of Cancer. Immunological Investigations 2017;46:880-97. [DOI: 10.1080/08820139.2017.1377407] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 7.6] [Reference Citation Analysis]
98 Georgantzoglou N, Kokkali S, Tsourouflis G, Theocharis S. Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success? Cancers (Basel) 2021;13:1798. [PMID: 33918733 DOI: 10.3390/cancers13081798] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
99 Leffers N, Daemen T, Boezen HM, Melief KJ, Nijman HW. Vaccine-based clinical trials in ovarian cancer. Expert Rev Vaccines 2011;10:775-84. [PMID: 21692699 DOI: 10.1586/erv.11.42] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
100 DePalma TJ, Sivakumar H, Skardal A. Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma. Adv Drug Deliv Rev 2021;180:114067. [PMID: 34822927 DOI: 10.1016/j.addr.2021.114067] [Reference Citation Analysis]
101 Zhang H, Liu Q, Lei Y, Zhou J, Jiang W, Cui Y, He Q, Zhu J, Zhu Z, Sun Y, Ke Z. Direct interaction between CD155 and CD96 promotes immunosuppression in lung adenocarcinoma. Cell Mol Immunol 2021;18:1575-7. [PMID: 32917981 DOI: 10.1038/s41423-020-00538-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
102 Shrestha B, Wang L, Brey EM, Uribe GR, Tang L. Smart Nanoparticles for Chemo-Based Combinational Therapy. Pharmaceutics 2021;13:853. [PMID: 34201333 DOI: 10.3390/pharmaceutics13060853] [Reference Citation Analysis]
103 Syrkina MS, Vassetzky YS, Rubtsov MA. MUC1 Story: Great Expectations, Disappointments and the Renaissance. Curr Med Chem 2019;26:554-63. [PMID: 28820070 DOI: 10.2174/0929867324666170817151954] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
104 Øvrevik J, Refsnes M, Låg M, Brinchmann BC, Schwarze PE, Holme JA. Triggering Mechanisms and Inflammatory Effects of Combustion Exhaust Particles with Implication for Carcinogenesis. Basic Clin Pharmacol Toxicol 2017;121 Suppl 3:55-62. [PMID: 28001342 DOI: 10.1111/bcpt.12746] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
105 Jiang Y, Cong X, Jiang S, Dong Y, Zhao L, Zang Y, Tan M, Li J. Phosphoproteomics Reveals AMPK Substrate Network in Response to DNA Damage and Histone Acetylation. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00017-6. [PMID: 33607295 DOI: 10.1016/j.gpb.2020.09.003] [Reference Citation Analysis]
106 Duan S, Wang S, Huang T, Wang J, Yuan X. circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. Front Oncol 2021;11:780744. [DOI: 10.3389/fonc.2021.780744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Zhu X, Tian X, Ji L, Zhang X, Cao Y, Shen C, Hu Y, Wong JWH, Fang JY, Hong J, Chen H. A tumor microenvironment-specific gene expression signature predicts chemotherapy resistance in colorectal cancer patients. NPJ Precis Oncol 2021;5:7. [PMID: 33580207 DOI: 10.1038/s41698-021-00142-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
108 Kawai H, Tsujigiwa H, Siar CH, Nakano K, Takabatake K, Fujii M, Hamada M, Tamamura R, Nagatsuka H. Characterization and potential roles of bone marrow-derived stromal cells in cancer development and metastasis. Int J Med Sci 2018;15:1406-14. [PMID: 30275769 DOI: 10.7150/ijms.24370] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
109 Huang C, Li N, Li Z, Chang A, Chen Y, Zhao T, Li Y, Wang X, Zhang W, Wang Z, Luo L, Shi J, Yang S, Ren H, Hao J. Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression. Nat Commun 2017;8:14035. [PMID: 28102193 DOI: 10.1038/ncomms14035] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
110 Witz IP. The tumor microenvironment: the making of a paradigm. Cancer Microenviron. 2009;2 Suppl 1:9-17. [PMID: 19701697 DOI: 10.1007/s12307-009-0025-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 6.8] [Reference Citation Analysis]
111 Knauer SK. Prognostic and therapeutic potential of nuclear receptors in head and neck squamous cell carcinomas. J Oncol 2009;2009:349205. [PMID: 19794826 DOI: 10.1155/2009/349205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
112 Crockford A, Jamal-Hanjani M, Hicks J, Swanton C. Implications of intratumour heterogeneity for treatment stratification. J Pathol 2014;232:264-73. [PMID: 24115146 DOI: 10.1002/path.4270] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
113 Feng ZZ, Luo N, Liu Y, Hu JN, Ma T, Yao YM. ER stress and its PERK branch enhance TCR-induced activation in regulatory T cells. Biochem Biophys Res Commun 2021;563:8-14. [PMID: 34058476 DOI: 10.1016/j.bbrc.2021.05.061] [Reference Citation Analysis]
114 Ağardan NBM, Torchilin VP. Engineering of stimuli-sensitive nanopreparations to overcome physiological barriers and cancer multidrug resistance. Engineering of Nanobiomaterials. Elsevier; 2016. pp. 1-28. [DOI: 10.1016/b978-0-323-41532-3.00001-4] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
115 Hong M, Clubb JD, Chen YY. Engineering CAR-T Cells for Next-Generation Cancer Therapy. Cancer Cell 2020;38:473-88. [DOI: 10.1016/j.ccell.2020.07.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 22.5] [Reference Citation Analysis]
116 Shi J, Song X, Traub B, Luxenhofer M, Kornmann M. Involvement of IL-4, IL-13 and Their Receptors in Pancreatic Cancer. Int J Mol Sci 2021;22:2998. [PMID: 33804263 DOI: 10.3390/ijms22062998] [Reference Citation Analysis]
117 Tsuda Y, Fukui H, Asai A, Fukunishi S, Miyaji K, Fujiwara S, Teramura K, Fukuda A, Higuchi K. An immunosuppressive subtype of neutrophils identified in patients with hepatocellular carcinoma. J Clin Biochem Nutr 2012;51:204-12. [PMID: 23170048 DOI: 10.3164/jcbn.12-32] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 0.8] [Reference Citation Analysis]
118 Fetah KL, DiPardo BJ, Kongadzem EM, Tomlinson JS, Elzagheid A, Elmusrati M, Khademhosseini A, Ashammakhi N. Cancer Modeling-on-a-Chip with Future Artificial Intelligence Integration. Small 2019;15:e1901985. [PMID: 31724305 DOI: 10.1002/smll.201901985] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
119 Chang ZL. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res. 2010;59:791-808. [PMID: 20593217 DOI: 10.1007/s00011-010-0208-2] [Cited by in Crossref: 141] [Cited by in F6Publishing: 139] [Article Influence: 11.8] [Reference Citation Analysis]
120 Bhargava A, Mishra D, Banerjee S, Mishra PK. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research. Journal of Drug Targeting 2012;21:126-36. [DOI: 10.3109/1061186x.2012.731069] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
121 Whiteside TL. Tumor-Derived Exosomes and Their Role in Cancer Progression. Adv Clin Chem. 2016;74:103-141. [PMID: 27117662 DOI: 10.1016/bs.acc.2015.12.005] [Cited by in Crossref: 279] [Cited by in F6Publishing: 281] [Article Influence: 46.5] [Reference Citation Analysis]
122 Battistella C, Callmann CE, Thompson MP, Yao S, Yeldandi AV, Hayashi T, Carson DA, Gianneschi NC. Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly. Adv Healthc Mater 2019;8:e1901105. [PMID: 31664791 DOI: 10.1002/adhm.201901105] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
123 Guo J, Yan Y, Yan Y, Guo Q, Zhang M, Zhang J, Goltzman D. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells. Oncol Rep 2017;38:2003-10. [PMID: 28791370 DOI: 10.3892/or.2017.5877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
124 Saggioro M, D'Angelo E, Bisogno G, Agostini M, Pozzobon M. Carcinoma and Sarcoma Microenvironment at a Glance: Where We Are. Front Oncol 2020;10:76. [PMID: 32195166 DOI: 10.3389/fonc.2020.00076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
125 Leitner J, Klauser C, Pickl WF, Stöckl J, Majdic O, Bardet AF, Kreil DP, Dong C, Yamazaki T, Zlabinger G, Pfistershammer K, Steinberger P. B7-H3 is a potent inhibitor of human T-cell activation: No evidence for B7-H3 and TREML2 interaction. Eur J Immunol 2009;39:1754-64. [PMID: 19544488 DOI: 10.1002/eji.200839028] [Cited by in Crossref: 161] [Cited by in F6Publishing: 158] [Article Influence: 12.4] [Reference Citation Analysis]
126 Wang M, Cai J, Huang F, Zhu M, Zhang Q, Yang T, Zhang X, Qian H, Xu W. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med. 2015;35:367-375. [PMID: 25483835 DOI: 10.3892/ijmm.2014.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
127 Miao L, Li J, Liu Q, Feng R, Das M, Lin CM, Goodwin TJ, Dorosheva O, Liu R, Huang L. Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer. ACS Nano 2017;11:8690-706. [PMID: 28809532 DOI: 10.1021/acsnano.7b01786] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 14.8] [Reference Citation Analysis]
128 Ito A, Kagawa S, Sakamoto S, Kuwada K, Kajioka H, Yoshimoto M, Kikuchi S, Kuroda S, Yoshida R, Tazawa H, Fujiwara T. Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation. BMC Cancer 2021;21:102. [PMID: 33509150 DOI: 10.1186/s12885-021-07816-6] [Reference Citation Analysis]
129 Nieland L, Morsett LM, Broekman MLD, Breakefield XO, Abels ER. Extracellular Vesicle-Mediated Bilateral Communication between Glioblastoma and Astrocytes. Trends Neurosci 2021;44:215-26. [PMID: 33234347 DOI: 10.1016/j.tins.2020.10.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
130 Wang H, Gu L, Jia R, Zeng J, Liu X, Zhang D, Wu Y, Luo G, Zhang X. Retrospective evaluation of ultrasound-indeterminate renal multilocular cystic masses by using neutrophil-lymphocyte ratio and computed tomography. Urol Oncol 2017;35:35.e7-35.e14. [PMID: 27671994 DOI: 10.1016/j.urolonc.2016.08.011] [Reference Citation Analysis]
131 Kishimoto N, Takao T, Kuribayashi S, Yamamichi G, Nakano K, Kawamura M, Tsutahara K, Tanigawa G, Yamaguchi S. The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy. Int J Clin Oncol 2017;22:153-8. [PMID: 27614622 DOI: 10.1007/s10147-016-1040-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
132 Mungenast F, Fernando A, Nica R, Boghiu B, Lungu B, Batra J, Ecker RC. Next-Generation Digital Histopathology of the Tumor Microenvironment. Genes (Basel) 2021;12:538. [PMID: 33917241 DOI: 10.3390/genes12040538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
133 Ngambenjawong C, Gustafson HH, Pineda JM, Kacherovsky NA, Cieslewicz M, Pun SH. Serum Stability and Affinity Optimization of an M2 Macrophage-Targeting Peptide (M2pep). Theranostics 2016;6:1403-14. [PMID: 27375788 DOI: 10.7150/thno.15394] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
134 Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED. Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens. 2010;75:201-206. [PMID: 20047640 DOI: 10.1111/j.1399-0039.2009.01438.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
135 Pinkert MA, Salkowski LR, Keely PJ, Hall TJ, Block WF, Eliceiri KW. Review of quantitative multiscale imaging of breast cancer. J Med Imaging (Bellingham) 2018;5:010901. [PMID: 29392158 DOI: 10.1117/1.JMI.5.1.010901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
136 Üçüncü M, Serilmez M, Sarı M, Bademler S, Karabulut S. The Diagnostic Significance of PDGF, EphA7, CCR5, and CCL5 Levels in Colorectal Cancer. Biomolecules 2019;9:E464. [PMID: 31505877 DOI: 10.3390/biom9090464] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
137 Mandai M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Konishi I. Ovarian clear cell carcinoma as a stress-responsive cancer: influence of the microenvironment on the carcinogenesis and cancer phenotype. Cancer Lett 2011;310:129-33. [PMID: 21802200 DOI: 10.1016/j.canlet.2011.06.039] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
138 Rojas A, Araya P, Romero J, Delgado-López F, Gonzalez I, Añazco C, Perez-Castro R. Skewed Signaling through the Receptor for Advanced Glycation End-Products Alters the Proinflammatory Profile of Tumor-Associated Macrophages. Cancer Microenviron 2018;11:97-105. [PMID: 30091031 DOI: 10.1007/s12307-018-0214-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
139 Sznurkowski JJ, Zawrocki A, Biernat W. Subtypes of cytotoxic lymphocytes and natural killer cells infiltrating cancer nests correlate with prognosis in patients with vulvar squamous cell carcinoma. Cancer Immunol Immunother 2014;63:297-303. [PMID: 24368339 DOI: 10.1007/s00262-013-1511-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
140 Karime C, Wang J, Woodhead G, Mody K, Hennemeyer CT, Borad MJ, Mahadevan D, Chandana SR, Babiker H. Tilsotolimod: an investigational synthetic toll-like receptor 9 (TLR9) agonist for the treatment of refractory solid tumors and melanoma. Expert Opin Investig Drugs 2021;:1-13. [PMID: 34913781 DOI: 10.1080/13543784.2022.2019706] [Reference Citation Analysis]
141 Maurice-Dror C, Perets R, Bar-Sela G. Glucocorticoids as an adjunct to oncologic treatment in solid malignancies - Not an innocent bystander. Crit Rev Oncol Hematol 2018;126:37-44. [PMID: 29759565 DOI: 10.1016/j.critrevonc.2018.03.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
142 Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, Yang J, Li YJ, Chen J, Filmus J, Spaner DE, Zacksenhaus E, Hao X, Ben-David Y. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis 2019;10:117. [PMID: 30741932 DOI: 10.1038/s41419-019-1363-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
143 Cai L, Gu Z, Zhong J, Wen D, Chen G, He L, Wu J, Gu Z. Advances in glycosylation-mediated cancer-targeted drug delivery. Drug Discovery Today 2018;23:1126-38. [DOI: 10.1016/j.drudis.2018.02.009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
144 Kitamura H, Onodera Y, Murakami S, Suzuki T, Motohashi H. IL-11 contribution to tumorigenesis in an NRF2 addiction cancer model. Oncogene 2017;36:6315-24. [PMID: 28714957 DOI: 10.1038/onc.2017.236] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
145 Houseni M, Chamroonrat W, Servaes S, Alavi A, Zhuang H. Applications of PET/CT in Pediatric Patients with Fever of Unknown Origin. PET Clinics 2008;3:605-19. [DOI: 10.1016/j.cpet.2009.04.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
146 Huang CW, Lin YC, Hung CH, Chen HM, Lin JT, Wang CJ, Kao SH. Adenine Inhibits the Invasive Potential of DLD-1 Human Colorectal Cancer Cell via the AMPK/FAK Axis. Pharmaceuticals (Basel) 2021;14:860. [PMID: 34577560 DOI: 10.3390/ph14090860] [Reference Citation Analysis]
147 Muller L, Mitsuhashi M, Simms P, Gooding WE, Whiteside TL. Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci Rep. 2016;6:20254. [PMID: 26842680 DOI: 10.1038/srep20254] [Cited by in Crossref: 176] [Cited by in F6Publishing: 181] [Article Influence: 29.3] [Reference Citation Analysis]
148 Xie P, Wang Y, Wei D, Zhang L, Zhang B, Xiao H, Song H, Mao X. Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance. J Mater Chem B 2021;9:5173-94. [PMID: 34116565 DOI: 10.1039/d1tb00753j] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Solman IG, Blum LK, Hoh HY, Kipps TJ, Burger JA, Barrientos JC, O'Brien S, Mulligan SP, Kay NE, Hillmen P, Byrd JC, Lal ID, Dean JP, Mongan A. Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia. Leuk Res 2020;97:106432. [PMID: 32911375 DOI: 10.1016/j.leukres.2020.106432] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
150 Chung HH, Lee CT, Hu JM, Chou YC, Lin YW, Shih YL. NKX6.1 Represses Tumorigenesis, Metastasis, and Chemoresistance in Colorectal Cancer. Int J Mol Sci 2020;21:E5106. [PMID: 32707737 DOI: 10.3390/ijms21145106] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
151 Mandapathil M, Szczepanski M, Harasymczuk M, Ren J, Cheng D, Jackson EK, Gorelik E, Johnson J, Lang S, Whiteside TL. CD26 expression and adenosine deaminase activity in regulatory T cells (Treg) and CD4(+) T effector cells in patients with head and neck squamous cell carcinoma. Oncoimmunology 2012;1:659-69. [PMID: 22934258 DOI: 10.4161/onci.20387] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 42.0] [Reference Citation Analysis]
152 Smith BN, Bhowmick NA. Role of EMT in Metastasis and Therapy Resistance. J Clin Med 2016;5:E17. [PMID: 26828526 DOI: 10.3390/jcm5020017] [Cited by in Crossref: 227] [Cited by in F6Publishing: 226] [Article Influence: 37.8] [Reference Citation Analysis]
153 Zhi X, Jiang K, Shen Y, Su X, Wang K, Ma Y, Zhou L. Peripheral blood cell count ratios are predictive biomarkers of clinical response and prognosis for non-surgical esophageal squamous cell carcinoma patients treated with radiotherapy. J Clin Lab Anal 2020;34:e23468. [PMID: 32681567 DOI: 10.1002/jcla.23468] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
154 Liu CC, Chang TC, Lin YT, Yu YL, Ko BS, Sung LY, Liou JY. Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3σ. Oncotarget 2016;7:36988-99. [PMID: 27175590 DOI: 10.18632/oncotarget.9234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
155 Chen X, Shen R, Liu S, Xiao X, Yan J, Zhang Y, Jiang Z, Nie B, Liu J. The sensitive detection of single-cell secreted lactic acid for glycolytic inhibitor screening with a microdroplet biosensor. Anal Methods 2020;12:3250-9. [PMID: 32930188 DOI: 10.1039/d0ay00633e] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Ravindran S, Rasool S, Maccalli C. The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy. Cancer Microenviron 2019;12:133-48. [PMID: 31758404 DOI: 10.1007/s12307-019-00233-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
157 Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A. The Multiple Layers of the Tumor Environment. Trends Cancer 2018;4:802-9. [PMID: 30470302 DOI: 10.1016/j.trecan.2018.10.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
158 Abken H. Building on Synthetic Immunology and T Cell Engineering: A Brief Journey Through the History of Chimeric Antigen Receptors. Hum Gene Ther 2021;32:1011-28. [PMID: 34405686 DOI: 10.1089/hum.2021.165] [Reference Citation Analysis]
159 Ivanovska I, Zhang C, Liu AM, Wong KF, Lee NP, Lewis P, Philippar U, Bansal D, Buser C, Scott M, Mao M, Poon RT, Fan ST, Cleary MA, Luk JM, Dai H. Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One 2011;6:e24582. [PMID: 21949730 DOI: 10.1371/journal.pone.0024582] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
160 Yamauchi Y, Safi S, Muley T, Warth A, Herth FJF, Dienemann H, Hoffmann H, Eichhorn ME. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients. Lung Cancer 2017;114:62-7. [PMID: 29173768 DOI: 10.1016/j.lungcan.2017.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
161 Drewes CC, Alves AC, Hebeda CB, Copetti I, Sandri S, Uchiyama MK, Araki K, Guterres SS, Pohlmann AR, Farsky SH. Role of poly(ε-caprolactone) lipid-core nanocapsules on melanoma-neutrophil crosstalk. Int J Nanomedicine 2017;12:7153-63. [PMID: 29026308 DOI: 10.2147/IJN.S140557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
162 Dong P, Hu J, Yu S, Zhou Y, Shi T, Zhao Y, Wang X, Liu X. A Mitochondrial Oxidative Stress Amplifier to Overcome Hypoxia Resistance for Enhanced Photodynamic Therapy. Small Methods 2021;5:e2100581. [PMID: 34928048 DOI: 10.1002/smtd.202100581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Blanchette-Farra N, Kita D, Konstorum A, Tesfay L, Lemler D, Hegde P, Claffey KP, Torti FM, Torti SV. Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer. Oncogene 2018;37:4013-32. [PMID: 29695834 DOI: 10.1038/s41388-018-0243-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
164 Relation T, Dominici M, Horwitz EM. Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells. Stem Cells 2017;35:1123-30. [PMID: 28207184 DOI: 10.1002/stem.2596] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
165 Salehi Khesht AM, Karpisheh V, Sahami Gilan P, Melnikova LA, Olegovna Zekiy A, Mohammadi M, Hojjat-Farsangi M, Majidi Zolbanin N, Mahmoodpoor A, Hassannia H, Aghebati-Maleki L, Jafari R, Jadidi-Niaragh F. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells both in vitro and in vivo. Int J Biol Macromol 2021;186:849-63. [PMID: 34245737 DOI: 10.1016/j.ijbiomac.2021.07.034] [Reference Citation Analysis]
166 Liu D, Qiu M. Immune and Metabolic Dysregulated Coding and Non-coding RNAs Reveal Survival Association in Uterine Corpus Endometrial Carcinoma. Front Genet 2021;12:673192. [PMID: 34249094 DOI: 10.3389/fgene.2021.673192] [Reference Citation Analysis]
167 Mercier J, Voutsadakis IA. Comparison of Hematologic and Other Prognostic Markers in Metastatic Colorectal Cancer. J Gastrointest Cancer 2019;50:493-506. [PMID: 29704170 DOI: 10.1007/s12029-018-0108-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
168 Zhang T, Ye L, Han L, He Q, Zhu J. Knockdown of HVEM, a Lymphocyte Regulator Gene, in Ovarian Cancer Cells Increases Sensitivity to Activated T Cells. Oncol Res 2016;24:189-96. [PMID: 27458100 DOI: 10.3727/096504016X14641336229602] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
169 Punzo F, Bellini G, Tortora C, Pinto DD, Argenziano M, Pota E, Paola AD, Martino MD, Rossi F. Mifamurtide and TAM-like macrophages: effect on proliferation, migration and differentiation of osteosarcoma cells. Oncotarget 2020;11:687-98. [PMID: 32133045 DOI: 10.18632/oncotarget.27479] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
170 Unlu S, Tang S, Wang E, Martinez I, Tang D, Bianchi ME, Zeh HJ 3rd, Lotze MT. Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. PLoS One 2012;7:e38899. [PMID: 22745684 DOI: 10.1371/journal.pone.0038899] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
171 Iesato A, Nucera C. Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid Cancer. Adv Exp Med Biol 2021;1329:253-69. [PMID: 34664244 DOI: 10.1007/978-3-030-73119-9_14] [Reference Citation Analysis]
172 Sasidharan Nair V, Saleh R, Toor SM, Cyprian FS, Elkord E. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment. Cancer Immunol Immunother 2021;70:2103-21. [PMID: 33532902 DOI: 10.1007/s00262-020-02842-y] [Reference Citation Analysis]
173 Li X, Jolly MK, George JT, Pienta KJ, Levine H. Computational Modeling of the Crosstalk Between Macrophage Polarization and Tumor Cell Plasticity in the Tumor Microenvironment. Front Oncol 2019;9:10. [PMID: 30729096 DOI: 10.3389/fonc.2019.00010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
174 Wang X, Xiao Z, Gong J, Liu Z, Zhang M, Zhang Z. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside. Transl Lung Cancer Res 2021;10:167-82. [PMID: 33569302 DOI: 10.21037/tlcr-20-822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
175 Gong F, Yang N, Wang X, Zhao Q, Chen Q, Liu Z, Cheng L. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics. Nano Today 2020;32:100851. [DOI: 10.1016/j.nantod.2020.100851] [Cited by in Crossref: 68] [Cited by in F6Publishing: 38] [Article Influence: 34.0] [Reference Citation Analysis]
176 Gadde M, Phillips C, Ghousifam N, Sorace AG, Wong E, Krishnamurthy S, Syed A, Rahal O, Yankeelov TE, Woodward WA, Rylander MN. In vitro vascularized tumor platform for modeling tumor-vasculature interactions of inflammatory breast cancer. Biotechnol Bioeng 2020;117:3572-90. [PMID: 32648934 DOI: 10.1002/bit.27487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
177 Kang J, Su M, Xu Q, Wang C, Yuan X, Han Z. Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma. Oral Dis 2021. [PMID: 34455659 DOI: 10.1111/odi.14013] [Reference Citation Analysis]
178 Riegel K, Yurugi H, Schlöder J, Jonuleit H, Kaulich M, Kirschner F, Arnold-Schild D, Tenzer S, Schild H, Rajalingam K. ERK5 modulates IL-6 secretion and contributes to tumor-induced immune suppression. Cell Death Dis 2021;12:969. [PMID: 34671021 DOI: 10.1038/s41419-021-04257-8] [Reference Citation Analysis]
179 Bankert RB, Balu-Iyer SV, Odunsi K, Shultz LD, Kelleher RJ Jr, Barnas JL, Simpson-Abelson M, Parsons R, Yokota SJ. Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One 2011;6:e24420. [PMID: 21935406 DOI: 10.1371/journal.pone.0024420] [Cited by in Crossref: 78] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
180 Ma X, Wang M, Yin T, Zhao Y, Wei X. Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer. Front Oncol 2019;9:855. [PMID: 31552179 DOI: 10.3389/fonc.2019.00855] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
181 Zhang C, Li D, Yu R, Li C, Song Y, Chen X, Fan Y, Liu Y, Qu X. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature. Front Immunol 2021;12:651033. [PMID: 34054812 DOI: 10.3389/fimmu.2021.651033] [Reference Citation Analysis]
182 Andersen BL, Thornton LM, Shapiro CL, Farrar WB, Mundy BL, Yang HC, Carson WE 3rd. Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clin Cancer Res 2010;16:3270-8. [PMID: 20530702 DOI: 10.1158/1078-0432.CCR-10-0278] [Cited by in Crossref: 95] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
183 Bourke MG, Salwa S, Harrington KJ, Kucharczyk MJ, Forde PF, de Kruijf M, Soden D, Tangney M, Collins JK, O’Sullivan GC. The emerging role of viruses in the treatment of solid tumours. Cancer Treat Rev. 2011;37:618-632. [PMID: 21232872 DOI: 10.1016/j.ctrv.2010.12.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
184 Jia D, Rao W, Wang C, Jin C, Wang S, Chen D, Zhang M, Guo J, Chang Z, Liu J. Inhibition of B16 murine melanoma metastasis and enhancement of immunity by fever-range whole body hyperthermia. Int J Hyperthermia 2011;27:275-85. [PMID: 21501029 DOI: 10.3109/02656736.2011.559613] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
185 Partecke LI, Günther C, Hagemann S, Jacobi C, Merkel M, Sendler M, van Rooijen N, Käding A, Nguyen Trung D, Lorenz E. Induction of M2-macrophages by tumour cells and tumour growth promotion by M2-macrophages: a quid pro quo in pancreatic cancer. Pancreatology. 2013;13:508-516. [PMID: 24075516 DOI: 10.1016/j.pan.2013.06.010] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
186 Yoosuf N, Navarro JF, Salmén F, Ståhl PL, Daub CO. Identification and transfer of spatial transcriptomics signatures for cancer diagnosis. Breast Cancer Res 2020;22:6. [PMID: 31931856 DOI: 10.1186/s13058-019-1242-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
187 Seiler A, Sood AK, Jenewein J, Fagundes CP. Can stress promote the pathophysiology of brain metastases? A critical review of biobehavioral mechanisms. Brain Behav Immun 2020;87:860-80. [PMID: 31881262 DOI: 10.1016/j.bbi.2019.12.013] [Reference Citation Analysis]
188 Zhu Y, Wen L, Shao S, Tan Y, Meng T, Yang X, Liu Y, Liu X, Yuan H, Hu F. Inhibition of tumor-promoting stroma to enforce subsequently targeting AT1R on tumor cells by pathological inspired micelles. Biomaterials 2018;161:33-46. [PMID: 29421561 DOI: 10.1016/j.biomaterials.2018.01.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
189 Hußtegge M, Hoang NA, Rebstock J, Monecke A, Gockel I, Weimann A, Schumacher G, Bechmann I, Lordick F, Kallendrusch S, Körfer J. PD-1 inhibition in patient derived tissue cultures of human gastric and gastroesophageal adenocarcinoma. Oncoimmunology 2021;10:1960729. [PMID: 34434611 DOI: 10.1080/2162402X.2021.1960729] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Ye J, Peng G. Controlling T cell senescence in the tumor microenvironment for tumor immunotherapy. Oncoimmunology 2015;4:e994398. [PMID: 25949919 DOI: 10.4161/2162402X.2014.994398] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
191 Wang Y, Xiao X, Wang T, Li L, Zhu Y, Xu H, Chu Y, Jiao F, Cui J, Wang L. A Survival Model in Locally Advanced and Metastatic Pancreatic Ductal Adenocarcinoma. J Cancer 2018;9:1301-7. [PMID: 29675111 DOI: 10.7150/jca.23984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
192 Murphy MA, O'Leary JJ, Cahill DJ. Assessment of the humoral immune response to cancer. J Proteomics 2012;75:4573-9. [PMID: 22300580 DOI: 10.1016/j.jprot.2012.01.021] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 3.2] [Reference Citation Analysis]
193 Hima S, Sreeja S. Modulatory role of 17 β -estradiol in the tumor microenvironment of thyroid cancer: ROLE OF 17β-ESTRADIOL IN THE TME OF THYROID CANCER. IUBMB Life 2016;68:85-96. [DOI: 10.1002/iub.1462] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
194 Budhwani KI, Oliver PG, Buchsbaum DJ, Thomas V. Novel Biomimetic Microphysiological Systems for Tissue Regeneration and Disease Modeling. Adv Exp Med Biol 2018;1077:87-113. [PMID: 30357685 DOI: 10.1007/978-981-13-0947-2_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
195 Wu X, Peng M, Huang B, Zhang H, Wang H, Huang B, Xue Z, Zhang L, Da Y, Yang D, Yao Z, Zhang R. Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma. Cancer Lett 2013;340:124-33. [PMID: 23920127 DOI: 10.1016/j.canlet.2013.07.038] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
196 Berindan-Neagoe I, Calin GA. Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res 2014;20:6247-53. [PMID: 25512634 DOI: 10.1158/1078-0432.CCR-13-2500] [Cited by in Crossref: 72] [Cited by in F6Publishing: 48] [Article Influence: 10.3] [Reference Citation Analysis]
197 Koustas E, Sarantis P, Papavassiliou AG, Karamouzis MV. The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. Biomolecules 2020;10:E666. [PMID: 32344837 DOI: 10.3390/biom10050666] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
198 Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Nitric Oxide 2010;22:43-50. [PMID: 19948239 DOI: 10.1016/j.niox.2009.11.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
199 Wang M, Cai J, Huang F, Zhu M, Zhang Q, Yang T, Zhang X, Qian H, Xu W. Pre-treatment of human umbilical cord-derived mesenchymal stem cells with interleukin-6 abolishes their growth-promoting effect on gastric cancer cells. Int J Mol Med 2015;35:367-75. [PMID: 25483835 DOI: 10.3892/ijmm.2014.2019] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
200 García-hevia L, Fernández F, Casafont I, Villegas JC, Fanarraga ML. A fast, reliable and cost-effective method to generate tumor organs for therapy screening in vivo. Biomed Phys Eng Express 2016;2:035009. [DOI: 10.1088/2057-1976/2/3/035009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
201 Li XM, Wang JR, Shen T, Gao SS, He XS, Li JN, Yang TY, Zhang S, Gan WJ, Li JM, Wu H. Nur77 deficiency in mice accelerates tumor invasion and metastasis by facilitating TNFα secretion and lowering CSF-1R expression. PLoS One 2017;12:e0171347. [PMID: 28170411 DOI: 10.1371/journal.pone.0171347] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
202 Jo Y, Choi N, Kim K, Koo HJ, Choi J, Kim HN. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development. Theranostics 2018;8:5259-75. [PMID: 30555545 DOI: 10.7150/thno.29098] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
203 Ma L, Khatib S, Craig AJ, Wang XW. Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution. Semin Liver Dis 2021;41:321-30. [PMID: 34130336 DOI: 10.1055/s-0041-1729970] [Reference Citation Analysis]
204 Gromov P, Gromova I, Olsen CJ, Timmermans-wielenga V, Talman M, Serizawa RR, Moreira JM. Tumor interstitial fluid — A treasure trove of cancer biomarkers. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2013;1834:2259-70. [DOI: 10.1016/j.bbapap.2013.01.013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
205 Tang J, Chen Z, Sun B, Dong J, Liu J, Zhou H, Wang L, Bai R, Miao Q, Zhao Y, Chen C, Liu Y. Polyhydroxylated fullerenols regulate macrophage for cancer adoptive immunotherapy and greatly inhibit the tumor metastasis. Nanomedicine 2016;12:945-54. [PMID: 26733256 DOI: 10.1016/j.nano.2015.11.021] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
206 Tang Z, Liu Y, He M, Bu W. Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions. Angew Chem 2018;131:958-68. [DOI: 10.1002/ange.201805664] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
207 Giri TK. Breaking the Barrier of Cancer Through Liposome Loaded with Phytochemicals. CDD 2018;16:3-17. [DOI: 10.2174/1567201815666180918112139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
208 Ziani L, Safta-Saadoun TB, Gourbeix J, Cavalcanti A, Robert C, Favre G, Chouaib S, Thiery J. Melanoma-associated fibroblasts decrease tumor cell susceptibility to NK cell-mediated killing through matrix-metalloproteinases secretion. Oncotarget 2017;8:19780-94. [PMID: 28423623 DOI: 10.18632/oncotarget.15540] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 10.4] [Reference Citation Analysis]
209 Liu G, Luo Y, Hou P. PRPS2 Enhances Resistance to Cisplatin via Facilitating Exosomes-mediated Macrophage M2 Polarization in Non-small Cell Lung Cancer. Immunol Invest 2021;:1-14. [PMID: 34251965 DOI: 10.1080/08820139.2021.1952217] [Reference Citation Analysis]
210 Li W, Khan M, Mao S, Feng S, Lin JM. Advances in tumor-endothelial cells co-culture and interaction on microfluidics. J Pharm Anal 2018;8:210-8. [PMID: 30140484 DOI: 10.1016/j.jpha.2018.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
211 Dawson MR, Xuan B, Hsu J, Ghosh D. Force balancing ACT-IN the tumor microenvironment: Cytoskeletal modifications in cancer and stromal cells to promote malignancy. Int Rev Cell Mol Biol 2021;360:1-31. [PMID: 33962748 DOI: 10.1016/bs.ircmb.2020.09.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Spivey KA, Chung I, Banyard J, Adini I, Feldman HA, Zetter BR. A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene 2012;31:2362-72. [PMID: 21963851 DOI: 10.1038/onc.2011.406] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
213 Tang Z, Liu Y, He M, Bu W. Chemodynamic Therapy: Tumour Microenvironment‐Mediated Fenton and Fenton‐like Reactions. Angew Chem Int Ed 2019;58:946-56. [DOI: 10.1002/anie.201805664] [Cited by in Crossref: 519] [Cited by in F6Publishing: 449] [Article Influence: 173.0] [Reference Citation Analysis]
214 Whiteside TL. Immune responses to cancer: are they potential biomarkers of prognosis? Front Oncol 2013;3:107. [PMID: 23730621 DOI: 10.3389/fonc.2013.00107] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 5.8] [Reference Citation Analysis]
215 Barriga V, Kuol N, Nurgali K, Apostolopoulos V. The Complex Interaction between the Tumor Micro-Environment and Immune Checkpoints in Breast Cancer. Cancers (Basel) 2019;11:E1205. [PMID: 31430935 DOI: 10.3390/cancers11081205] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
216 Seubwai W, Wongkham C, Puapairoj A, Okada S, Wongkham S. 22-oxa-1,25-dihydroxyvitamin D3 efficiently inhibits tumor growth in inoculated mice and primary histoculture of cholangiocarcinoma. Cancer. 2010;116:5535-5543. [PMID: 20681031 DOI: 10.1002/cncr.25478] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
217 Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Lin C, Yeh S, Cai X, Chang C. Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals. Cancer Lett 2016;373:45-56. [PMID: 26805759 DOI: 10.1016/j.canlet.2016.01.017] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 6.0] [Reference Citation Analysis]
218 Logsdon DK, Beeghly GF, Munson JM. Chemoprotection Across the Tumor Border: Cancer Cell Response to Doxorubicin Depends on Stromal Fibroblast Ratios and Interstitial Therapeutic Transport. Cell Mol Bioeng 2017;10:463-81. [PMID: 31719872 DOI: 10.1007/s12195-017-0498-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
219 Diwakar BT, Korwar AM, Paulson RF, Prabhu KS. The Regulation of Pathways of Inflammation and Resolution in Immune Cells and Cancer Stem Cells by Selenium. Adv Cancer Res 2017;136:153-72. [PMID: 29054417 DOI: 10.1016/bs.acr.2017.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
220 Espinoza I, Pochampally R, Xing F, Watabe K, Miele L. Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther 2013;6:1249-59. [PMID: 24043949 DOI: 10.2147/OTT.S36162] [Cited by in Crossref: 31] [Cited by in F6Publishing: 83] [Article Influence: 3.4] [Reference Citation Analysis]
221 Maleki M, Golchin A, Javadi S, Khelghati N, Morovat P, Asemi Z, Alemi F, Vaghari-Tabari M, Yousefi B, Majidinia M. Role of exosomal miRNA in chemotherapy resistance of Colorectal cancer: A systematic review. Chem Biol Drug Des 2021. [PMID: 34480511 DOI: 10.1111/cbdd.13947] [Reference Citation Analysis]
222 Kemp JA, Shim MS, Heo CY, Kwon YJ. “Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Advanced Drug Delivery Reviews 2016;98:3-18. [DOI: 10.1016/j.addr.2015.10.019] [Cited by in Crossref: 269] [Cited by in F6Publishing: 255] [Article Influence: 44.8] [Reference Citation Analysis]
223 Cho SY. Patient-derived xenografts as compatible models for precision oncology. Lab Anim Res 2020;36:14. [PMID: 32461927 DOI: 10.1186/s42826-020-00045-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
224 Lee E, Pandey NB, Popel AS. Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment. Expert Rev Mol Med 2015;17:e3. [PMID: 25634527 DOI: 10.1017/erm.2015.2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 6.4] [Reference Citation Analysis]
225 Weiss VL, Lee TH, Song H, Kouo TS, Black CM, Sgouros G, Jaffee EM, Armstrong TD. Trafficking of high avidity HER-2/neu-specific T cells into HER-2/neu-expressing tumors after depletion of effector/memory-like regulatory T cells. PLoS One 2012;7:e31962. [PMID: 22359647 DOI: 10.1371/journal.pone.0031962] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
226 Nagy N, Kuipers HF, Marshall PL, Wang E, Kaber G, Bollyky PL. Hyaluronan in immune dysregulation and autoimmune diseases. Matrix Biol 2019;78-79:292-313. [PMID: 29625181 DOI: 10.1016/j.matbio.2018.03.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
227 Karsch-Bluman A, Benny O. Necrosis in the Tumor Microenvironment and Its Role in Cancer Recurrence. Adv Exp Med Biol 2020;1225:89-98. [PMID: 32030649 DOI: 10.1007/978-3-030-35727-6_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
228 Polidoro MA, Mikulak J, Cazzetta V, Lleo A, Mavilio D, Torzilli G, Donadon M. Tumor microenvironment in primary liver tumors: A challenging role of natural killer cells. World J Gastroenterol 2020; 26(33): 4900-4918 [PMID: 32952338 DOI: 10.3748/wjg.v26.i33.4900] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
229 Cendrowicz E, Sas Z, Bremer E, Rygiel TP. The Role of Macrophages in Cancer Development and Therapy. Cancers (Basel) 2021;13:1946. [PMID: 33919517 DOI: 10.3390/cancers13081946] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
230 Syed Khaja AS, Toor SM, El Salhat H, Faour I, Ul Haq N, Ali BR, Elkord E. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment. Oncotarget 2017;8:33159-71. [PMID: 28388539 DOI: 10.18632/oncotarget.16565] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 16.5] [Reference Citation Analysis]
231 Vitale M, Cantoni C, Pietra G, Mingari MC, Moretta L. Effect of tumor cells and tumor microenvironment on NK-cell function: Highlights. Eur J Immunol 2014;44:1582-92. [DOI: 10.1002/eji.201344272] [Cited by in Crossref: 199] [Cited by in F6Publishing: 188] [Article Influence: 24.9] [Reference Citation Analysis]
232 Wells DK, Chuang Y, Knapp LM, Brockmann D, Kath WL, Leonard JN. Spatial and functional heterogeneities shape collective behavior of tumor-immune networks. PLoS Comput Biol 2015;11:e1004181. [PMID: 25905470 DOI: 10.1371/journal.pcbi.1004181] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
233 Bian C, Wang Y, Lu Z, An Y, Wang H, Kong L, Du Y, Tian J. ImmunoAIzer: A Deep Learning-Based Computational Framework to Characterize Cell Distribution and Gene Mutation in Tumor Microenvironment. Cancers (Basel) 2021;13:1659. [PMID: 33916145 DOI: 10.3390/cancers13071659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
234 Schilling B, Harasymczuk M, Schuler P, Egan JE, Whiteside TL. IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model. J Mol Med (Berl) 2012;90:139-47. [PMID: 21915712 DOI: 10.1007/s00109-011-0813-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
235 Jin H, Kim HJ. NK Cells Lose Their Cytotoxicity Function against Cancer Stem Cell-Rich Radiotherapy-Resistant Breast Cancer Cell Populations. Int J Mol Sci 2021;22:9639. [PMID: 34502547 DOI: 10.3390/ijms22179639] [Reference Citation Analysis]
236 Liu Y, Wang L, Lo KW, Lui VWY. Omics-wide quantitative B-cell infiltration analyses identify GPR18 for human cancer prognosis with superiority over CD20. Commun Biol 2020;3:234. [PMID: 32398659 DOI: 10.1038/s42003-020-0964-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
237 Yi L, Wu G, Guo L, Zou X, Huang P. Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma. Mol Ther Nucleic Acids 2020;21:299-314. [PMID: 32622331 DOI: 10.1016/j.omtn.2020.06.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
238 Buhrmann C, Shayan P, Banik K, Kunnumakkara AB, Kubatka P, Koklesova L, Shakibaei M. Targeting NF-κB Signaling by Calebin A, a Compound of Turmeric, in Multicellular Tumor Microenvironment: Potential Role of Apoptosis Induction in CRC Cells. Biomedicines 2020;8:E236. [PMID: 32708030 DOI: 10.3390/biomedicines8080236] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
239 Peng Z, Liu XY, Cheng Z, Kai W, Song Z. Comprehensive analysis of a new immune-related prognostic signature for esophageal cancer and its correlation with infiltrating immune cells and target genes. Ann Transl Med 2021;9:1576. [PMID: 34790782 DOI: 10.21037/atm-21-4756] [Reference Citation Analysis]
240 Shofolawe-Bakare OT, Stokes LD, Hossain M, Smith AE, Werfel TA. Immunostimulatory biomaterials to boost tumor immunogenicity. Biomater Sci 2020;8:5516-37. [PMID: 33049007 DOI: 10.1039/d0bm01183e] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Peng K, Liang B, Liu W, Mao Z. What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives. Coordination Chemistry Reviews 2021;449:214210. [DOI: 10.1016/j.ccr.2021.214210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
242 Azuma T, Nagase Y, Oshi M. Pyuria predicts poor prognosis in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin. Mol Clin Oncol 2015;3:1113-6. [PMID: 26623061 DOI: 10.3892/mco.2015.582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
243 Kurisu N, Kaminade T, Eguchi M, Ishigami I, Mizuguchi H, Sakurai F. Oncolytic reovirus-mediated killing of mouse cancer-associated fibroblasts. Int J Pharm 2021;610:121269. [PMID: 34748806 DOI: 10.1016/j.ijpharm.2021.121269] [Reference Citation Analysis]
244 Willrodt AH, Beffinger M, Vranova M, Protsyuk D, Schuler K, Jadhav M, Heikenwalder M, van den Broek M, Borsig L, Halin C. Stromal Expression of Activated Leukocyte Cell Adhesion Molecule Promotes Lung Tumor Growth and Metastasis. Am J Pathol 2017;187:2558-69. [PMID: 28822802 DOI: 10.1016/j.ajpath.2017.07.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
245 Hacking SM, Chakraborty B, Nasim R, Vitkovski T, Thomas R. A Holistic Appraisal of Stromal Differentiation in Colorectal Cancer: Biology, Histopathology, Computation, and Genomics. Pathol Res Pract 2021;220:153378. [PMID: 33690050 DOI: 10.1016/j.prp.2021.153378] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
246 Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett 2019;18:3031-8. [PMID: 31452781 DOI: 10.3892/ol.2019.10677] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
247 Waugh KA, Leach SM, Slansky JE. Targeting Transcriptional Regulators of CD8+ T Cell Dysfunction to Boost Anti-Tumor Immunity. Vaccines (Basel) 2015;3:771-802. [PMID: 26393659 DOI: 10.3390/vaccines3030771] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
248 Leffers N, Daemen T, van der Zee AG, Nijman HW. Multimodality treatment warranted for ovarian cancer: immunotherapy, a prerequisite to improve prognosis for this vicious disease. Immunotherapy 2009;1:163-5. [PMID: 20635935 DOI: 10.2217/1750743X.1.2.163] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
249 Hasegawa T, Suzuki H, Yamaura T, Muto S, Okabe N, Osugi J, Hoshino M, Higuchi M, Ise K, Gotoh M. Prognostic value of peripheral and local forkhead box P3+ regulatory T cells in patients with non-small-cell lung cancer. Mol Clin Oncol 2014;2:685-94. [PMID: 25054031 DOI: 10.3892/mco.2014.299] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
250 Janji B, Viry E, Moussay E, Paggetti J, Arakelian T, Mgrditchian T, Messai Y, Noman MZ, Van Moer K, Hasmim M, Mami-Chouaib F, Berchem G, Chouaib S. The multifaceted role of autophagy in tumor evasion from immune surveillance. Oncotarget 2016;7:17591-607. [PMID: 26910842 DOI: 10.18632/oncotarget.7540] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 7.2] [Reference Citation Analysis]
251 Thurlow JK, Peña Murillo CL, Hunter KD, Buffa FM, Patiar S, Betts G, West CM, Harris AL, Parkinson EK, Harrison PR, Ozanne BW, Partridge M, Kalna G. Spectral Clustering of Microarray Data Elucidates the Roles of Microenvironment Remodeling and Immune Responses in Survival of Head and Neck Squamous Cell Carcinoma. JCO 2010;28:2881-8. [DOI: 10.1200/jco.2009.24.8724] [Cited by in Crossref: 63] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
252 Kim JW, Cho YB, Lee S. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021;10:670. [PMID: 33802964 DOI: 10.3390/cells10030670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
253 He X, Lee B, Jiang Y. Cell-ECM Interactions in Tumor Invasion. Adv Exp Med Biol 2016;936:73-91. [PMID: 27739043 DOI: 10.1007/978-3-319-42023-3_4] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]
254 Misawa K, Kanazawa T, Imai A, Endo S, Mochizuki D, Fukushima H, Misawa Y, Mineta H. Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Mol Clin Oncol 2014;2:285-91. [PMID: 24649348 DOI: 10.3892/mco.2013.233] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
255 Estrela-Lima A, Araújo MS, Costa-Neto JM, Teixeira-Carvalho A, Barrouin-Melo SM, Cardoso SV, Martins-Filho OA, Serakides R, Cassali GD. Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates. BMC Cancer 2010;10:256. [PMID: 20525350 DOI: 10.1186/1471-2407-10-256] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
256 Xi Z, Jones PS, Mikamoto M, Jiang X, Faje AT, Nie C, Labelle KE, Zhou Y, Miller KK, Soberman RJ, Zhang X. The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas. Front Endocrinol (Lausanne) 2021;12:726448. [PMID: 34745002 DOI: 10.3389/fendo.2021.726448] [Reference Citation Analysis]
257 Green VL, Michno A, Greenman J, Stafford ND. Effect of treatment on systemic cytokines in head and neck squamous cell carcinoma patients. Results Immunol 2011;2:1-6. [PMID: 24371560 DOI: 10.1016/j.rinim.2011.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
258 Mandal CC, Sharma A, Panwar MS, Radosevich JA. Is cholesterol a mediator of cold-induced cancer? Tumor Biol 2016;37:9635-48. [DOI: 10.1007/s13277-016-4799-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
259 Sheikh H, Abdulghani J, Ali S, Sinha R, Lipton A. Impact of Genetic Targets on Prostate Cancer Therapy. In: El-deiry WS, editor. Impact of Genetic Targets on Cancer Therapy. New York: Springer; 2013. pp. 359-83. [DOI: 10.1007/978-1-4614-6176-0_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
260 Shen S, Liu M, Li T, Lin S, Mo R. Recent progress in nanomedicine-based combination cancer therapy using a site-specific co-delivery strategy. Biomater Sci 2017;5:1367-81. [DOI: 10.1039/c7bm00297a] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 8.8] [Reference Citation Analysis]
261 Kai MP, Brighton HE, Fromen CA, Shen TW, Luft JC, Luft YE, Keeler AW, Robbins GR, Ting JP, Zamboni WC, Bear JE, DeSimone JM. Tumor Presence Induces Global Immune Changes and Enhances Nanoparticle Clearance. ACS Nano 2016;10:861-70. [PMID: 26592524 DOI: 10.1021/acsnano.5b05999] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
262 Sato Y, Goto Y, Narita N, Hoon DS. Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment. Cancer Microenviron. 2009;2 Suppl 1:205-214. [PMID: 19685283 DOI: 10.1007/s12307-009-0022-y] [Cited by in Crossref: 182] [Cited by in F6Publishing: 181] [Article Influence: 14.0] [Reference Citation Analysis]
263 Chan MS, Chen SF, Felizola SJ, Wang L, Nemoto N, Tamaki K, Ishida T, Chow LW, Ohuchi N, Sasano H. Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients. Int J Biol Markers 2014;29:e193-203. [PMID: 24803281 DOI: 10.5301/jbm.5000082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
264 Wang XQ, Wang W, Peng M, Zhang XZ. Free radicals for cancer theranostics. Biomaterials 2021;266:120474. [PMID: 33125969 DOI: 10.1016/j.biomaterials.2020.120474] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
265 Rana P, Shrama A, Mandal CC. Molecular insights into phytochemicals-driven break function in tumor microenvironment. J Food Biochem 2021;:e13824. [PMID: 34219240 DOI: 10.1111/jfbc.13824] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Ding X, Cao H, Chen X, Zhao Y, Jin H, Niu C, Ma K, Liu Z, Chen J, Wang X, Yang L, He H, Han W, Li D, Tian H, Li W, Cui J. Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer in extensive stage. Journal of Cellular Immunotherapy 2016;2:36-43. [DOI: 10.1016/j.jocit.2016.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
267 Sidana A. Cancer immunotherapy using tumor cryoablation. Immunotherapy 2014;6:85-93. [PMID: 24341887 DOI: 10.2217/imt.13.151] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
268 Viswanath DI, Liu HC, Huston DP, Chua CYX, Grattoni A. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 2022;280:121297. [PMID: 34902729 DOI: 10.1016/j.biomaterials.2021.121297] [Reference Citation Analysis]
269 Pretscher D, Distel LV, Grabenbauer GG, Wittlinger M, Buettner M, Niedobitek G. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer. 2009;9:292. [PMID: 19698134 DOI: 10.1186/1471-2407-9-292] [Cited by in Crossref: 105] [Cited by in F6Publishing: 110] [Article Influence: 8.1] [Reference Citation Analysis]
270 Provinciali M. Immunosenescence and cancer vaccines. Cancer Immunol Immunother 2009;58:1959-67. [PMID: 19198836 DOI: 10.1007/s00262-009-0665-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
271 Lin CH, Lin HH, Kuo CY, Kao SH. Aeroallergen Der p 2 promotes motility of human non-small cell lung cancer cells via toll-like receptor-mediated up-regulation of urokinase-type plasminogen activator and integrin/focal adhesion kinase signaling. Oncotarget 2017;8:11316-28. [PMID: 28076322 DOI: 10.18632/oncotarget.14514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
272 Arce F, Breckpot K, Collins M, Escors D. Targeting lentiviral vectors for cancer immunotherapy. Curr Cancer Ther Rev 2011;7:248-60. [PMID: 22983382 DOI: 10.2174/157339411797642605] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
273 Bianchi G, Vuerich M, Pellegatti P, Marimpietri D, Emionite L, Marigo I, Bronte V, Di Virgilio F, Pistoia V, Raffaghello L. ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment. Cell Death Dis 2014;5:e1135. [PMID: 24651438 DOI: 10.1038/cddis.2014.109] [Cited by in Crossref: 76] [Cited by in F6Publishing: 77] [Article Influence: 9.5] [Reference Citation Analysis]
274 Ochieng J, Nangami GN, Ogunkua O, Miousse IR, Koturbash I, Odero-Marah V, McCawley LJ, Nangia-Makker P, Ahmed N, Luqmani Y, Chen Z, Papagerakis S, Wolf GT, Dong C, Zhou BP, Brown DG, Colacci AM, Hamid RA, Mondello C, Raju J, Ryan EP, Woodrick J, Scovassi AI, Singh N, Vaccari M, Roy R, Forte S, Memeo L, Salem HK, Amedei A, Al-Temaimi R, Al-Mulla F, Bisson WH, Eltom SE. The impact of low-dose carcinogens and environmental disruptors on tissue invasion and metastasis. Carcinogenesis 2015;36 Suppl 1:S128-59. [PMID: 26106135 DOI: 10.1093/carcin/bgv034] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
275 Vacca P, Munari E, Tumino N, Moretta F, Pietra G, Vitale M, Del Zotto G, Mariotti FR, Mingari MC, Moretta L. Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes? Immunol Lett 2018;201:14-9. [PMID: 30439479 DOI: 10.1016/j.imlet.2018.11.004] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
276 Meyer HJ, Höhn AK, Surov A. Histogram parameters derived from T1 and T2 weighted images correlate with tumor infiltrating lymphocytes and tumor-stroma ratio in head and neck squamous cell cancer. Magn Reson Imaging 2021;80:127-31. [PMID: 33971242 DOI: 10.1016/j.mri.2021.05.003] [Reference Citation Analysis]
277 Cess CG, Finley SD. Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment. PLoS Comput Biol 2020;16:e1008519. [PMID: 33362239 DOI: 10.1371/journal.pcbi.1008519] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
278 Debacker JM, Gondry O, Lahoutte T, Keyaerts M, Huvenne W. The Prognostic Value of CD206 in Solid Malignancies: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:3422. [PMID: 34298638 DOI: 10.3390/cancers13143422] [Reference Citation Analysis]
279 Bie Q, Zhang P, Su Z, Zheng D, Ying X, Wu Y, Yang H, Chen D, Wang S, Xu H. Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer. J Immunol Res 2014;2014:923135. [PMID: 24741632 DOI: 10.1155/2014/923135] [Cited by in Crossref: 53] [Cited by in F6Publishing: 58] [Article Influence: 6.6] [Reference Citation Analysis]
280 Rasmusson A, Zilenaite D, Nestarenkaite A, Augulis R, Laurinaviciene A, Ostapenko V, Poskus T, Laurinavicius A. Immunogradient Indicators for Antitumor Response Assessment by Automated Tumor-Stroma Interface Zone Detection. Am J Pathol 2020;190:1309-22. [PMID: 32194048 DOI: 10.1016/j.ajpath.2020.01.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
281 Wang M, Wu C, Guo Y, Cao X, Zheng W, Fan GK. The primary growth of laryngeal squamous cell carcinoma cells in vitro is effectively supported by paired cancer-associated fibroblasts alone. Tumour Biol 2017;39:1010428317705512. [PMID: 28475003 DOI: 10.1177/1010428317705512] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
282 Tam SY, Law HK. JNK in Tumor Microenvironment: Present Findings and Challenges in Clinical Translation. Cancers (Basel) 2021;13:2196. [PMID: 34063627 DOI: 10.3390/cancers13092196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Goedegebuure P, Mitchem JB, Porembka MR, Tan MC, Belt BA, Wang-Gillam A, Gillanders WE, Hawkins WG, Linehan DC. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Curr Cancer Drug Targets. 2011;11:734-751. [PMID: 21599634 DOI: 10.2174/156800911796191024] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 6.6] [Reference Citation Analysis]
284 Szczygieł A, Anger-Góra N, Węgierek-Ciura K, Mierzejewska J, Rossowska J, Goszczyński TM, Świtalska M, Pajtasz-Piasecka E. Immunomodulatory potential of anticancer therapy composed of methotrexate nanoconjugate and dendritic cell‑based vaccines in murine colon carcinoma. Oncol Rep 2021;45:945-62. [PMID: 33432365 DOI: 10.3892/or.2021.7930] [Reference Citation Analysis]
285 Yang Y, Nam GH, Kim GB, Kim YK, Kim IS. Intrinsic cancer vaccination. Adv Drug Deliv Rev 2019;151-152:2-22. [PMID: 31132376 DOI: 10.1016/j.addr.2019.05.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
286 Valashedi MR, Najafi-Ghalehlou N, Nikoo A, Bamshad C, Tomita K, Kuwahara Y, Sato T, Roushandeh AM, Roudkenar MH. Cashing in on ferroptosis against tumor cells: Usher in the next chapter. Life Sci 2021;285:119958. [PMID: 34534562 DOI: 10.1016/j.lfs.2021.119958] [Reference Citation Analysis]
287 Mu J, Zhong H, Zou H, Liu T, Yu N, Zhang X, Xu Z, Chen Z, Guo S. Acid-sensitive PEGylated paclitaxel prodrug nanoparticles for cancer therapy: Effect of PEG length on antitumor efficacy. J Control Release 2020;326:265-75. [PMID: 32687940 DOI: 10.1016/j.jconrel.2020.07.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
288 Hosseini F, Hassannia H, Mahdian-Shakib A, Jadidi-Niaragh F, Enderami SE, Fattahi M, Anissian A, Mirshafiey A, Kokhaei P. Targeting of crosstalk between tumor and tumor microenvironment by β-D mannuronic acid (M2000) in murine breast cancer model. Cancer Med 2017;6:640-50. [PMID: 28211615 DOI: 10.1002/cam4.1013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
289 Goswami KK, Bose A, Baral R. Macrophages in tumor: An inflammatory perspective. Clin Immunol 2021;232:108875. [PMID: 34740843 DOI: 10.1016/j.clim.2021.108875] [Reference Citation Analysis]
290 Gu L, Mooney DJ. Biomaterials and emerging anticancer therapeutics: engineering the microenvironment. Nat Rev Cancer 2016;16:56-66. [PMID: 26694936 DOI: 10.1038/nrc.2015.3] [Cited by in Crossref: 224] [Cited by in F6Publishing: 202] [Article Influence: 37.3] [Reference Citation Analysis]
291 Bizzini B, Drouet B, Zagury D, Abitbol M, Burny A, Boissier M. Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer. Immunotherapy 2010;2:347-65. [DOI: 10.2217/imt.10.16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
292 Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization. Curr Cancer Drug Targets 2020;20:130-45. [PMID: 31738153 DOI: 10.2174/1568009619666191019143539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
293 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
294 O'Brien RM, Cannon A, Reynolds JV, Lysaght J, Lynam-Lennon N. Complement in Tumourigenesis and the Response to Cancer Therapy. Cancers (Basel) 2021;13:1209. [PMID: 33802004 DOI: 10.3390/cancers13061209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
295 Dzobo K, Vogelsang M, Thomford NE, Dandara C, Kallmeyer K, Pepper MS, Parker MI. Wharton's Jelly-Derived Mesenchymal Stromal Cells and Fibroblast-Derived Extracellular Matrix Synergistically Activate Apoptosis in a p21-Dependent Mechanism in WHCO1 and MDA MB 231 Cancer Cells In Vitro. Stem Cells Int 2016;2016:4842134. [PMID: 26880967 DOI: 10.1155/2016/4842134] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
296 Pozzi S, Scomparin A, Israeli Dangoor S, Rodriguez Ajamil D, Ofek P, Neufeld L, Krivitsky A, Vaskovich-Koubi D, Kleiner R, Dey P, Koshrovski-Michael S, Reisman N, Satchi-Fainaro R. Meet me halfway: Are in vitro 3D cancer models on the way to replace in vivo models for nanomedicine development? Adv Drug Deliv Rev 2021;175:113760. [PMID: 33838208 DOI: 10.1016/j.addr.2021.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
297 Bi YL, Mi PY, Zhao SJ, Pan HM, Li HJ, Liu F, Shao LR, Zhang HF, Zhang P, Jiang SL. Salinomycin exhibits anti-angiogenic activity against human glioma in vitro and in vivo by suppressing the VEGF-VEGFR2-AKT/FAK signaling axis. Int J Mol Med 2017;39:1255-61. [PMID: 28358414 DOI: 10.3892/ijmm.2017.2940] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
298 Pacifico F, Pisa L, Mellone S, Cillo M, Lepore A, Leonardi A. NGAL promotes recruitment of tumor infiltrating leukocytes. Oncotarget 2018;9:30761-72. [PMID: 30112105 DOI: 10.18632/oncotarget.25625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
299 Trebeschi S, Drago SG, Birkbak NJ, Kurilova I, Cǎlin AM, Delli Pizzi A, Lalezari F, Lambregts DMJ, Rohaan MW, Parmar C, Rozeman EA, Hartemink KJ, Swanton C, Haanen JBAG, Blank CU, Smit EF, Beets-Tan RGH, Aerts HJWL. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol 2019;30:998-1004. [PMID: 30895304 DOI: 10.1093/annonc/mdz108] [Cited by in Crossref: 130] [Cited by in F6Publishing: 121] [Article Influence: 65.0] [Reference Citation Analysis]
300 Sidana A, Chowdhury WH, Fuchs EJ, Rodriguez R. Cryoimmunotherapy in urologic oncology. Urology. 2010;75:1009-1014. [PMID: 19758686 DOI: 10.1016/j.urology.2009.06.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
301 Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK. The tumor microenvironment in esophageal cancer. Oncogene 2016;35:5337-49. [PMID: 26923327 DOI: 10.1038/onc.2016.34] [Cited by in Crossref: 119] [Cited by in F6Publishing: 128] [Article Influence: 19.8] [Reference Citation Analysis]
302 Bregenzer ME, Horst EN, Mehta P, Novak CM, Raghavan S, Snyder CS, Mehta G. Integrated cancer tissue engineering models for precision medicine. PLoS One 2019;14:e0216564. [PMID: 31075118 DOI: 10.1371/journal.pone.0216564] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
303 Poillet-Perez L, Sarry JE, Joffre C. Autophagy is a major metabolic regulator involved in cancer therapy resistance. Cell Rep 2021;36:109528. [PMID: 34407408 DOI: 10.1016/j.celrep.2021.109528] [Reference Citation Analysis]
304 Schweitzer A, Knauer SK, Stauber RH. Nuclear receptors in head and neck cancer: current knowledge and perspectives. Int J Cancer 2010;126:801-9. [PMID: 19839054 DOI: 10.1002/ijc.24968] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
305 Ghosh D, Dawson MR. Microenvironment Influences Cancer Cell Mechanics from Tumor Growth to Metastasis. Adv Exp Med Biol 2018;1092:69-90. [PMID: 30368749 DOI: 10.1007/978-3-319-95294-9_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
306 Ashrafizadeh M, Mohammadinejad R, Samarghandian S, Yaribeygi H, Johnston TP, Sahebkar A. Anti-Tumor Effects of Osthole on Different Malignant Tissues: A Review of Molecular Mechanisms. Anticancer Agents Med Chem 2020;20:918-31. [PMID: 32108003 DOI: 10.2174/1871520620666200228110704] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
307 Berguetti T, Quintaes LSP, Hancio T, Robaina MC, Cruz ALS, Maia RC, de Souza PS. TNF-α Modulates P-Glycoprotein Expression and Contributes to Cellular Proliferation via Extracellular Vesicles. Cells 2019;8:E500. [PMID: 31137684 DOI: 10.3390/cells8050500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
308 Harden JL, Gu T, Kilinc MO, Rowswell-Turner RB, Virtuoso LP, Egilmez NK. Dichotomous effects of IFN-γ on dendritic cell function determine the extent of IL-12-driven antitumor T cell immunity. J Immunol 2011;187:126-32. [PMID: 21632715 DOI: 10.4049/jimmunol.1100168] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
309 Sharma V, Fernando V, Letson J, Walia Y, Zheng X, Fackelman D, Furuta S. S-Nitrosylation in Tumor Microenvironment. Int J Mol Sci 2021;22:4600. [PMID: 33925645 DOI: 10.3390/ijms22094600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
310 Ong ST, Ng AS, Ng XR, Zhuang Z, Wong BHS, Prasannan P, Kok YJ, Bi X, Shim H, Wulff H, Chandy KG, Verma NK. Extracellular K+ Dampens T Cell Functions: Implications for Immune Suppression in the Tumor Microenvironment. Bioelectricity 2019;1:169-79. [PMID: 34471819 DOI: 10.1089/bioe.2019.0016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
311 Gao X, Lampraki EM, Al-Khalidi S, Qureshi MA, Desai R, Wilson JB. N-acetylcysteine (NAC) ameliorates Epstein-Barr virus latent membrane protein 1 induced chronic inflammation. PLoS One 2017;12:e0189167. [PMID: 29228057 DOI: 10.1371/journal.pone.0189167] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
312 He H, Guo C, Wang J, Korzun WJ, Wang XY, Ghosh S, Yang H. Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing. Nano Lett 2018;18:6164-74. [PMID: 30207473 DOI: 10.1021/acs.nanolett.8b01892] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 10.8] [Reference Citation Analysis]
313 Lee Y, Lee S, Jon S. Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment-Responsive Drug Delivery System for Targeted Cancer Therapy. Adv Sci (Weinh) 2018;5:1800017. [PMID: 29938184 DOI: 10.1002/advs.201800017] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
314 Arab S, Kheshtchin N, Ajami M, Ashurpoor M, Safvati A, Namdar A, Mirzaei R, Mousavi Niri N, Jadidi-niaragh F, Ghahremani MH, Hadjati J. Increased efficacy of a dendritic cell–based therapeutic cancer vaccine with adenosine receptor antagonist and CD73 inhibitor. Tumour Biol 2017;39:101042831769502. [DOI: 10.1177/1010428317695021] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 7.6] [Reference Citation Analysis]
315 Takigawa H, Kitadai Y, Shinagawa K, Yuge R, Higashi Y, Tanaka S, Yasui W, Chayama K. Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact. Neoplasia 2017;19:429-38. [PMID: 28433772 DOI: 10.1016/j.neo.2017.02.010] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
316 Pillay P, Moodley K, Vatish M, Moodley J. Exosomal MicroRNAs in Pregnancy Provides Insight into a Possible Cure for Cancer. Int J Mol Sci 2020;21:E5384. [PMID: 32751127 DOI: 10.3390/ijms21155384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
317 Liu Y, Zhou H, Zheng J, Zeng X, Yu W, Liu W, Huang G, Zhang Y, Fu W. Identification of Immune-Related Prognostic Biomarkers Based on the Tumor Microenvironment in 20 Malignant Tumor Types With Poor Prognosis. Front Oncol 2020;10:1008. [PMID: 32903590 DOI: 10.3389/fonc.2020.01008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
318 Horowitz M, Schreiber H, Elder A, Heidenreich O, Vormoor J, Toffalori C, Vago L, Kröger N. Epidemiology and biology of relapse after stem cell transplantation. Bone Marrow Transplant 2018;53:1379-89. [PMID: 29670211 DOI: 10.1038/s41409-018-0171-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
319 Rojas JM, Knight K, Watmough S, Bell J, Wang L, Callaghan T, Clark RE. BCR-ABL peptide vaccination in healthy subjects: immunological responses are equivalent to those in chronic myeloid leukaemia patients. Leuk Res 2011;35:369-72. [PMID: 20573399 DOI: 10.1016/j.leukres.2010.05.028] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
320 Yin Q, Wyatt CJ, Han T, Smalley KSM, Wan L. ITCH as a potential therapeutic target in human cancers. Semin Cancer Biol 2020;67:117-30. [PMID: 32165318 DOI: 10.1016/j.semcancer.2020.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
321 Henrik Heiland D, Ravi VM, Behringer SP, Frenking JH, Wurm J, Joseph K, Garrelfs NWC, Strähle J, Heynckes S, Grauvogel J, Franco P, Mader I, Schneider M, Potthoff AL, Delev D, Hofmann UG, Fung C, Beck J, Sankowski R, Prinz M, Schnell O. Tumor-associated reactive astrocytes aid the evolution of immunosuppressive environment in glioblastoma. Nat Commun 2019;10:2541. [PMID: 31186414 DOI: 10.1038/s41467-019-10493-6] [Cited by in Crossref: 75] [Cited by in F6Publishing: 67] [Article Influence: 25.0] [Reference Citation Analysis]
322 Al-Matary YS, Botezatu L, Opalka B, Hönes JM, Lams RF, Thivakaran A, Schütte J, Köster R, Lennartz K, Schroeder T, Haas R, Dührsen U, Khandanpour C. Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner. Haematologica 2016;101:1216-27. [PMID: 27390361 DOI: 10.3324/haematol.2016.143180] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
323 Fuentes NR, Phan J, Huang Y, Lin D, Taniguchi CM. Resolving the HIF paradox in pancreatic cancer. Cancer Lett. 2020;489:50-55. [PMID: 32512024 DOI: 10.1016/j.canlet.2020.05.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
324 Jogalekar MP, Cooper LG, Serrano EE. Hydrogel Environment Supports Cell Culture Expansion of a Grade IV Astrocytoma. Neurochem Res 2017;42:2610-24. [PMID: 28589519 DOI: 10.1007/s11064-017-2308-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
325 Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos M, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. A role for microRNA-155 expression in microenvironment associated to HPV-induced carcinogenesis in K14-HPV16 transgenic mice. PLoS One 2015;10:e0116868. [PMID: 25625305 DOI: 10.1371/journal.pone.0116868] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
326 Buhrmann C, Kunnumakkara AB, Kumar A, Samec M, Kubatka P, Aggarwal BB, Shakibaei M. Multitargeting Effects of Calebin A on Malignancy of CRC Cells in Multicellular Tumor Microenvironment. Front Oncol 2021;11:650603. [PMID: 34660256 DOI: 10.3389/fonc.2021.650603] [Reference Citation Analysis]
327 Ramesh P, Shivde R, Jaishankar D, Saleiro D, Le Poole IC. A Palette of Cytokines to Measure Anti-Tumor Efficacy of T Cell-Based Therapeutics. Cancers (Basel) 2021;13:821. [PMID: 33669271 DOI: 10.3390/cancers13040821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 Benigni R, Bossa C. Alternative strategies for carcinogenicity assessment: an efficient and simplified approach based on in vitro mutagenicity and cell transformation assays. Mutagenesis 2011;26:455-60. [DOI: 10.1093/mutage/ger004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
329 Li Y, Ji X, Su Z, Tong J, Xia S, Chen X, Lu P, Barnie PA, Wang S, Huang X, Xu H. Downregulation of Runx3 is closely related to the decreased Th1-associated factors in patients with gastric carcinoma. Tumour Biol 2014;35:12235-44. [PMID: 25270738 DOI: 10.1007/s13277-014-2532-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
330 Yuanyuan L, Yakun L, Zhongyao L, Le Y, Weisong D, Moran G, Hui B, Chunyan L. Myeloid NEMO deficiency promotes tumor immunosuppression partly via MCP1-CCR2 axis. Exp Cell Res 2021;399:112467. [PMID: 33428904 DOI: 10.1016/j.yexcr.2020.112467] [Reference Citation Analysis]
331 Chen JA, Ma W, Yuan J, Li T. Translational Biomarkers and Rationale Strategies to Overcome Resistance to Immune Checkpoint Inhibitors in Solid Tumors. Cancer Treat Res 2020;180:251-79. [PMID: 32215873 DOI: 10.1007/978-3-030-38862-1_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
332 Coleman MF, Cozzo AJ, Pfeil AJ, Etigunta SK, Hursting SD. Cell Intrinsic and Systemic Metabolism in Tumor Immunity and Immunotherapy. Cancers (Basel) 2020;12:E852. [PMID: 32244756 DOI: 10.3390/cancers12040852] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
333 Sieow JL, Gun SY, Wong SC. The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment. Front Cell Dev Biol 2018;6:168. [PMID: 30619850 DOI: 10.3389/fcell.2018.00168] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
334 Li J, Shi K, Drechsler M, Tang BZ, Huang J, Yan Y. A supramolecular fluorescent vesicle based on a coordinating aggregation induced emission amphiphile: insight into the role of electrical charge in cancer cell division. Chem Commun (Camb) 2016;52:12466-9. [PMID: 27711439 DOI: 10.1039/c6cc06432a] [Cited by in Crossref: 29] [Cited by in F6Publishing: 1] [Article Influence: 7.3] [Reference Citation Analysis]
335 Lamichhane S, Lee S. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy. Arch Pharm Res 2020;43:118-33. [PMID: 31916145 DOI: 10.1007/s12272-020-01204-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
336 Obrador E, Salvador R, López-Blanch R, Jihad-Jebbar A, Alcácer J, Benlloch M, Pellicer JA, Estrela JM. Melanoma in the liver: Oxidative stress and the mechanisms of metastatic cell survival. Semin Cancer Biol 2021;71:109-21. [PMID: 32428715 DOI: 10.1016/j.semcancer.2020.05.001] [Reference Citation Analysis]
337 Mosayebzadeh Roshan H, Abtahi-Eivary SH, Shojaee-Mend H, Mohammadzadeh A, Bahari Sani Z. The Effects of WW2/WW3 Domains of Smurf2 Molecule on CD4+CD25+/CD4+ Proportion in Spleen of 4T1 Tumor Bearing BALB/c Mice. Iran Biomed J 2020;24:214-9. [PMID: 32306719 DOI: 10.29252/ibj.24.4.214] [Reference Citation Analysis]
338 Khajeh Alizadeh Attar M, Anwar MA, Eskian M, Keshavarz-Fathi M, Choi S, Rezaei N. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis. Med Res Rev 2018;38:1469-84. [PMID: 29283184 DOI: 10.1002/med.21480] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
339 Naito T, Yuge R, Kitadai Y, Takigawa H, Higashi Y, Kuwai T, Kuraoka K, Tanaka S, Chayama K. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer. Oncol Rep 2021;45:104. [PMID: 33907853 DOI: 10.3892/or.2021.8055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
340 Jin K, Ren C, Liu Y, Lan H, Wang Z. An update on colorectal cancer microenvironment, epigenetic and immunotherapy. Int Immunopharmacol 2020;89:107041. [PMID: 33045561 DOI: 10.1016/j.intimp.2020.107041] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
341 Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 [PMID: 27559435 DOI: 10.4251/wjgo.v8.i7.555] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
342 Geller A, Shrestha R, Yan J. Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic. Int J Mol Sci 2019;20:E3618. [PMID: 31344853 DOI: 10.3390/ijms20153618] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 6.7] [Reference Citation Analysis]
343 Li Y, Zhang X, Liu X, Pan W, Li N, Tang B. Intelligent stimuli-responsive nano immunomodulators for cancer immunotherapy. Chem Sci 2021;12:3130-45. [PMID: 34164080 DOI: 10.1039/d0sc06557a] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
344 Li ZL, Wang ZJ, Wei GH, Yang Y, Wang XW. Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells. World J Gastrointest Oncol 2020; 12(3): 267-275 [PMID: 32206177 DOI: 10.4251/wjgo.v12.i3.267] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
345 Li H, Liu W, Zhang X, Wang Y. Cancer-associated fibroblast-secreted collagen triple helix repeat containing-1 promotes breast cancer cell migration, invasiveness and epithelial-mesenchymal transition by activating the Wnt/β-catenin pathway. Oncol Lett 2021;22:814. [PMID: 34671428 DOI: 10.3892/ol.2021.13075] [Reference Citation Analysis]
346 Jaafar H, Tuan Sharif SE, Das Murtey M. Pattern of Collagen Fibers and Localization of Matrix Metalloproteinase 2 and 9 during Breast Cancer Invasion. Tumori Journal 2018;100:e204-11. [DOI: 10.1177/1660.18194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
347 Ben-Shmuel A, Biber G, Barda-Saad M. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy? Front Immunol 2020;11:275. [PMID: 32153582 DOI: 10.3389/fimmu.2020.00275] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 16.5] [Reference Citation Analysis]
348 MacMullan MA, Dunn ZS, Graham N, Yang L, Wang P. Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy. Theranostics 2019;9:7872-88. [PMID: 31695805 DOI: 10.7150/thno.37373] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
349 Mendes C, Serpa J. Revisiting lactate dynamics in cancer—a metabolic expertise or an alternative attempt to survive? J Mol Med 2020;98:1397-414. [DOI: 10.1007/s00109-020-01965-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
350 Dong J, Zhu C, Zhang F, Zhou Z, Sun M. "Attractive/adhesion force" dual-regulatory nanogels capable of CXCR4 antagonism and autophagy inhibition for the treatment of metastatic breast cancer. J Control Release 2021;341:892-903. [PMID: 34953982 DOI: 10.1016/j.jconrel.2021.12.026] [Reference Citation Analysis]
351 Chan WJ. Pathogenesis of diffuse large B cell lymphoma. Int J Hematol 2010;92:219-30. [PMID: 20582737 DOI: 10.1007/s12185-010-0602-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
352 Newton JM, Hanoteau A, Liu HC, Gaspero A, Parikh F, Gartrell-Corrado RD, Hart TD, Laoui D, Van Ginderachter JA, Dharmaraj N, Spanos WC, Saenger Y, Young S, Sikora AG. Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition. J Immunother Cancer 2019;7:216. [PMID: 31409394 DOI: 10.1186/s40425-019-0698-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
353 Newton JM, Hanoteau A, Sikora AG. Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors. J Vis Exp 2018. [PMID: 29939180 DOI: 10.3791/57685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
354 Wu LS, Liu Y, Wang XW, Xu B, Lin YL, Song Y, Dong Y, Liu JL, Wang XJ, Liu S, Kong P, Han M, Li BH. LPS Enhances the Chemosensitivity of Oxaliplatin in HT29 Cells via GSDMD-Mediated Pyroptosis. Cancer Manag Res 2020;12:10397-409. [PMID: 33116894 DOI: 10.2147/CMAR.S244374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
355 He C, Duan X, Guo N, Chan C, Poon C, Weichselbaum RR, Lin W. Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy. Nat Commun. 2016;7:12499. [PMID: 27530650 DOI: 10.1038/ncomms12499] [Cited by in Crossref: 395] [Cited by in F6Publishing: 383] [Article Influence: 65.8] [Reference Citation Analysis]
356 Messex JK, Liou GY. Targeting BTK Signaling in the Microenvironment of Solid Tumors as a Feasible Cancer Therapy Option. Cancers (Basel) 2021;13:2198. [PMID: 34063667 DOI: 10.3390/cancers13092198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
357 Schellhammer PF, Chodak G, Whitmore JB, Sims R, Frohlich MW, Kantoff PW. Lower baseline prostate-specific antigen is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial. Urology 2013;81:1297-302. [PMID: 23582482 DOI: 10.1016/j.urology.2013.01.061] [Cited by in Crossref: 153] [Cited by in F6Publishing: 128] [Article Influence: 17.0] [Reference Citation Analysis]
358 Xie YJ, Dougan M, Ingram JR, Pishesha N, Fang T, Momin N, Ploegh HL. Improved Antitumor Efficacy of Chimeric Antigen Receptor T Cells that Secrete Single-Domain Antibody Fragments. Cancer Immunol Res 2020;8:518-29. [PMID: 32019780 DOI: 10.1158/2326-6066.CIR-19-0734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
359 Frión-Herrera Y, Gabbia D, Cuesta-Rubio O, De Martin S, Carrara M. Nemorosone inhibits the proliferation and migration of hepatocellular carcinoma cells. Life Sci 2019;235:116817. [PMID: 31476309 DOI: 10.1016/j.lfs.2019.116817] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
360 Qu Y, Dunn ZS, Chen X, MacMullan M, Cinay G, Wang HY, Liu J, Hu F, Wang P. Adenosine Deaminase 1 Overexpression Enhances the Antitumor Efficacy of Chimeric Antigen Receptor-Engineered T Cells. Hum Gene Ther 2021. [PMID: 34225478 DOI: 10.1089/hum.2021.050] [Reference Citation Analysis]
361 Lee SA, Kim YM, Kwak TK, Kim HJ, Kim S, Ko W, Kim SH, Park KH, Kim HJ, Cho M, Lee JW. The extracellular loop 2 of TM4SF5 inhibits integrin alpha2 on hepatocytes under collagen type I environment. Carcinogenesis 2009;30:1872-9. [PMID: 19789264 DOI: 10.1093/carcin/bgp234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
362 Mager LF, Wasmer MH, Rau TT, Krebs P. Cytokine-Induced Modulation of Colorectal Cancer. Front Oncol. 2016;6:96. [PMID: 27148488 DOI: 10.3389/fonc.2016.00096] [Cited by in Crossref: 102] [Cited by in F6Publishing: 102] [Article Influence: 17.0] [Reference Citation Analysis]
363 Yang HY, Wu CY, Chen JJ, Lee TH. Treatment Strategies and Metabolic Pathway Regulation in Urothelial Cell Carcinoma: A Comprehensive Review. Int J Mol Sci 2020;21:E8993. [PMID: 33256165 DOI: 10.3390/ijms21238993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
364 Pandey MK, Gupta SC, Nabavizadeh A, Aggarwal BB. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment. Semin Cancer Biol 2017;46:158-81. [PMID: 28823533 DOI: 10.1016/j.semcancer.2017.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
365 Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J; University of Michigan Head and Neck SPORE Program. Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol. 2015;51:90-95. [PMID: 25283344 DOI: 10.1016/j.oraloncology.2014.09.006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 10.9] [Reference Citation Analysis]
366 Masuda H, Mikami K, Otsuka K, Hou K, Suyama T, Araki K, Kojima S, Naya Y. Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/ml. In Vivo 2021;35:1641-6. [PMID: 33910847 DOI: 10.21873/invivo.12422] [Reference Citation Analysis]
367 Xia R, Pei Q, Wang J, Wang Z, Hu X, Xie Z. Redox responsive paclitaxel dimer for programmed drug release and selectively killing cancer cells. Journal of Colloid and Interface Science 2020;580:785-93. [DOI: 10.1016/j.jcis.2020.07.086] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
368 Li G, Song Q, Cai A, Wei Z, Zhang R, Yi D, Chen J, Li F, Zhang Y, Liu L, Wu Y, Yi D. An immunoscore nomogram for predicting survival in patients with oesophageal cancer. Aging (Albany NY) 2021;13:8762-76. [PMID: 33714960 DOI: 10.18632/aging.202686] [Reference Citation Analysis]
369 Roy S, Sethi TK, Taylor D, Kim YJ, Johnson DB. Breakthrough concepts in immune-oncology: Cancer vaccines at the bedside. J Leukoc Biol. 2020;108:1455-1489. [PMID: 32557857 DOI: 10.1002/jlb.5bt0420-585rr] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
370 Wen X, He X, Jiao F, Wang C, Sun Y, Ren X, Li Q. Fibroblast Activation Protein-α-Positive Fibroblasts Promote Gastric Cancer Progression and Resistance to Immune Checkpoint Blockade. Oncol Res 2017;25:629-40. [PMID: 27983931 DOI: 10.3727/096504016X14768383625385] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
371 Jia D, Li X, Bocci F, Tripathi S, Deng Y, Jolly MK, Onuchic JN, Levine H. Quantifying Cancer Epithelial-Mesenchymal Plasticity and its Association with Stemness and Immune Response. J Clin Med 2019;8:E725. [PMID: 31121840 DOI: 10.3390/jcm8050725] [Cited by in Crossref: 39] [Cited by in F6Publishing: 27] [Article Influence: 13.0] [Reference Citation Analysis]
372 Álvarez-Artime A, García-Soler B, Sainz RM, Mayo JC. Emerging Roles for Browning of White Adipose Tissue in Prostate Cancer Malignant Behaviour. Int J Mol Sci 2021;22:5560. [PMID: 34074045 DOI: 10.3390/ijms22115560] [Reference Citation Analysis]
373 Sayegh ET, Bloch O, Parsa AT. Complement anaphylatoxins as immune regulators in cancer. Cancer Med 2014;3:747-58. [PMID: 24711204 DOI: 10.1002/cam4.241] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
374 Metelitsa LS. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol 2011;140:119-29. [PMID: 21095162 DOI: 10.1016/j.clim.2010.10.005] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 5.9] [Reference Citation Analysis]
375 Zeng X, Yang P, Chen B, Jin X, Liu Y, Zhao X, Liang S. Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. Journal of Proteomics 2013;89:51-70. [DOI: 10.1016/j.jprot.2013.05.032] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.3] [Reference Citation Analysis]
376 Azuma T, Matayoshi Y, Nagase Y, Oshi M. Neutrophil Number After Interferon-Alfa Treatment is an Independent Predictive Marker of Overall Survival in Metastatic Renal Cell Carcinoma. Clinical Genitourinary Cancer 2012;10:180-4. [DOI: 10.1016/j.clgc.2012.03.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
377 Achyut BR, Arbab AS. Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancer. Onco Targets Ther 2016;9:1047-55. [PMID: 27042097 DOI: 10.2147/OTT.S102907] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
378 Wang L, Zheng G. Macrophages in leukemia microenvironment. Blood Science 2019;1:29-33. [DOI: 10.1097/bs9.0000000000000014] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
379 Hu Q, Kang T, Feng J, Zhu Q, Jiang T, Yao J, Jiang X, Chen J. Tumor Microenvironment and Angiogenic Blood Vessels Dual-Targeting for Enhanced Anti-Glioma Therapy. ACS Appl Mater Interfaces 2016;8:23568-79. [DOI: 10.1021/acsami.6b08239] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
380 Freeman P, Mielgo A. Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities. Cancers (Basel) 2020;12:E2687. [PMID: 32967079 DOI: 10.3390/cancers12092687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
381 Tu VY, Ayari A, O'Connor RS. Beyond the Lactate Paradox: How Lactate and Acidity Impact T Cell Therapies against Cancer. Antibodies (Basel) 2021;10:25. [PMID: 34203136 DOI: 10.3390/antib10030025] [Reference Citation Analysis]
382 Zhuo S, Zhang F, Yu J, Zhang X, Yang G, Liu X. pH-Sensitive Biomaterials for Drug Delivery. Molecules 2020;25:E5649. [PMID: 33266162 DOI: 10.3390/molecules25235649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
383 Bashyam MD, Animireddy S, Bala P, Naz A, George SA. The Yin and Yang of cancer genes. Gene 2019;704:121-33. [DOI: 10.1016/j.gene.2019.04.025] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
384 Green VL, Michno A, Stafford ND, Greenman J. Increased prevalence of tumour infiltrating immune cells in oropharyngeal tumours in comparison to other subsites: relationship to peripheral immunity. Cancer Immunol Immunother 2013;62:863-73. [DOI: 10.1007/s00262-013-1395-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
385 Shen M, Kang Y. Complex interplay between tumor microenvironment and cancer therapy. Front Med 2018;12:426-39. [PMID: 30097962 DOI: 10.1007/s11684-018-0663-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
386 Dellacherie MO, Seo BR, Mooney DJ. Macroscale biomaterials strategies for local immunomodulation. Nat Rev Mater 2019;4:379-97. [DOI: 10.1038/s41578-019-0106-3] [Cited by in Crossref: 74] [Cited by in F6Publishing: 39] [Article Influence: 24.7] [Reference Citation Analysis]
387 Muntimadugu E, Kommineni N, Khan W. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy. Pharmacol Res 2017;126:109-22. [PMID: 28511988 DOI: 10.1016/j.phrs.2017.05.010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
388 Wang J, Liu YX, Li XL, Chen HY, Xu JJ. Core-Shell Plasmonic Nanomaterials toward: Dual-Mode Imaging Analysis of Glutathione and Enhanced Chemodynamic Therapy. Anal Chem 2021;93:10317-25. [PMID: 34270215 DOI: 10.1021/acs.analchem.1c01858] [Reference Citation Analysis]
389 Gao Y, Guo W, Geng X, Zhang Y, Zhang G, Qiu B, Tan F, Xue Q, Gao S, He J. Prognostic value of tumor-infiltrating lymphocytes in esophageal cancer: an updated meta-analysis of 30 studies with 5,122 patients. Ann Transl Med 2020;8:822. [PMID: 32793667 DOI: 10.21037/atm-20-151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
390 Saini J, Faroni A, Reid AJ, Mamchaoui K, Mouly V, Butler-Browne G, Lightfoot AP, McPhee JS, Degens H, Al-Shanti N. A Novel Bioengineered Functional Motor Unit Platform to Study Neuromuscular Interaction. J Clin Med 2020;9:E3238. [PMID: 33050427 DOI: 10.3390/jcm9103238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
391 Azimi I, Petersen RM, Thompson EW, Roberts-Thomson SJ, Monteith GR. Hypoxia-induced reactive oxygen species mediate N-cadherin and SERPINE1 expression, EGFR signalling and motility in MDA-MB-468 breast cancer cells. Sci Rep 2017;7:15140. [PMID: 29123322 DOI: 10.1038/s41598-017-15474-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 11.4] [Reference Citation Analysis]
392 Satapathy S, Kumar C, Singh RK. MicroRNAs as Key Regulators of Ovarian Cancers. Cell Med 2019;11:2155179019873849. [PMID: 32634196 DOI: 10.1177/2155179019873849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
393 Dumina M, Zhgun A, Pokrovskaya M, Aleksandrova S, Zhdanov D, Sokolov N, El'darov M. Highly Active Thermophilic L-Asparaginase from Melioribacter roseus Represents a Novel Large Group of Type II Bacterial L-Asparaginases from Chlorobi-Ignavibacteriae-Bacteroidetes Clade. Int J Mol Sci 2021;22:13632. [PMID: 34948436 DOI: 10.3390/ijms222413632] [Reference Citation Analysis]
394 Kaylan KB, Kourouklis AP, Underhill GH. A High-throughput Cell Microarray Platform for Correlative Analysis of Cell Differentiation and Traction Forces. J Vis Exp 2017. [PMID: 28287589 DOI: 10.3791/55362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
395 Manuel ER, Blache CA, Paquette R, Kaltcheva TI, Ishizaki H, Ellenhorn JD, Hensel M, Metelitsa L, Diamond DJ. Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors. Cancer Res 2011;71:4183-91. [PMID: 21527558 DOI: 10.1158/0008-5472.CAN-10-4676] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 4.8] [Reference Citation Analysis]
396 Yu J, Piazza A, Sparks S, Hind LE, Niles DJ, Ingram PN, Huang W, Ricke WA, Jarrard DF, Huttenlocher A, Basu H, Beebe DJ. A reconfigurable microscale assay enables insights into cancer-associated fibroblast modulation of immune cell recruitment. Integr Biol (Camb) 2021;13:87-97. [PMID: 33822934 DOI: 10.1093/intbio/zyab004] [Reference Citation Analysis]
397 Chang WJ, Du Y, Zhao X, Ma LY, Cao GW. Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20(16): 4586-4596 [PMID: 24782611 DOI: 10.3748/wjg.v20.i16.4586] [Cited by in CrossRef: 96] [Cited by in F6Publishing: 97] [Article Influence: 12.0] [Reference Citation Analysis]
398 Laplane L, Duluc D, Bikfalvi A, Larmonier N, Pradeu T. Beyond the tumour microenvironment. Int J Cancer 2019;145:2611-8. [PMID: 30989643 DOI: 10.1002/ijc.32343] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
399 Shinagawa K, Kitadai Y, Tanaka M, Sumida T, Onoyama M, Ohnishi M, Ohara E, Higashi Y, Tanaka S, Yasui W, Chayama K. Stroma-directed imatinib therapy impairs the tumor-promoting effect of bone marrow-derived mesenchymal stem cells in an orthotopic transplantation model of colon cancer. Int J Cancer 2013;132:813-23. [DOI: 10.1002/ijc.27735] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.9] [Reference Citation Analysis]
400 Papale M. A Review of Proteomics Strategies to Study T-Cell Activation and Function in Cancer Disease. Methods Mol Biol 2021;2325:125-36. [PMID: 34053055 DOI: 10.1007/978-1-0716-1507-2_9] [Reference Citation Analysis]
401 Ji T, Zhao Y, Wang J, Zheng X, Tian Y, Zhao Y, Nie G. Tumor fibroblast specific activation of a hybrid ferritin nanocage-based optical probe for tumor microenvironment imaging. Small 2013;9:2427-31. [PMID: 23853124 DOI: 10.1002/smll.201300600] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
402 Karkada M, Quinton T, Blackman R, Mansour M. Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration. ISRN Oncol 2013;2013:753427. [PMID: 23533812 DOI: 10.1155/2013/753427] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
403 Guo ZS, Parimi V, O'Malley ME, Thirunavukarasu P, Sathaiah M, Austin F, Bartlett DL. The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Gene Ther 2010;17:1465-75. [PMID: 20703311 DOI: 10.1038/gt.2010.104] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
404 Heusinkveld M, de Vos van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJP, van Hall T, van der Burg SH. M2 Macrophages Induced by Prostaglandin E 2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4 + Th1 Cells. J I 2011;187:1157-65. [DOI: 10.4049/jimmunol.1100889] [Cited by in Crossref: 238] [Cited by in F6Publishing: 229] [Article Influence: 21.6] [Reference Citation Analysis]
405 Liu M, Jiang L, Guan XY. The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell. 2014;5:673-691. [PMID: 24916440 DOI: 10.1007/s13238- 014-0065-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
406 Kawano Y, Moschetta M, Manier S, Glavey S, Görgün GT, Roccaro AM, Anderson KC, Ghobrial IM. Targeting the bone marrow microenvironment in multiple myeloma. Immunol Rev 2015;263:160-72. [PMID: 25510276 DOI: 10.1111/imr.12233] [Cited by in Crossref: 183] [Cited by in F6Publishing: 181] [Article Influence: 26.1] [Reference Citation Analysis]
407 Miller V, Lin A, Fridman A. Why Target Immune Cells for Plasma Treatment of Cancer. Plasma Chem Plasma Process 2016;36:259-68. [DOI: 10.1007/s11090-015-9676-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
408 Lee B, Konen J, Wilkinson S, Marcus AI, Jiang Y. Local alignment vectors reveal cancer cell-induced ECM fiber remodeling dynamics. Sci Rep 2017;7:39498. [PMID: 28045069 DOI: 10.1038/srep39498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
409 Paiva I, Gil da Costa RM, Ribeiro J, Sousa H, Bastos MM, Faustino-Rocha A, Lopes C, Oliveira PA, Medeiros R. MicroRNA-21 expression and susceptibility to HPV-induced carcinogenesis - role of microenvironment in K14-HPV16 mice model. Life Sci 2015;128:8-14. [PMID: 25771247 DOI: 10.1016/j.lfs.2015.02.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
410 Guo M, Sun T, Zhao Z, Ming L. Preoperative Platelet to Albumin Ratio Predicts Outcome of Patients with Non-Small-Cell Lung Cancer. Ann Thorac Cardiovasc Surg 2021;27:84-90. [PMID: 33162436 DOI: 10.5761/atcs.oa.20-00090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
411 Hapakova N, Sestakova Z, Holickova A, Hurbanova L, Miskovska V, Chovanec M, Rejlekova K, Svetlovska D, Kalavska K, Obertova J, Palacka P, Sycova-Mila Z, Mardiak J, Chovanec M, Mego M. High Endogenous DNA Damage Levels Predict Hematological Toxicity in Testicular Germ Cell Tumor Patients Treated With First-Line Chemotherapy. Clin Genitourin Cancer 2019;17:e1020-5. [PMID: 31281064 DOI: 10.1016/j.clgc.2019.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
412 Khadirnaikar S, Chatterjee A, Shukla SK. Genetic and Epigenetic landscape of leukocyte infiltration identifies an immune prognosticator in lung adenocarcinoma. Cancer Biomark 2021. [PMID: 34275893 DOI: 10.3233/CBM-203071] [Reference Citation Analysis]
413 Devkota L, Starosolski Z, Rivas CH, Stupin I, Annapragada A, Ghaghada KB, Parihar R. Detection of response to tumor microenvironment-targeted cellular immunotherapy using nano-radiomics. Sci Adv 2020;6:eaba6156. [PMID: 32832602 DOI: 10.1126/sciadv.aba6156] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
414 Hammerstrom AE, Cauley DH, Atkinson BJ, Sharma P. Cancer immunotherapy: sipuleucel-T and beyond. Pharmacotherapy 2011;31:813-28. [PMID: 21923608 DOI: 10.1592/phco.31.8.813] [Cited by in Crossref: 55] [Cited by in F6Publishing: 47] [Article Influence: 5.5] [Reference Citation Analysis]
415 Yang Y, Zhu W, Cheng L, Cai R, Yi X, He J, Pan X, Yang L, Yang K, Liu Z, Tan W, Chen M. Tumor microenvironment (TME)-activatable circular aptamer-PEG as an effective hierarchical-targeting molecular medicine for photodynamic therapy. Biomaterials 2020;246:119971. [DOI: 10.1016/j.biomaterials.2020.119971] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 11.5] [Reference Citation Analysis]
416 Findlay IJ, De Iuliis GN, Duchatel RJ, Jackson ER, Vitanza NA, Cain JE, Waszak SM, Dun MD. Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies. Oncogene 2021. [PMID: 34759345 DOI: 10.1038/s41388-021-02102-y] [Reference Citation Analysis]
417 Liu Y, Zhang J, Tu Y, Zhu L. Potential-Independent Intracellular Drug Delivery and Mitochondrial Targeting. ACS Nano 2021. [PMID: 34920667 DOI: 10.1021/acsnano.1c09456] [Reference Citation Analysis]
418 Cheng GM, To KK. Adverse Cell Culture Conditions Mimicking the Tumor Microenvironment Upregulate ABCG2 to Mediate Multidrug Resistance and a More Malignant Phenotype. ISRN Oncol 2012;2012:746025. [PMID: 22778999 DOI: 10.5402/2012/746025] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
419 Nariman-Saleh-Fam Z, Saadatian Z, Daraei A, Mansoori Y, Bastami M, Tavakkoli-Bazzaz J. The intricate role of miR-155 in carcinogenesis: potential implications for esophageal cancer research. Biomark Med 2019;13:147-59. [PMID: 30672305 DOI: 10.2217/bmm-2018-0127] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
420 Kitadai Y. Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol. 2010;2010:468725. [PMID: 20369064 DOI: 10.1155/2010/468725] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
421 Enderle L, Shalaby KH, Gorelik M, Weiss A, Blazer LL, Paduch M, Cardarelli L, Kossiakoff A, Adams JJ, Sidhu SS. A T cell redirection platform for co-targeting dual antigens on solid tumors. MAbs 2021;13:1933690. [PMID: 34190031 DOI: 10.1080/19420862.2021.1933690] [Reference Citation Analysis]
422 Dong X, Song J, Chen B, Qi Y, Jiang W, Li H, Zheng D, Wang Y, Zhang X, Liu H. Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma. Front Oncol 2020;10:592811. [PMID: 33718105 DOI: 10.3389/fonc.2020.592811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
423 Ozmen S, Timur O, Calik I, Altinkaynak K, Simsek E, Gozcu H, Arslan A, Carlioglu A. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer. Endocr Regul 2017;51:131-6. [PMID: 28858848 DOI: 10.1515/enr-2017-0013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
424 Chuang Y, Hung ME, Cangelose BK, Leonard JN. Regulation of the IL-10-driven macrophage phenotype under incoherent stimuli. Innate Immun 2016;22:647-57. [PMID: 27670945 DOI: 10.1177/1753425916668243] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
425 Das M, Law S. Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence. The International Journal of Biochemistry & Cell Biology 2018;103:115-24. [DOI: 10.1016/j.biocel.2018.08.011] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
426 Zhu W, Cai EL, Li HZ, Wang P, Shen AG, Popp J, Hu JM. Precise Encoding of Triple-Bond Raman Scattering of Single Polymer Nanoparticles for Multiplexed Imaging Application. Angew Chem Int Ed Engl 2021. [PMID: 34227191 DOI: 10.1002/anie.202106136] [Reference Citation Analysis]
427 Singh R, Alape D, de Lima A, Ascanio J, Majid A, Gangadharan SP. Regulatory T Cells in Respiratory Health and Diseases. Pulm Med 2019;2019:1907807. [PMID: 31827925 DOI: 10.1155/2019/1907807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
428 Alcolea MP. Oesophageal Stem Cells and Cancer. Adv Exp Med Biol 2017;1041:187-206. [PMID: 29204834 DOI: 10.1007/978-3-319-69194-7_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
429 Zhao Y, Rahmy S, Liu Z, Zhang C, Lu X. Rational targeting of immunosuppressive neutrophils in cancer. Pharmacol Ther 2020;212:107556. [PMID: 32343986 DOI: 10.1016/j.pharmthera.2020.107556] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
430 Giallongo C, Romano A, Parrinello NL, La Cava P, Brundo MV, Bramanti V, Stagno F, Vigneri P, Chiarenza A, Palumbo GA, Tibullo D, Di Raimondo F. Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients. PLoS One 2016;11:e0158392. [PMID: 27391078 DOI: 10.1371/journal.pone.0158392] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
431 Mittal S, Yeh K, Leslie LS, Kenkel S, Kajdacsy-Balla A, Bhargava R. Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology. Proc Natl Acad Sci U S A 2018;115:E5651-60. [PMID: 29866827 DOI: 10.1073/pnas.1719551115] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 14.5] [Reference Citation Analysis]
432 Krashin E, Ellis M, Cohen K, Viner M, Neumark E, Rashid G, Ashur-Fabian O. Chemical and thyroid hormone profile of the bone marrow interstitial fluid in hematologic disorders and patients without primary hematologic disorders. Hematol Oncol 2018;36:445-50. [PMID: 29380910 DOI: 10.1002/hon.2493] [Reference Citation Analysis]
433 Song S, Zhang K, You H, Wang J, Wang Z, Yan C, Liu F. Significant anti-tumour activity of adoptively transferred T cells elicited by intratumoral dendritic cell vaccine injection through enhancing the ratio of CD8(+) T cell/regulatory T cells in tumour. Clin Exp Immunol 2010;162:75-83. [PMID: 20735440 DOI: 10.1111/j.1365-2249.2010.04226.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
434 Gentile P, Garcovich S. Concise Review: Adipose-Derived Stem Cells (ASCs) and Adipocyte-Secreted Exosomal microRNA (A-SE-miR) Modulate Cancer Growth and proMote Wound Repair. J Clin Med. 2019;8. [PMID: 31208047 DOI: 10.3390/jcm8060855] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 18.7] [Reference Citation Analysis]
435 Kim S, Moon EK. Development of novel avenues to overcome challenges facing CAR T cells. Translational Research 2017;187:22-31. [DOI: 10.1016/j.trsl.2017.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
436 Zhao L, Xing Y, Wang R, Yu F, Yu F. Self-Assembled Nanomaterials for Enhanced Phototherapy of Cancer. ACS Appl Bio Mater 2020;3:86-106. [DOI: 10.1021/acsabm.9b00843] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
437 Kim BH, Yi EH, Ye SK. Signal transducer and activator of transcription 3 as a therapeutic target for cancer and the tumor microenvironment. Arch Pharm Res 2016;39:1085-99. [PMID: 27515050 DOI: 10.1007/s12272-016-0795-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
438 Chen YS, Huang TH, Liu CL, Chen HS, Lee MH, Chen HW, Shen CR. Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model. Hum Gene Ther 2019;30:273-85. [PMID: 30079767 DOI: 10.1089/hum.2018.104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
439 Wilson EB, El-Jawhari JJ, Neilson AL, Hall GD, Melcher AA, Meade JL, Cook GP. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS One 2011;6:e22842. [PMID: 21909397 DOI: 10.1371/journal.pone.0022842] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 8.9] [Reference Citation Analysis]
440 Fukushima H, Kobayashi M, Kawano K, Morimoto S. Effect of Preoperative Bacteriuria and Pyuria on Intravesical Recurrence in Patients with Upper Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy. In Vivo 2017;31:1215-20. [PMID: 29102949 DOI: 10.21873/invivo.11193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
441 Leibovici J, Itzhaki O, Huszar M, Sinai J. The tumor microenvironment: part 1. Immunotherapy 2011;3:1367-84. [DOI: 10.2217/imt.11.111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
442 Rezaei R, Esmaeili Gouvarchin Ghaleh H, Farzanehpour M, Dorostkar R, Ranjbar R, Bolandian M, Mirzaei Nodooshan M, Ghorbani Alvanegh A. Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy. Cancer Gene Ther 2021. [PMID: 34158626 DOI: 10.1038/s41417-021-00359-9] [Reference Citation Analysis]
443 Goncharenko-Khaider N, Matte I, Lane D, Rancourt C, Piché A. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Mol Cancer 2012;11:84. [PMID: 23158473 DOI: 10.1186/1476-4598-11-84] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
444 Morikawa R, Nemoto Y, Yonemoto Y, Tanaka S, Takei Y, Oshima S, Nagaishi T, Tsuchiya K, Nozaki K, Mizutani T, Nakamura T, Watanabe M, Okamoto R. Intraepithelial Lymphocytes Suppress Intestinal Tumor Growth by Cell-to-Cell Contact via CD103/E-Cadherin Signal. Cell Mol Gastroenterol Hepatol 2021;11:1483-503. [PMID: 33515805 DOI: 10.1016/j.jcmgh.2021.01.014] [Reference Citation Analysis]
445 Peterson EE, Barry KC. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy. Front Immunol 2020;11:621254. [PMID: 33613552 DOI: 10.3389/fimmu.2020.621254] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
446 Wen S, Hou Y, Fu L, Xi L, Yang D, Zhao M, Qin Y, Sun K, Teng Y, Liu M. Cancer-associated fibroblast (CAF)-derived IL32 promotes breast cancer cell invasion and metastasis via integrin β3-p38 MAPK signalling. Cancer Lett 2019;442:320-32. [PMID: 30391782 DOI: 10.1016/j.canlet.2018.10.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 57] [Article Influence: 11.5] [Reference Citation Analysis]
447 Molina ER, Chim LK, Barrios S, Ludwig JA, Mikos AG. Modeling the Tumor Microenvironment and Pathogenic Signaling in Bone Sarcoma. Tissue Eng Part B Rev 2020;26:249-71. [PMID: 32057288 DOI: 10.1089/ten.teb.2019.0302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
448 Sun J, Sun J, Song B, Zhang L, Shao Q, Liu Y, Yuan D, Zhang Y, Qu X. Fucoidan inhibits CCL22 production through NF-κB pathway in M2 macrophages: a potential therapeutic strategy for cancer. Sci Rep 2016;6:35855. [PMID: 27775051 DOI: 10.1038/srep35855] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
449 Vermeij R, Leffers N, van der Burg SH, Melief CJ, Daemen T, Nijman HW. Immunological and clinical effects of vaccines targeting p53-overexpressing malignancies. J Biomed Biotechnol 2011;2011:702146. [PMID: 21541192 DOI: 10.1155/2011/702146] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
450 Whiteside TL. Exosomes and tumor-mediated immune suppression. J Clin Invest. 2016;126:1216-1223. [PMID: 26927673 DOI: 10.1172/jci81136] [Cited by in Crossref: 251] [Cited by in F6Publishing: 188] [Article Influence: 41.8] [Reference Citation Analysis]
451 Kim JY, Park T, Jeong SH, Jeong CY, Ju YT, Lee YJ, Hong SC, Ha WS, Choi SK, Jung EJ. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine 2014;46:526-31. [PMID: 24272600 DOI: 10.1007/s12020-013-0089-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
452 Pham TH, Bak Y, Kwon T, Kwon SB, Oh JW, Park JH, Choi YK, Hong JT, Yoon DY. Interleukin-32θ inhibits tumor-promoting effects of macrophage-secreted CCL18 in breast cancer. Cell Commun Signal 2019;17:53. [PMID: 31126309 DOI: 10.1186/s12964-019-0374-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
453 Ramamoorthy P, Thomas SM, Kaushik G, Subramaniam D, Chastain KM, Dhar A, Tawfik O, Kasi A, Sun W, Ramalingam S, Gunewardena S, Umar S, Mammen JM, Padhye SB, Weir SJ, Jensen RA, Sittampalam GS, Anant S. Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response. Cancer Res 2019;79:1681-95. [PMID: 30674533 DOI: 10.1158/0008-5472.CAN-18-2602] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
454 Crinier A, Kerdiles Y, Vienne M, Cózar B, Vivier E, Berruyer C. Multidimensional molecular controls defining NK/ILC1 identity in cancers. Seminars in Immunology 2020. [DOI: 10.1016/j.smim.2020.101424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
455 Garon EB, Li DY. What Is on the Horizon for Novel Immunotherapies in Lung Cancer? Cancer J 2020;26:555-60. [PMID: 33298728 DOI: 10.1097/PPO.0000000000000486] [Reference Citation Analysis]
456 Kader A, Brangsch J, Kaufmann JO, Zhao J, Mangarova DB, Moeckel J, Adams LC, Sack I, Taupitz M, Hamm B, Makowski MR. Molecular MR Imaging of Prostate Cancer. Biomedicines 2020;9:1. [PMID: 33375045 DOI: 10.3390/biomedicines9010001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
457 Lu W, Lu L, Feng Y, Chen J, Li Y, Kong X, Chen S, Li X, Chen Q, Zhang P. Inflammation promotes oral squamous carcinoma immune evasion via induced programmed death ligand-1 surface expression. Oncol Lett 2013;5:1519-26. [PMID: 23761816 DOI: 10.3892/ol.2013.1238] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
458 Ng CF, Frieboes HB. Simulation of Multispecies Desmoplastic Cancer Growth via a Fully Adaptive Non-linear Full Multigrid Algorithm. Front Physiol 2018;9:821. [PMID: 30050447 DOI: 10.3389/fphys.2018.00821] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
459 Sun X, Nomoto T, Takemoto H, Matsui M, Guo H, Sun Y, Miura Y, Nishiyama N. Potential urinary monitoring of the enhanced permeability and retention effect using MMP-2-responsive poly(ethylene glycol) derivatives. Journal of Controlled Release 2021;329:513-23. [DOI: 10.1016/j.jconrel.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
460 Ma K, Li X, Lv J, Liu Z, Zhang L, Cong H, Wang H, Shen F, Yue L. Correlations between CD4+ FoxP3+ Treg and expression of FoxM1 and Ki-67 in gastric cancer patients. Asia Pac J Clin Oncol 2021;17:e63-9. [PMID: 31957250 DOI: 10.1111/ajco.13302] [Reference Citation Analysis]
461 Li Y, Qi W, Song X, Lv S, Zhang H, Yang Q. Huaier extract suppresses breast cancer via regulating tumor-associated macrophages. Sci Rep 2016;6:20049. [PMID: 26831282 DOI: 10.1038/srep20049] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
462 Erez N, Truitt M, Olson P, Hanahan D. Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent Manner. Cancer Cell 2010;17:135-47. [DOI: 10.1016/j.ccr.2009.12.041] [Cited by in Crossref: 935] [Cited by in F6Publishing: 935] [Article Influence: 77.9] [Reference Citation Analysis]
463 Mills MN, Figura NB, Arrington JA, Yu HM, Etame AB, Vogelbaum MA, Soliman H, Czerniecki BJ, Forsyth PA, Han HS, Ahmed KA. Management of brain metastases in breast cancer: a review of current practices and emerging treatments. Breast Cancer Res Treat 2020;180:279-300. [PMID: 32030570 DOI: 10.1007/s10549-020-05552-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
464 Schättler H, Ledzewicz U, Amini B. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy. J Math Biol 2016;72:1255-80. [DOI: 10.1007/s00285-015-0907-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
465 Kim A, Ma JY. Isoliquiritin Apioside Suppresses in vitro Invasiveness and Angiogenesis of Cancer Cells and Endothelial Cells. Front Pharmacol 2018;9:1455. [PMID: 30618749 DOI: 10.3389/fphar.2018.01455] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
466 Lavanya V, Bommanabonia AK, Ahmed N, Jamal S. Immunomodulatory Effects of Jacalin, a Dietary Plant Lectin on the Peripheral Blood Mononuclear Cells (PBMCs). Appl Biochem Biotechnol 2021. [PMID: 34709568 DOI: 10.1007/s12010-021-03722-6] [Reference Citation Analysis]
467 Wilcox RA, Wada DA, Ziesmer SC, Elsawa SF, Comfere NI, Dietz AB, Novak AJ, Witzig TE, Feldman AL, Pittelkow MR, Ansell SM. Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells. Blood. 2009;114:2936-2944. [PMID: 19671921 DOI: 10.1182/blood-2009-05-220111] [Cited by in Crossref: 105] [Cited by in F6Publishing: 103] [Article Influence: 8.1] [Reference Citation Analysis]
468 Li X, Wang S, Zhu R, Li H, Han Q, Zhao RC. Lung tumor exosomes induce a pro-inflammatory phenotype in mesenchymal stem cells via NFκB-TLR signaling pathway. J Hematol Oncol 2016;9:42. [PMID: 27090786 DOI: 10.1186/s13045-016-0269-y] [Cited by in Crossref: 99] [Cited by in F6Publishing: 108] [Article Influence: 16.5] [Reference Citation Analysis]
469 Paladini L, Fabris L, Bottai G, Raschioni C, Calin GA, Santarpia L. Targeting microRNAs as key modulators of tumor immune response. J Exp Clin Cancer Res 2016;35:103. [PMID: 27349385 DOI: 10.1186/s13046-016-0375-2] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 16.5] [Reference Citation Analysis]
470 Zayed AA, Mandrekar SJ, Haluska P. Molecular and clinical implementations of ovarian cancer mouse avatar models. Chin Clin Oncol 2015;4:30. [PMID: 26408297 DOI: 10.3978/j.issn.2304-3865.2015.04.01] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
471 Liu W, Jiang D, Gong F, Huang Y, Luo Y, Rong Y, Wang J, Ge X, Ji C, Fan J, Cai W. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells. Cell Death Dis 2020;11:93. [PMID: 32024814 DOI: 10.1038/s41419-020-2270-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
472 Shi X, Hou M, Ma X, Bai S, Zhang T, Xue P, Zhang X, Liu G, Kang Y, Xu Z. Starburst Diblock Polyprodrugs: Reduction-Responsive Unimolecular Micelles with High Drug Loading and Robust Micellar Stability for Programmed Delivery of Anticancer Drugs. Biomacromolecules 2019;20:1190-202. [PMID: 30658038 DOI: 10.1021/acs.biomac.8b01566] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
473 Scioli MG, Storti G, D'Amico F, Gentile P, Kim BS, Cervelli V, Orlandi A. Adipose-Derived Stem Cells in Cancer Progression: New Perspectives and Opportunities. Int J Mol Sci 2019;20:E3296. [PMID: 31277510 DOI: 10.3390/ijms20133296] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
474 Liu P, Atkinson SJ, Akbareian SE, Zhou Z, Munsterberg A, Robinson SD, Bao Y. Sulforaphane exerts anti-angiogenesis effects against hepatocellular carcinoma through inhibition of STAT3/HIF-1α/VEGF signalling. Sci Rep 2017;7:12651. [PMID: 28978924 DOI: 10.1038/s41598-017-12855-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
475 Yu JS, Bagheri N. Modular microenvironment components reproduce vascular dynamics de novo in a multi-scale agent-based model. Cell Syst 2021;12:795-809.e9. [PMID: 34139155 DOI: 10.1016/j.cels.2021.05.007] [Reference Citation Analysis]
476 Espinoza JA, Jabeen S, Batra R, Papaleo E, Haakensen V, Timmermans Wielenga V, Møller Talman ML, Brunner N, Børresen-Dale AL, Gromov P, Helland Å, Kristensen VN, Gromova I. Cytokine profiling of tumor interstitial fluid of the breast and its relationship with lymphocyte infiltration and clinicopathological characteristics. Oncoimmunology 2016;5:e1248015. [PMID: 28123884 DOI: 10.1080/2162402X.2016.1248015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
477 Krstic J, Santibanez JF. Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. ScientificWorldJournal 2014;2014:521754. [PMID: 24578639 DOI: 10.1155/2014/521754] [Cited by in Crossref: 82] [Cited by in F6Publishing: 85] [Article Influence: 10.3] [Reference Citation Analysis]
478 Zhou RR, Fan XG. Role of alarmins in the pathogenesis of primary hepatic carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(13): 1326-1330 [DOI: 10.11569/wcjd.v19.i13.1326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
479 He Q, Xue S, Wa Q, He M, Feng S, Chen Z, Chen W, Luo X. Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma. Medicine (Baltimore) 2021;100:e25715. [PMID: 33907159 DOI: 10.1097/MD.0000000000025715] [Reference Citation Analysis]
480 Montes P, Kerick M, Bernal M, Hernández F, Jiménez P, Garrido P, Márquez A, Jurado M, Martin J, Garrido F, Ruiz-Cabello F. Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients. Oncotarget 2018;9:36929-44. [PMID: 30651926 DOI: 10.18632/oncotarget.26405] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
481 Halvorsen EC, Mahmoud SM, Bennewith KL. Emerging roles of regulatory T cells in tumour progression and metastasis. Cancer Metastasis Rev 2014;33:1025-41. [PMID: 25359584 DOI: 10.1007/s10555-014-9529-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
482 Adjei IM, Blanka S. Modulation of the tumor microenvironment for cancer treatment: a biomaterials approach. J Funct Biomater 2015;6:81-103. [PMID: 25695337 DOI: 10.3390/jfb6010081] [Cited by in Crossref: 65] [Cited by in F6Publishing: 52] [Article Influence: 9.3] [Reference Citation Analysis]
483 DiNatale RG, Hakimi AA, Chan TA. Genomics-based immuno-oncology: bridging the gap between immunology and tumor biology. Hum Mol Genet 2020;29:R214-25. [PMID: 33029628 DOI: 10.1093/hmg/ddaa203] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
484 Behrouzfar K, Burton K, Mutsaers SE, Morahan G, Lake RA, Fisher SA. How to Better Understand the Influence of Host Genetics on Developing an Effective Immune Response to Thoracic Cancers. Front Oncol 2021;11:679609. [PMID: 34235080 DOI: 10.3389/fonc.2021.679609] [Reference Citation Analysis]
485 Haehnel S, Reiche K, Loeffler D, Horn A, Blumert C, Puppel SH, Kaiser N, Rapp F, Rade M, Horn F, Meixensberger J, Bechmann I, Gaunitz F, Winter K. Deep sequencing and automated histochemistry of human tissue slice cultures improve their usability as preclinical model for cancer research. Sci Rep 2019;9:19961. [PMID: 31882946 DOI: 10.1038/s41598-019-56509-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
486 Wang K, Zhang H, Shen A, Zhao P, Meng X, Chen X, Liu Y, Liu Y, Gong T, Wu W, Fang X, Wang P, Bu W. Magnetic resonance energy transfer for in vivo glutathione susceptibility weighted imaging. Biomaterials 2020;232:119703. [PMID: 31901504 DOI: 10.1016/j.biomaterials.2019.119703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
487 Jung YH, Choi DH, Park K, Lee SB, Kim J, Kim H, Jeong HW, Yang JH, Kim JA, Chung S, Min BS. Drug screening by uniform patient derived colorectal cancer hydro-organoids. Biomaterials 2021;276:121004. [PMID: 34273688 DOI: 10.1016/j.biomaterials.2021.121004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
488 Wang X, Sun X, Mu L, Chen W. Cancer-Associated Fibroblasts Induce Epithelial-Mesenchymal Transition in Endometrial Cancer Cells by Regulating Pituitary Tumor Transforming Gene. Cancer Investigation 2019;37:134-43. [DOI: 10.1080/07357907.2019.1575969] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
489 Zhong QY, Fan EX, Feng GY, Chen QY, Gou XX, Yue GJ, Zhang GH. A gene expression-based study on immune cell subtypes and glioma prognosis. BMC Cancer 2019;19:1116. [PMID: 31729963 DOI: 10.1186/s12885-019-6324-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
490 Tai YL, Chen LC, Shen TL. Emerging roles of focal adhesion kinase in cancer. Biomed Res Int. 2015;2015:690690. [PMID: 25918719 DOI: 10.1155/2015/690690] [Cited by in Crossref: 89] [Cited by in F6Publishing: 104] [Article Influence: 12.7] [Reference Citation Analysis]
491 Alhamarneh O, Agada F, Madden L, Stafford N, Greenman J. Serum IL10 and circulating CD4(+) CD25(high) regulatory T cell numbers as predictors of clinical outcome and survival in patients with head and neck squamous cell carcinoma. Head Neck 2011;33:415-23. [PMID: 20645289 DOI: 10.1002/hed.21464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 20] [Article Influence: 0.7] [Reference Citation Analysis]
492 Stephens AJ, Burgess-Brown NA, Jiang S. Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines. Front Immunol 2021;12:696791. [PMID: 34276688 DOI: 10.3389/fimmu.2021.696791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
493 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]
494 Dong X, Chu D, Wang Z. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites. Theranostics 2017;7:751-63. [PMID: 28255364 DOI: 10.7150/thno.18069] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 12.4] [Reference Citation Analysis]
495 Brocato T, Dogra P, Koay EJ, Day A, Chuang YL, Wang Z, Cristini V. Understanding Drug Resistance in Breast Cancer with Mathematical Oncology. Curr Breast Cancer Rep 2014;6:110-20. [PMID: 24891927 DOI: 10.1007/s12609-014-0143-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
496 Spector I, Zilberstein Y, Lavy A, Nagler A, Genin O, Pines M. Involvement of host stroma cells and tissue fibrosis in pancreatic tumor development in transgenic mice. PLoS One. 2012;7:e41833. [PMID: 22848627 DOI: 10.1371/journal.pone.0041833] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
497 Marin-Acevedo JA, Kimbrough EO, Manochakian R, Zhao Y, Lou Y. Immunotherapies targeting stimulatory pathways and beyond. J Hematol Oncol 2021;14:78. [PMID: 33980266 DOI: 10.1186/s13045-021-01085-3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
498 Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nat Rev Cancer. 2013;13:739-752. [PMID: 24060865 DOI: 10.1038/nrc3581] [Cited by in Crossref: 671] [Cited by in F6Publishing: 656] [Article Influence: 74.6] [Reference Citation Analysis]
499 Wang Y, Weng Y, Shi Y, Xia X, Wang S, Duan H. Expression and functional analysis of Toll-like receptor 4 in human cervical carcinoma. J Membr Biol 2014;247:591-9. [PMID: 24878539 DOI: 10.1007/s00232-014-9675-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
500 Mintz J, Vedenko A, Rosete O, Shah K, Goldstein G, Hare JM, Ramasamy R, Arora H. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. Vaccines (Basel) 2021;9:94. [PMID: 33513777 DOI: 10.3390/vaccines9020094] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
501 Sleeman JP. The lymph node pre-metastatic niche. J Mol Med (Berl) 2015;93:1173-84. [PMID: 26489604 DOI: 10.1007/s00109-015-1351-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
502 Mercier J, Voutsadakis IA. The platelets-neutrophils to lymphocytes ratio: a new prognostic marker in metastatic colorectal cancer. J Gastrointest Oncol 2018;9:478-86. [PMID: 29998013 DOI: 10.21037/jgo.2018.03.13] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
503 Perdicchio M, Cornelissen LA, Streng-Ouwehand I, Engels S, Verstege MI, Boon L, Geerts D, van Kooyk Y, Unger WW. Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells. Oncotarget 2016;7:8771-82. [PMID: 26741508 DOI: 10.18632/oncotarget.6822] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 8.2] [Reference Citation Analysis]
504 Huang W, Luo S, Burgess R, Yi YH, Huang GF, Huang RP. New Insights into the Tumor Microenvironment Utilizing Protein Array Technology. Int J Mol Sci 2018;19:E559. [PMID: 29438283 DOI: 10.3390/ijms19020559] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
505 Landskron G, De la Fuente López M, Dubois-Camacho K, Díaz-Jiménez D, Orellana-Serradell O, Romero D, Sepúlveda SA, Salazar C, Parada-Venegas D, Quera R, Simian D, González MJ, López-Köstner F, Kronberg U, Abedrapo M, Gallegos I, Contreras HR, Peña C, Díaz-Araya G, Roa JC, Hermoso MA. Interleukin 33/ST2 Axis Components Are Associated to Desmoplasia, a Metastasis-Related Factor in Colorectal Cancer. Front Immunol 2019;10:1394. [PMID: 31281317 DOI: 10.3389/fimmu.2019.01394] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
506 Zulueta A, Colombo M, Peli V, Falleni M, Tosi D, Ricciardi M, Baisi A, Bulfamante G, Chiaramonte R, Caretti A. Lung mesenchymal stem cells-derived extracellular vesicles attenuate the inflammatory profile of Cystic Fibrosis epithelial cells. Cell Signal 2018;51:110-8. [PMID: 30076968 DOI: 10.1016/j.cellsig.2018.07.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
507 Chen X, Tian F, Lun P, Feng Y. Profiles of immune infiltration and its relevance to survival outcome in meningiomas. Biosci Rep 2020;40:BSR20200538. [PMID: 32378707 DOI: 10.1042/BSR20200538] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
508 Noguera NI, Hasan SK, Ammatuna E, Venditti A. Editorial: Metabolic Rewiring in Leukemias. Front Oncol 2021;11:775167. [PMID: 34692556 DOI: 10.3389/fonc.2021.775167] [Reference Citation Analysis]
509 Asmamaw MD, Liu Y, Zheng YC, Shi XJ, Liu HM. Skp2 in the ubiquitin-proteasome system: A comprehensive review. Med Res Rev 2020;40:1920-49. [PMID: 32391596 DOI: 10.1002/med.21675] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
510 Deng Z, Wang N, Ai F, Wang Z, Zhu G. Nanomaterial‐mediated platinum drug‐based combinatorial cancer therapy. View 2021;2:20200030. [DOI: 10.1002/viw.20200030] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
511 Wu Y, Zhou Y, Qin X, Liu Y. From cell spheroids to vascularized cancer organoids: Microfluidic tumor-on-a-chip models for preclinical drug evaluations. Biomicrofluidics 2021;15:061503. [PMID: 34804315 DOI: 10.1063/5.0062697] [Reference Citation Analysis]
512 Spyridopoulou K, Aindelis G, Lampri E, Giorgalli M, Lamprianidou E, Kotsianidis I, Tsingotjidou A, Pappa A, Kalogirou O, Chlichlia K. Improving the Subcutaneous Mouse Tumor Model by Effective Manipulation of Magnetic Nanoparticles-Treated Implanted Cancer Cells. Ann Biomed Eng 2018;46:1975-87. [PMID: 30076502 DOI: 10.1007/s10439-018-2107-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
513 Chalbatani GM, Momeni SA, Mohammadi Hadloo MH, Karimi Z, Hadizadeh M, Jalali SA, Miri SR, Memari F, Hamblin MR. Comprehensive analysis of ceRNA networks to determine genes related to prognosis, overall survival, and immune infiltration in clear cell renal carcinoma. Comput Biol Med 2021;:105043. [PMID: 34839901 DOI: 10.1016/j.compbiomed.2021.105043] [Reference Citation Analysis]
514 Eubel J, Enk AH. Dendritic cell vaccination as a treatment modality for melanoma. Expert Rev Anticancer Ther 2009;9:1631-42. [PMID: 19895246 DOI: 10.1586/era.09.139] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
515 Jászai J, Schmidt MHH. Trends and Challenges in Tumor Anti-Angiogenic Therapies. Cells 2019;8:E1102. [PMID: 31540455 DOI: 10.3390/cells8091102] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 18.7] [Reference Citation Analysis]
516 Rettori MM, de Carvalho AC, Bomfim Longo AL, de Oliveira CZ, Kowalski LP, Carvalho AL, Vettore AL. Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis 2013;34:20-7. [PMID: 23042095 DOI: 10.1093/carcin/bgs311] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.0] [Reference Citation Analysis]
517 Cong X, Chen J, Xu R. Tumor-Acidity Responsive Polymeric Nanoparticles for Targeting Delivery of Angiogenesis Inhibitor for Enhanced Antitumor Efficacy With Decreased Toxicity. Front Bioeng Biotechnol 2021;9:664051. [PMID: 33842451 DOI: 10.3389/fbioe.2021.664051] [Reference Citation Analysis]
518 Shibuki T, Mizuta T, Shimokawa M, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Fukahori M, Makiyama A, Taguchi H, Honda T, Mitsugi K, Nio K, Ide Y, Ureshino N, Shirakawa T, Otsuka T. Prognostic nomogram for patients with unresectable pancreatic cancer treated with gemcitabine plus nab-paclitaxel or FOLFIRINOX: A post-hoc analysis of a multicenter retrospective study in Japan (NAPOLEON study). BMC Cancer 2022;22:19. [PMID: 34980029 DOI: 10.1186/s12885-021-09139-y] [Reference Citation Analysis]
519 Delom F, Nazaraliyev A, Fessart D. The role of protein disulphide isomerase AGR2 in the tumour niche: AGR2, tumour microenvironment and chemoresistance. Biol Cell 2018;110:271-82. [DOI: 10.1111/boc.201800024] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
520 Basmaeil Y, Al Subayyil A, Abumaree M, Khatlani T. Conditions Mimicking the Cancer Microenvironment Modulate the Functional Outcome of Human Chorionic Villus Mesenchymal Stem/Stromal Cells in vitro. Front Cell Dev Biol 2021;9:650125. [PMID: 34235143 DOI: 10.3389/fcell.2021.650125] [Reference Citation Analysis]
521 Strong AD, Indart MC, Hill NR, Daniels RL. GL261 glioma tumor cells respond to ATP with an intracellular calcium rise and glutamate release. Mol Cell Biochem 2018;446:53-62. [PMID: 29318454 DOI: 10.1007/s11010-018-3272-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
522 Cohen G, Chandran P, Lorsung RM, Aydin O, Tomlinson LE, Rosenblatt RB, Burks SR, Frank JA. Pulsed-Focused Ultrasound Slows B16 Melanoma and 4T1 Breast Tumor Growth through Differential Tumor Microenvironmental Changes. Cancers (Basel) 2021;13:1546. [PMID: 33801627 DOI: 10.3390/cancers13071546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
523 Zhang W, Wu H, Li Z. Complete deconvolution of DNA methylation signals from complex tissues: a geometric approach. Bioinformatics 2021;37:1052-9. [PMID: 33135072 DOI: 10.1093/bioinformatics/btaa930] [Reference Citation Analysis]
524 Li W, Yue W, Wang H, Lai B, Yang X, Zhang C, Wang Y, Gu M. Cyclooxygenase-2 is associated with malignant phenotypes in human lung cancer. Oncol Lett 2016;12:3836-44. [PMID: 27895738 DOI: 10.3892/ol.2016.5207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
525 Toor SM, Sasidharan Nair V, Saleh R, Taha RZ, Murshed K, Al-Dhaheri M, Khawar M, Ahmed AA, Kurer MA, Abu Nada M, Elkord E. Transcriptome of Tumor-Infiltrating T Cells in Colorectal Cancer Patients Uncovered a Unique Gene Signature in CD4+ T Cells Associated with Poor Disease-Specific Survival. Vaccines (Basel) 2021;9:334. [PMID: 33916009 DOI: 10.3390/vaccines9040334] [Reference Citation Analysis]
526 Li Z, Kang Y. Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther 2016;161:79-96. [PMID: 27000769 DOI: 10.1016/j.pharmthera.2016.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
527 Christie JR, Lang P, Zelko LM, Palma DA, Abdelrazek M, Mattonen SA. Artificial Intelligence in Lung Cancer: Bridging the Gap Between Computational Power and Clinical Decision-Making. Can Assoc Radiol J. 2021;72:86-97. [PMID: 32735493 DOI: 10.1177/0846537120941434] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
528 Liu Q, Zhang A, Wang R, Zhang Q, Cui D. A Review on Metal- and Metal Oxide-Based Nanozymes: Properties, Mechanisms, and Applications. Nanomicro Lett 2021;13:154. [PMID: 34241715 DOI: 10.1007/s40820-021-00674-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
529 Serr I, Kral M, Scherm MG, Daniel C. Advances in Human Immune System Mouse Models for Personalized Treg-Based Immunotherapies. Front Immunol 2021;12:643544. [PMID: 33679808 DOI: 10.3389/fimmu.2021.643544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
530 Sivakumar H, Strowd R, Skardal A. Exploration of Dynamic Elastic Modulus Changes on Glioblastoma Cell Populations with Aberrant EGFR Expression as a Potential Therapeutic Intervention Using a Tunable Hyaluronic Acid Hydrogel Platform. Gels 2017;3:E28. [PMID: 30920523 DOI: 10.3390/gels3030028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
531 Diwanji N, Bergmann A. Two Sides of the Same Coin - Compensatory Proliferation in Regeneration and Cancer. Adv Exp Med Biol 2019;1167:65-85. [PMID: 31520349 DOI: 10.1007/978-3-030-23629-8_4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
532 Gong ZY, Kidoya H, Mohri T, Han Y, Takakura N. DNA damage enhanced by the attenuation of SLD5 delays cell cycle restoration in normal cells but not in cancer cells. PLoS One 2014;9:e110483. [PMID: 25334017 DOI: 10.1371/journal.pone.0110483] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
533 Kunze MM, Benz F, Brauß TF, Lampe S, Weigand JE, Braun J, Richter FM, Wittig I, Brüne B, Schmid T. sST2 translation is regulated by FGF2 via an hnRNP A1-mediated IRES-dependent mechanism. Biochim Biophys Acta 2016;1859:848-59. [PMID: 27168114 DOI: 10.1016/j.bbagrm.2016.05.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
534 Onoyama M, Kitadai Y, Tanaka Y, Yuge R, Shinagawa K, Tanaka S, Yasui W, Chayama K. Combining molecular targeted drugs to inhibit both cancer cells and activated stromal cells in gastric cancer. Neoplasia 2013;15:1391-9. [PMID: 24403861 DOI: 10.1593/neo.131668] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
535 Morad G, Moses MA. Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment. J Extracell Vesicles 2019;8:1627164. [PMID: 31275532 DOI: 10.1080/20013078.2019.1627164] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
536 Kwon CH, Moon HJ, Park HJ, Choi JH, Park do Y. S100A8 and S100A9 promotes invasion and migration through p38 mitogen-activated protein kinase-dependent NF-κB activation in gastric cancer cells. Mol Cells. 2013;35:226-234. [PMID: 23456298 DOI: 10.1007/s10059-013-2269-x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 8.0] [Reference Citation Analysis]
537 Forterre A, Komuro H, Aminova S, Harada M. A Comprehensive Review of Cancer MicroRNA Therapeutic Delivery Strategies. Cancers (Basel) 2020;12:E1852. [PMID: 32660045 DOI: 10.3390/cancers12071852] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 16.5] [Reference Citation Analysis]
538 Zhang J, Chen L, Zhou R, Sun H, Liao Y, Liao W. Pretreatment Lymphocyte Monocyte Ratio Predicts Long-Term Outcomes in Patients with Digestive System Tumor: A Meta-Analysis. Gastroenterol Res Pract 2016;2016:9801063. [PMID: 27594882 DOI: 10.1155/2016/9801063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
539 Mordant P, Loriot Y, Lahon B, Castier Y, Lesèche G, Soria JC, Vozenin MC, Decraene C, Deutsch E. Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells. PLoS One 2011;6:e26073. [PMID: 22022511 DOI: 10.1371/journal.pone.0026073] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
540 Thakkar S, Sharma D, Kalia K, Tekade RK. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review. Acta Biomaterialia 2020;101:43-68. [DOI: 10.1016/j.actbio.2019.09.009] [Cited by in Crossref: 88] [Cited by in F6Publishing: 71] [Article Influence: 44.0] [Reference Citation Analysis]
541 Maher SG, Reynolds JV. Basic Concepts of Inflammation and its Role in Carcinogenesis. In: Jankowski JAZ, editor. Inflammation and Gastrointestinal Cancers. Berlin: Springer Berlin Heidelberg; 2011. pp. 1-34. [DOI: 10.1007/978-3-642-03503-6_1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
542 van Pijkeren JP, Morrissey D, Monk IR, Cronin M, Rajendran S, O'Sullivan GC, Gahan CG, Tangney M. A novel Listeria monocytogenes-based DNA delivery system for cancer gene therapy. Hum Gene Ther 2010;21:405-16. [PMID: 20105075 DOI: 10.1089/hum.2009.022] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
543 Vitale G, Carra S, Ferraù F, Guadagno E, Faggiano A, Colao A; NIKE. Gastroenteropancreatic neuroendocrine neoplasms and inflammation: A complex cross-talk with relevant clinical implications. Crit Rev Oncol Hematol 2020;146:102840. [PMID: 31918344 DOI: 10.1016/j.critrevonc.2019.102840] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
544 Jarvis C, Nelius T, Martinez-Marin D, Sennoune SR, Filleur S. Cabazitaxel regimens inhibit the growth of prostate cancer cells and enhances the anti-tumor properties of PEDF with various efficacy and toxicity. Prostate 2018;78:905-14. [PMID: 29749077 DOI: 10.1002/pros.23647] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
545 Izzi V, Lakkala J, Devarajan R, Kääriäinen A, Koivunen J, Heljasvaara R, Pihlajaniemi T. Pan-Cancer analysis of the expression and regulation of matrisome genes across 32 tumor types. Matrix Biol Plus 2019;1:100004. [PMID: 33543003 DOI: 10.1016/j.mbplus.2019.04.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 7.7] [Reference Citation Analysis]
546 Khan S, Anwar N. Gelatin/carboxymethyl cellulose based stimuli-responsive hydrogels for controlled delivery of 5-fluorouracil, development, in vitro characterization, in vivo safety and bioavailability evaluation. Carbohydr Polym 2021;257:117617. [PMID: 33541645 DOI: 10.1016/j.carbpol.2021.117617] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
547 McNamara G, Lucas J, Beeler JF, Basavanhally A, Lee G, Hedvat CV, Baxi VA, Locke D, Borowsky A, Levenson R. New Technologies to Image Tumors. Cancer Treat Res 2020;180:51-94. [PMID: 32215866 DOI: 10.1007/978-3-030-38862-1_2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
548 Kakarla M, ChallaSivaKanaka S, Hayward SW, Franco OE. Race as a Contributor to Stromal Modulation of Tumor Progression. Cancers (Basel) 2021;13:2656. [PMID: 34071280 DOI: 10.3390/cancers13112656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
549 Chen Y, Jung S, Zhang Z, Wicha MS, Yoon E. Co-culture of functionally enriched cancer stem-like cells and cancer-associated fibroblasts for single-cell whole transcriptome analysis. Integrative Biology 2019;11:353-61. [DOI: 10.1093/intbio/zyz029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
550 Benevides L, Cardoso CR, Tiezzi DG, Marana HR, Andrade JM, Silva JS. Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor. Eur J Immunol. 2013;43:1518-1528. [PMID: 23529839 DOI: 10.1002/eji.201242951] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 6.6] [Reference Citation Analysis]
551 Wu X, Hu W, Lu L, Zhao Y, Zhou Y, Xiao Z, Zhang L, Zhang H, Li X, Li W, Wang S, Cho CH, Shen J, Li M. Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment.Acta Pharm Sin B. 2019;9:203-219. [PMID: 30972274 DOI: 10.1016/j.apsb.2018.09.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
552 Jutzy JM, Khan S, Asuncion-Valenzuela MM, Milford TA, Payne KJ, Wall NR. Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro. Cancer Microenviron 2013;6:57-68. [PMID: 22322461 DOI: 10.1007/s12307-012-0096-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
553 Voynov V, Adam PJ, Nixon AE, Scheer JM. Discovery Strategies to Maximize the Clinical Potential of T-Cell Engaging Antibodies for the Treatment of Solid Tumors. Antibodies (Basel) 2020;9:E65. [PMID: 33217946 DOI: 10.3390/antib9040065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
554 Salvatore V, Focaroli S, Teti G, Mazzotti A, Falconi M. Changes in the gene expression of co-cultured human fibroblast cells and osteosarcoma cells: the role of microenvironment. Oncotarget 2015;6:28988-98. [PMID: 26418748 DOI: 10.18632/oncotarget.4902] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
555 Cohen G, Chandran P, Lorsung RM, Tomlinson LE, Sundby M, Burks SR, Frank JA. The Impact of Focused Ultrasound in Two Tumor Models: Temporal Alterations in the Natural History on Tumor Microenvironment and Immune Cell Response. Cancers (Basel) 2020;12:E350. [PMID: 32033171 DOI: 10.3390/cancers12020350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
556 Wu K, Xing F, Wu SY, Watabe K. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside. Biochim Biophys Acta Rev Cancer 2017;1868:538-63. [PMID: 29054476 DOI: 10.1016/j.bbcan.2017.10.001] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 11.2] [Reference Citation Analysis]
557 Yan S, Wan G. Tumor-associated macrophages in immunotherapy. FEBS J 2021;288:6174-86. [PMID: 33492779 DOI: 10.1111/febs.15726] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
558 Yi J, Cheng C, Li X, Zhao H, Qu H, Wang Z, Wang L. Protective mechanisms of purified polyphenols from pinecones of Pinus koraiensis on spleen tissues in tumor-bearing S180 mice in vivo. Food Funct 2017;8:151-66. [DOI: 10.1039/c6fo01235c] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
559 Li BL, Lu W, Qu JJ, Ye L, Du GQ, Wan XP. Loss of exosomal miR-148b from cancer-associated fibroblasts promotes endometrial cancer cell invasion and cancer metastasis. J Cell Physiol 2019;234:2943-53. [PMID: 30146796 DOI: 10.1002/jcp.27111] [Cited by in Crossref: 49] [Cited by in F6Publishing: 54] [Article Influence: 12.3] [Reference Citation Analysis]
560 Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009;11:615-28. [PMID: 19568407 DOI: 10.1593/neo.09284] [Cited by in Crossref: 178] [Cited by in F6Publishing: 176] [Article Influence: 13.7] [Reference Citation Analysis]
561 Choudhury B, Srivastava S, Choudhury HH, Purkayastha A, Duttagupta S, Ghosh SK. Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India. Tumor Biol 2014;35:6739-48. [DOI: 10.1007/s13277-014-1851-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
562 Kareva I. What can ecology teach us about cancer? Transl Oncol 2011;4:266-70. [PMID: 21966543 DOI: 10.1593/tlo.11154] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
563 Kawahara R, Lima RN, Domingues RR, Pauletti BA, Meirelles GV, Assis M, Figueira ACM, Leme AFP. Deciphering the Role of the ADAM17-Dependent Secretome in Cell Signaling. J Proteome Res 2014;13:2080-93. [DOI: 10.1021/pr401224u] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
564 [DOI: 10.1101/053058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
565 Deng B, Zhu JM, Wang Y, Liu TT, Ding YB, Xiao WM, Lu GT, Bo P, Shen XZ. Intratumor hypoxia promotes immune tolerance by inducing regulatory T cells via TGF-β1 in gastric cancer. PLoS One 2013;8:e63777. [PMID: 23723999 DOI: 10.1371/journal.pone.0063777] [Cited by in Crossref: 57] [Cited by in F6Publishing: 65] [Article Influence: 6.3] [Reference Citation Analysis]
566 Kumari S, Advani D, Sharma S, Ambasta RK, Kumar P. Combinatorial therapy in tumor microenvironment: Where do we stand? Biochim Biophys Acta Rev Cancer 2021;1876:188585. [PMID: 34224836 DOI: 10.1016/j.bbcan.2021.188585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
567 Park JI, Kim KS, Kong SY, Park KS. Novel function of E26 transformation-specific domain-containing protein ELK3 in lymphatic endothelial cells. Oncol Lett 2018;15:55-60. [PMID: 29375705 DOI: 10.3892/ol.2017.7308] [Reference Citation Analysis]
568 Sineh Sepehr K, Razavi A, Saeidi M, Mossahebi-Mohammadi M, Abdollahpour-Alitappeh M, Hashemi SM. Development of a novel explant culture method for the isolation of mesenchymal stem cells from human breast tumor. J Immunoassay Immunochem 2018;39:207-17. [PMID: 29741994 DOI: 10.1080/15321819.2018.1447487] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
569 Ahmadi M, Rezaie J. Tumor cells derived-exosomes as angiogenenic agents: possible therapeutic implications. J Transl Med 2020;18:249. [PMID: 32571337 DOI: 10.1186/s12967-020-02426-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
570 Yaghoubi A, Khazaei M, Hasanian SM, Avan A, Cho WC, Soleimanpour S. Bacteriotherapy in Breast Cancer. Int J Mol Sci 2019;20:E5880. [PMID: 31771178 DOI: 10.3390/ijms20235880] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
571 Higashi M, Tokuhira M, Fujino S, Yamashita T, Abe K, Arai E, Kizaki M, Tamaru J. Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma. Leukemia & Lymphoma 2015;57:161-6. [DOI: 10.3109/10428194.2015.1038708] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
572 Sippel TR, Johnson AM, Li HY, Hanson D, Nguyen TT, Bullock BL, Poczobutt JM, Kwak JW, Kleczko EK, Weiser-Evans MC, Nemenoff RA. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1. Mol Cancer Res 2019;17:1748-58. [PMID: 31088909 DOI: 10.1158/1541-7786.MCR-19-0236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
573 Huo J, Wu L, Zang Y. Development and Validation of a Robust Immune-Related Prognostic Signature for Gastric Cancer. J Immunol Res 2021;2021:5554342. [PMID: 34007851 DOI: 10.1155/2021/5554342] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
574 Carmi Y, Prestwood TR, Spitzer MH, Linde IL, Chabon J, Reticker-Flynn NE, Bhattacharya N, Zhang H, Zhang X, Basto PA, Burt BM, Alonso MN, Engleman EG. Akt and SHP-1 are DC-intrinsic checkpoints for tumor immunity. JCI Insight 2016;1:e89020. [PMID: 27812544 DOI: 10.1172/jci.insight.89020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
575 Snezhkina AV, Kudryavtseva AV, Kardymon OL, Savvateeva MV, Melnikova NV, Krasnov GS, Dmitriev AA. ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells. Oxid Med Cell Longev 2019;2019:6175804. [PMID: 31467634 DOI: 10.1155/2019/6175804] [Cited by in Crossref: 132] [Cited by in F6Publishing: 122] [Article Influence: 44.0] [Reference Citation Analysis]
576 Min A, Zhu C, Peng S, Shuai C, Sun L, Han Y, Qian Y, Gao S, Su T. Downregulation of Microrna-148a in Cancer-Associated Fibroblasts from Oral Cancer Promotes Cancer Cell Migration and Invasion by Targeting Wnt10b. J Biochem Mol Toxicol 2016;30:186-91. [PMID: 26709120 DOI: 10.1002/jbt.21777] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
577 Kang Y, Datta P, Shanmughapriya S, Ozbolat IT. 3D Bioprinting of Tumor Models for Cancer Research. ACS Appl Bio Mater 2020;3:5552-73. [DOI: 10.1021/acsabm.0c00791] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
578 Dhawan U, Sue MW, Lan KC, Buddhakosai W, Huang PH, Chen YC, Chen PC, Chen WL. Nanochip-Induced Epithelial-to-Mesenchymal Transition: Impact of Physical Microenvironment on Cancer Metastasis. ACS Appl Mater Interfaces 2018;10:11474-85. [PMID: 29557633 DOI: 10.1021/acsami.7b19467] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
579 Sasada T, Suekane S. Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance. Immunotherapy. 2011;3:1235-1251. [PMID: 21995574 DOI: 10.2217/imt.11.106] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
580 Zhang T, Sentman CL. Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells. J I 2013;190:2455-63. [DOI: 10.4049/jimmunol.1201314] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
581 Ye J, Ma C, Hsueh EC, Dou J, Mo W, Liu S, Han B, Huang Y, Zhang Y, Varvares MA, Hoft DF, Peng G. TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence. EMBO Mol Med 2014;6:1294-311. [PMID: 25231413 DOI: 10.15252/emmm.201403918] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
582 Di J, Duiveman-de Boer T, Figdor CG, Torensma R. Aiming to immune elimination of ovarian cancer stem cells. World J Stem Cells 2013; 5(4): 149-162 [PMID: 24179603 DOI: 10.4252/wjsc.v5.i4.149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
583 Kwong B, Liu H, Irvine DJ. Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials 2011;32:5134-47. [PMID: 21514665 DOI: 10.1016/j.biomaterials.2011.03.067] [Cited by in Crossref: 121] [Cited by in F6Publishing: 106] [Article Influence: 11.0] [Reference Citation Analysis]
584 Costello E, Greenhalf W, Neoptolemos JP. New biomarkers and targets in pancreatic cancer and their application to treatment. Nat Rev Gastroenterol Hepatol. 2012;9:435-444. [PMID: 22733351 DOI: 10.1038/nrgastro.2012.119] [Cited by in Crossref: 139] [Cited by in F6Publishing: 132] [Article Influence: 13.9] [Reference Citation Analysis]
585 Ito Y, Onoda N, Kihara M, Miya A, Miyauchi A. Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Differentiated Thyroid Carcinoma Having Distant Metastasis: A Comparison With Thyroglobulin-doubling Rate and Tumor Volume-doubling Rate. In Vivo 2021;35:1125-32. [PMID: 33622910 DOI: 10.21873/invivo.12358] [Reference Citation Analysis]
586 Fan JH, Fan GL, Yuan P, Deng FA, Liu LS, Zhou X, Yu XY, Cheng H, Li SY. A Theranostic Nanoprobe for Hypoxia Imaging and Photodynamic Tumor Therapy. Front Chem 2019;7:868. [PMID: 31921785 DOI: 10.3389/fchem.2019.00868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
587 Ko J, Ahn J, Kim S, Lee Y, Lee J, Park D, Jeon NL. Tumor spheroid-on-a-chip: a standardized microfluidic culture platform for investigating tumor angiogenesis. Lab Chip 2019;19:2822-33. [DOI: 10.1039/c9lc00140a] [Cited by in Crossref: 46] [Cited by in F6Publishing: 28] [Article Influence: 15.3] [Reference Citation Analysis]
588 Xu P, Sun X, Song X, Peng Y, He B, Wu Z, Zhu J. Prognostic value of lymphocyte-to-monocyte ratio and histone methyltransferase G9a histone methyltransferase in patients with double expression lymphoma: A retrospective observational study. Medicine (Baltimore) 2021;100:e24449. [PMID: 33530253 DOI: 10.1097/MD.0000000000024449] [Reference Citation Analysis]
589 Kumar V, Giacomantonio MA, Gujar S. Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy. Viruses 2021;13:654. [PMID: 33920168 DOI: 10.3390/v13040654] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
590 Sun B, Karin M. Inflammation and liver tumorigenesis. Front Med. 2013;7:242-254. [PMID: 23681888 DOI: 10.1007/s11684-013-0256-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 6.1] [Reference Citation Analysis]
591 Sahinbegovic H, Jelinek T, Hrdinka M, Bago JR, Turi M, Sevcikova T, Kurtovic-Kozaric A, Hajek R, Simicek M. Intercellular Mitochondrial Transfer in the Tumor Microenvironment. Cancers (Basel) 2020;12:E1787. [PMID: 32635428 DOI: 10.3390/cancers12071787] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
592 Anand A, Fang HY, Mohammad-Shahi D, Ingermann J, Baumeister T, Strangmann J, Schmid RM, Wang TC, Quante M. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus. Carcinogenesis 2021;42:405-13. [PMID: 33068426 DOI: 10.1093/carcin/bgaa109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
593 Katano A, Takahashi W, Yamashita H, Yamamoto K, Ando M, Yoshida M, Saito Y, Abe O, Nakagawa K. The impact of elevated C-reactive protein level on the prognosis for oro-hypopharynx cancer patients treated with radiotherapy. Sci Rep 2017;7:17805. [PMID: 29259311 DOI: 10.1038/s41598-017-18233-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
594 Whiteside TL. Tricks tumors use to escape from immune control. Oral Oncology 2009;45:e119-23. [DOI: 10.1016/j.oraloncology.2009.03.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
595 Tanaka F, Rizqiawan A, Higashikawa K, Tobiume K, Okui G, Shigeishi H, Ono S, Shimasue H, Kamata N. Snail promotes Cyr61 secretion to prime collective cell migration and form invasive tumor nests in squamous cell carcinoma. Cancer Letters 2013;329:243-52. [DOI: 10.1016/j.canlet.2012.11.023] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
596 Berger Fridman I, Kostas J, Gregus M, Ray S, Sullivan MR, Ivanov AR, Cohen S, Konry T. High-throughput microfluidic 3D biomimetic model enabling quantitative description of the human breast tumor microenvironment. Acta Biomater 2021:S1742-7061(21)00399-8. [PMID: 34153511 DOI: 10.1016/j.actbio.2021.06.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
597 Wu J, Chen J, Feng Y, Tian H, Chen X. Tumor microenvironment as the "regulator" and "target" for gene therapy. J Gene Med 2019;21:e3088. [PMID: 30938916 DOI: 10.1002/jgm.3088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
598 Kitadai Y. Cancer-stromal cell interaction and tumor angiogenesis in gastric cancer. Cancer Microenviron. 2010;3:109-116. [PMID: 20020278 DOI: 10.1007/s12307-009-0032-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
599 Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Front Immunol 2015;6:402. [PMID: 26300886 DOI: 10.3389/fimmu.2015.00402] [Cited by in Crossref: 75] [Cited by in F6Publishing: 72] [Article Influence: 10.7] [Reference Citation Analysis]
600 El Baba R, Herbein G. Immune Landscape of CMV Infection in Cancer Patients: From "Canonical" Diseases Toward Virus-Elicited Oncomodulation. Front Immunol 2021;12:730765. [PMID: 34566995 DOI: 10.3389/fimmu.2021.730765] [Reference Citation Analysis]
601 Dai E, Zhu Z, Wahed S, Qu Z, Storkus WJ, Guo ZS. Epigenetic modulation of antitumor immunity for improved cancer immunotherapy. Mol Cancer 2021;20. [DOI: 10.1186/s12943-021-01464-x] [Reference Citation Analysis]
602 Azambuja JH, Ludwig N, Braganhol E, Whiteside TL. Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity. Int J Mol Sci 2019;20:E5698. [PMID: 31739402 DOI: 10.3390/ijms20225698] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
603 Izadi S, Moslehi A, Kheiry H, Karoon Kiani F, Ahmadi A, Masjedi A, Ghani S, Rafiee B, Karpisheh V, Hajizadeh F, Atyabi F, Assali A, Mirzazadeh Tekie FS, Namdar A, Ghalamfarsa G, Sojoodi M, Jadidi-Niaragh F. Codelivery of HIF-1α siRNA and Dinaciclib by Carboxylated Graphene Oxide-Trimethyl Chitosan-Hyaluronate Nanoparticles Significantly Suppresses Cancer Cell Progression. Pharm Res 2020;37:196. [PMID: 32944844 DOI: 10.1007/s11095-020-02892-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
604 Yoshimura K, Tsujikawa T, Mitsuda J, Ogi H, Saburi S, Ohmura G, Arai A, Shibata S, Thibault G, Chang YH, Clayburgh DR, Yasukawa S, Miyagawa-Hayashino A, Konishi E, Itoh K, Coussens LM, Hirano S. Spatial Profiles of Intratumoral PD-1+ Helper T Cells Predict Prognosis in Head and Neck Squamous Cell Carcinoma. Front Immunol 2021;12:769534. [PMID: 34777389 DOI: 10.3389/fimmu.2021.769534] [Reference Citation Analysis]
605 Pathania AS, Challagundla KB. Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment. Mol Ther Nucleic Acids 2021;23:1371-83. [PMID: 33738133 DOI: 10.1016/j.omtn.2020.09.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
606 Valous NA, Moraleda RR, Jäger D, Zörnig I, Halama N. Interrogating the microenvironmental landscape of tumors with computational image analysis approaches. Semin Immunol 2020;48:101411. [PMID: 33168423 DOI: 10.1016/j.smim.2020.101411] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
607 Rouce RH, Shaim H, Sekine T, Weber G, Ballard B, Ku S, Barese C, Murali V, Wu MF, Liu H, Shpall EJ, Bollard CM, Rabin KR, Rezvani K. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia. Leukemia 2016;30:800-11. [PMID: 26621337 DOI: 10.1038/leu.2015.327] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
608 Xie Y, Zhong Y, Gao T, Zhang X, Li LI, Ruan H, Li D. Human lymphatic endothelial cells contribute to epithelial ovarian carcinoma metastasis by promoting lymphangiogenesis and tumour cell invasion. Exp Ther Med 2016;11:1587-94. [PMID: 27168777 DOI: 10.3892/etm.2016.3134] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
609 Luo R, Guo W, Wang H. A comprehensive analysis of tumor microenvironment-related genes in colon cancer. Clin Transl Oncol 2021;23:1769-81. [PMID: 33689097 DOI: 10.1007/s12094-021-02578-w] [Reference Citation Analysis]
610 Zhou R, Zeng D, Zhang J, Sun H, Wu J, Li N, Liang L, Shi M, Bin J, Liao Y, Huang N, Liao W. A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer. EBioMedicine 2019;42:420-30. [PMID: 30917936 DOI: 10.1016/j.ebiom.2019.03.043] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
611 Accomando WP, Wiencke JK, Houseman EA, Butler RA, Zheng S, Nelson HH, Kelsey KT. Decreased NK cells in patients with head and neck cancer determined in archival DNA. Clin Cancer Res 2012;18:6147-54. [PMID: 23014525 DOI: 10.1158/1078-0432.CCR-12-1008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
612 Dayyani F, Gallick GE, Logothetis CJ, Corn PG. Novel therapies for metastatic castrate-resistant prostate cancer. J Natl Cancer Inst 2011;103:1665-75. [PMID: 21917607 DOI: 10.1093/jnci/djr362] [Cited by in Crossref: 100] [Cited by in F6Publishing: 87] [Article Influence: 9.1] [Reference Citation Analysis]
613 Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan ZR, Roberts AI, Zhang L, Zheng B. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell. 2012;11:812-824. [PMID: 23168163 DOI: 10.1016/j.stem.2012.08.013] [Cited by in Crossref: 201] [Cited by in F6Publishing: 194] [Article Influence: 20.1] [Reference Citation Analysis]
614 Zhang Y, Cuerdo J, Halushka MK, McCall MN. The effect of tissue composition on gene co-expression. Brief Bioinform 2021;22:127-39. [PMID: 31813949 DOI: 10.1093/bib/bbz135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 2.3] [Reference Citation Analysis]
615 Estrela-Lima A, Araújo MS, da Costa-Neto JM, Ribeiro LG, Damasceno KA, D'Assis MJ, Martins-Filho OA, Teixeira-Carvalho A, Serakides R, Cassali GD. Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers. Breast Cancer Res Treat 2012;131:751-63. [PMID: 21448671 DOI: 10.1007/s10549-011-1452-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
616 Lu Y, Miao L, Wang Y, Xu Z, Zhao Y, Shen Y, Xiang G, Huang L. Curcumin Micelles Remodel Tumor Microenvironment and Enhance Vaccine Activity in an Advanced Melanoma Model. Mol Ther 2016;24:364-74. [PMID: 26334519 DOI: 10.1038/mt.2015.165] [Cited by in Crossref: 69] [Cited by in F6Publishing: 61] [Article Influence: 9.9] [Reference Citation Analysis]
617 Wang J, Meng F, Kim BK, Ke X, Yeo Y. In-vitro and in-vivo difference in gene delivery by lithocholic acid-polyethyleneimine conjugate. Biomaterials 2019;217:119296. [PMID: 31254934 DOI: 10.1016/j.biomaterials.2019.119296] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
618 Wallis SP, Stafford ND, Greenman J, Myers JN. Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers: Clinical Relevance of Immune Parameters in the Tumor Microenvironment. Head Neck 2015;37:449-59. [DOI: 10.1002/hed.23736] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
619 Cheng Y, Li H, Deng Y, Tai Y, Zeng K, Zhang Y, Liu W, Zhang Q, Yang Y. Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma. Cell Death Dis. 2018;9:422. [PMID: 29556041 DOI: 10.1038/s41419-018-0458-4] [Cited by in Crossref: 82] [Cited by in F6Publishing: 95] [Article Influence: 20.5] [Reference Citation Analysis]
620 Heo CK, Bahk YY, Cho EW. Tumor-associated autoantibodies as diagnostic and prognostic biomarkers. BMB Rep 2012;45:677-85. [PMID: 23261052 DOI: 10.5483/bmbrep.2012.45.12.236] [Cited by in Crossref: 45] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
621 Sun Z, Wang S, Zhao RC. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol. 2014;7:14. [PMID: 24502410 DOI: 10.1186/1756-8722-7-14] [Cited by in Crossref: 138] [Cited by in F6Publishing: 137] [Article Influence: 17.3] [Reference Citation Analysis]
622 Takigawa H, Kitadai Y, Shinagawa K, Yuge R, Higashi Y, Tanaka S, Yasui W, Chayama K. Multikinase inhibitor regorafenib inhibits the growth and metastasis of colon cancer with abundant stroma. Cancer Sci 2016;107:601-8. [PMID: 26865419 DOI: 10.1111/cas.12907] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
623 Spennati G, Horowitz LF, McGarry DJ, Rudzka DA, Armstrong G, Olson MF, Folch A, Yin H. Organotypic platform for studying cancer cell metastasis. Exp Cell Res 2021;401:112527. [PMID: 33675807 DOI: 10.1016/j.yexcr.2021.112527] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Kolenda T, Przybyła W, Kapałczyńska M, Teresiak A, Zajączkowska M, Bliźniak R, Lamperska KM. Tumor microenvironment - Unknown niche with powerful therapeutic potential. Rep Pract Oncol Radiother 2018;23:143-53. [PMID: 29760589 DOI: 10.1016/j.rpor.2018.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
625 dos Santos RV, da Silva LM. A possible explanation for the variable frequencies of cancer stem cells in tumors. PLoS One 2013;8:e69131. [PMID: 23950884 DOI: 10.1371/journal.pone.0069131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
626 Chandrasekaran S, Giang UB, King MR, DeLouise LA. Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane. Biomaterials 2011;32:7159-68. [PMID: 21724250 DOI: 10.1016/j.biomaterials.2011.06.013] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
627 Lucchetti D, Ricciardi Tenore C, Colella F, Sgambato A. Extracellular Vesicles and Cancer: A Focus on Metabolism, Cytokines, and Immunity. Cancers (Basel) 2020;12:E171. [PMID: 32015297 DOI: 10.3390/cancers12010171] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
628 Medvedeva GF, Kuzmina DO, Nuzhina J, Shtil AA, Dukhinova MS. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy. Int J Mol Sci 2021;22:2662. [PMID: 33800829 DOI: 10.3390/ijms22052662] [Reference Citation Analysis]
629 Ceylan Y, Kumanlıoğlu K, Oral A, Ertan Y, Özcan Z. The Correlation of Clinicopathological Findings and Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Papillary Thyroid Carcinoma. Mol Imaging Radionucl Ther 2019;28:15-20. [PMID: 30942057 DOI: 10.4274/mirt.galenos.2018.60490] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
630 Martinez-Lage M, Lynch TM, Bi Y, Cocito C, Way GP, Pal S, Haller J, Yan RE, Ziober A, Nguyen A, Kandpal M, O'Rourke DM, Greenfield JP, Greene CS, Davuluri RV, Dahmane N. Immune landscapes associated with different glioblastoma molecular subtypes. Acta Neuropathol Commun 2019;7:203. [PMID: 31815646 DOI: 10.1186/s40478-019-0803-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
631 Flörcken A, Grau M, Wolf A, Weilemann A, Kopp J, Dörken B, Blankenstein T, Pezzutto A, Lenz P, Lenz G, Westermann J. Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB. Int J Cancer 2015;136:1814-26. [PMID: 25242680 DOI: 10.1002/ijc.29230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
632 Dumitru CA, Gholaman H, Trellakis S, Bruderek K, Dominas N, Gu X, Bankfalvi A, Whiteside TL, Lang S, Brandau S. Tumor-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer 2011;129:859-69. [DOI: 10.1002/ijc.25991] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 8.1] [Reference Citation Analysis]
633 Sand LGL, Buckle T, van Leeuwen FWB, Corver WE, Kruisselbrink AB, Jochemsen AG, Hogendoorn PCW, Szuhai K. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma. BMC Cancer 2017;17:383. [PMID: 28549419 DOI: 10.1186/s12885-017-3352-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
634 Baurain JF, Robert C, Mortier L, Neyns B, Grange F, Lebbe C, Ulloa-Montoya F, De Sousa Alves PM, Gillet M, Louahed J, Jarnjak S, Lehmann FF. Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic. ESMO Open 2018;3:e000384. [PMID: 30094070 DOI: 10.1136/esmoopen-2018-000384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
635 Chung HW, Lim JB. Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol 2014; 20(7): 1667-1680 [PMID: 24587646 DOI: 10.3748/wjg.v20.i7.1667] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 52] [Article Influence: 6.6] [Reference Citation Analysis]
636 Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, Zhang S, Bettigole SE, Gupta D, Holcomb K, Ellenson LH, Caputo T, Lee AH, Conejo-Garcia JR, Glimcher LH. ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis. Cell 2015;161:1527-38. [PMID: 26073941 DOI: 10.1016/j.cell.2015.05.025] [Cited by in Crossref: 350] [Cited by in F6Publishing: 350] [Article Influence: 50.0] [Reference Citation Analysis]
637 Martinez-Perez AG, Perez-Trujillo JJ, Garza-Morales R, Loera-Arias MJ, Saucedo-Cardenas O, Garcia-Garcia A, Rodriguez-Rocha H, Montes-de-Oca-Luna R. 4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer. Int J Mol Sci 2021;22:6210. [PMID: 34207500 DOI: 10.3390/ijms22126210] [Reference Citation Analysis]
638 Pacella I, Grimaldi A, Piconese S. Assessment of lipid load in tumor-infiltrating Tregs by flow cytometry. Methods Enzymol 2020;632:283-94. [PMID: 32000901 DOI: 10.1016/bs.mie.2019.07.024] [Reference Citation Analysis]
639 Espinoza-Sánchez NA, Götte M. Role of cell surface proteoglycans in cancer immunotherapy. Semin Cancer Biol 2020;62:48-67. [PMID: 31336150 DOI: 10.1016/j.semcancer.2019.07.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
640 Proctor DT, Huang J, Lama S, Albakr A, Van Marle G, Sutherland GR. Tumor-associated macrophage infiltration in meningioma. Neurooncol Adv 2019;1:vdz018. [PMID: 32642654 DOI: 10.1093/noajnl/vdz018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
641 Zhao Y, Huo M, Xu Z, Wang Y, Huang L. Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma. Biomaterials 2015;68:54-66. [PMID: 26264646 DOI: 10.1016/j.biomaterials.2015.07.053] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 7.1] [Reference Citation Analysis]
642 Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun 2012;26:830-48. [PMID: 22595751 DOI: 10.1016/j.bbi.2012.05.004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 96] [Article Influence: 10.6] [Reference Citation Analysis]
643 Watanabe Y, Itoh M, Nakagawa H, Asahina A, Nobeyama Y. Role of interleukin‐24 in the tumor‐suppressive effects of interferon‐β on melanoma. Exp Dermatol 2019;28:836-44. [DOI: 10.1111/exd.13955] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
644 Liang W, Huang X, Carlos CJJ, Lu X. Research progress of tumor microenvironment and tumor-associated macrophages. Clin Transl Oncol 2020;22:2141-52. [PMID: 32447645 DOI: 10.1007/s12094-020-02367-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
645 Lin PP. Aneuploid Circulating Tumor-Derived Endothelial Cell (CTEC): A Novel Versatile Player in Tumor Neovascularization and Cancer Metastasis. Cells 2020;9:E1539. [PMID: 32599893 DOI: 10.3390/cells9061539] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
646 Choi SY, Gout PW, Collins CC, Wang Y. Epithelial immune cell-like transition (EIT): a proposed transdifferentiation process underlying immune-suppressive activity of epithelial cancers. Differentiation 2012;83:293-8. [PMID: 22472059 DOI: 10.1016/j.diff.2012.02.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
647 Li Y, Chen Z, Wu L, Ye J, Tao W. Cellular heterogeneity map of diverse immune and stromal phenotypes within breast tumor microenvironment. PeerJ 2020;8:e9478. [PMID: 32728493 DOI: 10.7717/peerj.9478] [Reference Citation Analysis]
648 Li W, Jian YB. Antitumor necrosis factor-α antibodies as a noveltherapy for hepatocellular carcinoma. Exp Ther Med 2018;16:529-36. [PMID: 30116311 DOI: 10.3892/etm.2018.6235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
649 Johnson AM, Kleczko EK, Nemenoff RA. Eicosanoids in Cancer: New Roles in Immunoregulation. Front Pharmacol 2020;11:595498. [PMID: 33364964 DOI: 10.3389/fphar.2020.595498] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
650 Huang FY, Lei J, Sun Y, Yan F, Chen B, Zhang L, Lu Z, Cao R, Lin YY, Wang CC, Tan GH. Induction of enhanced immunogenic cell death through ultrasound-controlled release of doxorubicin by liposome-microbubble complexes. Oncoimmunology 2018;7:e1446720. [PMID: 29900064 DOI: 10.1080/2162402X.2018.1446720] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
651 Tunali I, Gray JE, Qi J, Abdalah M, Jeong DK, Guvenis A, Gillies RJ, Schabath MB. Novel clinical and radiomic predictors of rapid disease progression phenotypes among lung cancer patients treated with immunotherapy: An early report. Lung Cancer. 2019;129:75-79. [PMID: 30797495 DOI: 10.1016/j.lungcan.2019.01.010] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 18.7] [Reference Citation Analysis]
652 Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, Song JI, Bowles DW, Schedin P, Tan AC, Roop DR, Wang XJ, Refaeli Y, Jimeno A. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene. 2016;35:290-300. [PMID: 25893296 DOI: 10.1038/onc.2015.94] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 11.1] [Reference Citation Analysis]
653 Banerjee S, Halder K, Bose A, Bhattacharya P, Gupta G, Karmahapatra S, Das S, Chaudhuri S, Bhattacharyya Majumdar S, Majumdar S. TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages. Carcinogenesis 2011;32:1789-97. [PMID: 21926109 DOI: 10.1093/carcin/bgr208] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
654 Zhang Y, Jiang B, Lee MH. A Novel 3D Model for Visualization and Tracking of Fibroblast-Guided Directional Cancer Cell Migration. Biology (Basel) 2020;9:E328. [PMID: 33049958 DOI: 10.3390/biology9100328] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
655 Bose A, Taylor JL, Alber S, Watkins SC, Garcia JA, Rini BI, Ko JS, Cohen PA, Finke JH, Storkus WJ. Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination. Int J Cancer 2011;129:2158-70. [PMID: 21170961 DOI: 10.1002/ijc.25863] [Cited by in Crossref: 94] [Cited by in F6Publishing: 99] [Article Influence: 8.5] [Reference Citation Analysis]
656 Liu Z, Ravindranathan R, Li J, Kalinski P, Guo ZS, Bartlett DL. CXCL11-Armed oncolytic poxvirus elicits potent antitumor immunity and shows enhanced therapeutic efficacy. Oncoimmunology 2016;5:e1091554. [PMID: 27141352 DOI: 10.1080/2162402X.2015.1091554] [Cited by in Crossref: 48] [Cited by in F6Publishing: 42] [Article Influence: 6.9] [Reference Citation Analysis]
657 Marzan AL, Stewart SE. Elucidating the Role of Extracellular Vesicles in Pancreatic Cancer. Cancers (Basel) 2021;13:5669. [PMID: 34830825 DOI: 10.3390/cancers13225669] [Reference Citation Analysis]
658 Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, Fridman WH, Tartour E. Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 2010;32:946-58. [PMID: 20191626 DOI: 10.1002/hed.21346] [Cited by in Crossref: 9] [Cited by in F6Publishing: 29] [Article Influence: 0.8] [Reference Citation Analysis]
659 Michaelidou K, Agelaki S, Mavridis K. Molecular markers related to immunosurveillance as predictive and monitoring tools in non-small cell lung cancer: recent accomplishments and future promises. Expert Rev Mol Diagn 2020;20:335-44. [PMID: 32000550 DOI: 10.1080/14737159.2020.1724785] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
660 Whiteside TL. The role of regulatory T cells in cancer immunology. Immunotargets Ther 2015;4:159-71. [PMID: 27471721 DOI: 10.2147/ITT.S55415] [Cited by in Crossref: 64] [Cited by in F6Publishing: 43] [Article Influence: 9.1] [Reference Citation Analysis]
661 Perli SD, Cui CH, Lu TK. Continuous genetic recording with self-targeting CRISPR-Cas in human cells. Science 2016;353:aag0511. [PMID: 27540006 DOI: 10.1126/science.aag0511] [Cited by in Crossref: 123] [Cited by in F6Publishing: 103] [Article Influence: 20.5] [Reference Citation Analysis]
662 Sulaieva O, Selezniov O, Shapochka D, Belemets N, Nechay O, Chereshneva Y, Tsomartova D, Ivanova M. Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links. Heliyon 2020;6:e03077. [PMID: 31938743 DOI: 10.1016/j.heliyon.2019.e03077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
663 Chang Z. Recent development of the mononuclear phagocyte system: in memory of Metchnikoff and Ehrlich on the 100th Anniversary of the 1908 Nobel Prize in Physiology or Medicine. Biology of the Cell 2009;101:709-21. [DOI: 10.1042/bc20080227] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 3.4] [Reference Citation Analysis]
664 Mazmishvili K, Jayant K, Janikashvili N, Kikodze N, Mizandari M, Pantsulaia I, Paksashvili N, Sodergren MH, Reccia I, Pai M, Habib N, Chikovani T. Study to evaluate the immunomodulatory effects of radiofrequency ablation compared to surgical resection for liver cancer. J Cancer 2018;9:3187-95. [PMID: 30210642 DOI: 10.7150/jca.25084] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
665 Owyong M, Hosseini-Nassab N, Efe G, Honkala A, van den Bijgaart RJE, Plaks V, Smith BR. Cancer Immunotherapy Getting Brainy: Visualizing the Distinctive CNS Metastatic Niche to Illuminate Therapeutic Resistance. Drug Resist Updat 2017;33-35:23-35. [PMID: 29145972 DOI: 10.1016/j.drup.2017.10.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
666 Vartuli RL, Zhou H, Zhang L, Powers RK, Klarquist J, Rudra P, Vincent MY, Ghosh D, Costello JC, Kedl RM, Slansky JE, Zhao R, Ford HL. Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. J Clin Invest 2018;128:2535-50. [PMID: 29757193 DOI: 10.1172/JCI96784] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
667 Huang FY, Huang FR, Chen B, Liu Q, Wang H, Zhou SL, Zhao HG, Huang YH, Lin YY, Tan GH. Microencapsulation of tumor lysates and live cell engineering with MIP-3α as an effective vaccine. Biomaterials 2015;53:554-65. [PMID: 25890751 DOI: 10.1016/j.biomaterials.2015.02.123] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
668 Makaremi S, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Sgambato A, Ghorbaninezhad F, Safarpour H, Argentiero A, Brunetti O, Bernardini R, Silvestris N, Baradaran B. Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects. Biomedicines 2021;9:1075. [PMID: 34572263 DOI: 10.3390/biomedicines9091075] [Reference Citation Analysis]
669 Melzer C, Yang Y, Hass R. Interaction of MSC with tumor cells. Cell Commun Signal 2016;14:20. [PMID: 27608835 DOI: 10.1186/s12964-016-0143-0] [Cited by in Crossref: 94] [Cited by in F6Publishing: 98] [Article Influence: 15.7] [Reference Citation Analysis]
670 Zheng M, Long J, Chelariu-Raicu A, Mullikin H, Vilsmaier T, Vattai A, Heidegger HH, Batz F, Keckstein S, Jeschke U, Trillsch F, Mahner S, Kaltofen T. Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer. Cancers (Basel) 2021;13:3343. [PMID: 34283076 DOI: 10.3390/cancers13133343] [Reference Citation Analysis]
671 Peppicelli S, Andreucci E, Ruzzolini J, Bianchini F, Nediani C, Supuran CT, Calorini L. The Carbonic Anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells. J Enzyme Inhib Med Chem 2020;35:1185-93. [PMID: 32396749 DOI: 10.1080/14756366.2020.1764549] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
672 Arab S, Hadjati J. Adenosine Blockage in Tumor Microenvironment and Improvement of Cancer Immunotherapy. Immune Netw 2019;19:e23. [PMID: 31501711 DOI: 10.4110/in.2019.19.e23] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 11.0] [Reference Citation Analysis]
673 Ali DA, El-Guindy DM, Elrashidy MA, Sabry NM, Kabel AM, Gaber RA, Ibrahim RR, Samy SM, Shalaby MM, Salama SA, Abdelhai D. The Prognostic Significance of MACC1 Expression in Breast Cancer and Its Relationship to Immune Cells in the Tumor Microenvironment and Patient Survival. Medicina (Kaunas) 2021;57:934. [PMID: 34577857 DOI: 10.3390/medicina57090934] [Reference Citation Analysis]
674 Kim W, Pyo J, Noh BJ, Jeong JW, Lee J, Kim JE. CCAR2 negatively regulates IL-8 production in cervical cancer cells. Oncotarget 2018;9:1143-55. [PMID: 29416683 DOI: 10.18632/oncotarget.23199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
675 Zhang D, Li X, Liu X, Wang Y, Zhang M, Wang Q, Chen T, Li Z. Disease-Specific IgG Fc Glycosylation Ratios as Personalized Biomarkers to Differentiate Non-Small Cell Lung Cancer from Benign Lung Diseases. Proteomics Clin Appl 2020;14:e1900016. [PMID: 31707769 DOI: 10.1002/prca.201900016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
676 Cao K, Tait SWG. Apoptosis and Cancer: Force Awakens, Phantom Menace, or Both? Int Rev Cell Mol Biol 2018;337:135-52. [PMID: 29551159 DOI: 10.1016/bs.ircmb.2017.12.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
677 Liu YP, Suksanpaisan L, Steele MB, Russell SJ, Peng KW. Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. Sci Rep 2013;3:2375. [PMID: 23921465 DOI: 10.1038/srep02375] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
678 Lesack K, Naugler C. Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes. BMC Dermatol 2012;12:1. [PMID: 22405101 DOI: 10.1186/1471-5945-12-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
679 Imlimthan S, Moon ES, Rathke H, Afshar-Oromieh A, Rösch F, Rominger A, Gourni E. New Frontiers in Cancer Imaging and Therapy Based on Radiolabeled Fibroblast Activation Protein Inhibitors: A Rational Review and Current Progress. Pharmaceuticals (Basel) 2021;14:1023. [PMID: 34681246 DOI: 10.3390/ph14101023] [Reference Citation Analysis]
680 Law AY, Wong CK. Stanniocalcin-2 promotes epithelial-mesenchymal transition and invasiveness in hypoxic human ovarian cancer cells. Exp Cell Res. 2010;316:3425-3434. [PMID: 20619259 DOI: 10.1016/j.yexcr.2010.06.026] [Cited by in Crossref: 46] [Cited by in F6Publishing: 49] [Article Influence: 3.8] [Reference Citation Analysis]
681 Whiteside TL, Mandapathil M, Schuler P. The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). Curr Med Chem 2011;18:5217-23. [PMID: 22087822 DOI: 10.2174/092986711798184334] [Cited by in Crossref: 51] [Cited by in F6Publishing: 42] [Article Influence: 5.1] [Reference Citation Analysis]
682 Laha D, Grant R, Mishra P, Nilubol N. The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment. Front Immunol 2021;12:656908. [PMID: 33986746 DOI: 10.3389/fimmu.2021.656908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
683 Rojas A, Figueroa H, Morales E. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis. 2010;31:334-341. [PMID: 20028726 DOI: 10.1093/carcin/bgp322] [Cited by in Crossref: 91] [Cited by in F6Publishing: 97] [Article Influence: 7.0] [Reference Citation Analysis]
684 He D, Li H, Yusuf N, Elmets CA, Li J, Mountz JD, Xu H. IL-17 promotes tumor development through the induction of tumor promoting microenvironments at tumor sites and myeloid-derived suppressor cells. J Immunol 2010;184:2281-8. [PMID: 20118280 DOI: 10.4049/jimmunol.0902574] [Cited by in Crossref: 211] [Cited by in F6Publishing: 206] [Article Influence: 17.6] [Reference Citation Analysis]
685 Singh L, Singh MK, Rizvi MA, Pushker N, Bakhshi S, Sen S, Kashyap S. Prognostic significance of immune checkpoints in the tumour-stromal microenvironment of sebaceous gland carcinoma. Br J Ophthalmol 2021;105:48-56. [PMID: 32277010 DOI: 10.1136/bjophthalmol-2019-315490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
686 Schmidinger M. Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors. EJC Suppl. 2013;11:172-191. [PMID: 26217127 DOI: 10.1016/j.ejcsup.2013.07.016] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 9.1] [Reference Citation Analysis]
687 Muller-haegele S, Muller L, Whiteside TL. Immunoregulatory activity of adenosine and its role in human cancer progression. Expert Review of Clinical Immunology 2014;10:897-914. [DOI: 10.1586/1744666x.2014.915739] [Cited by in Crossref: 54] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
688 De Lellis L, Florio R, Di Bella MC, Brocco D, Guidotti F, Tinari N, Grassadonia A, Lattanzio R, Cama A, Veschi S. Exosomes as Pleiotropic Players in Pancreatic Cancer. Biomedicines 2021;9:275. [PMID: 33803470 DOI: 10.3390/biomedicines9030275] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
689 Huang CH, Liao YJ, Chiou TJ, Huang HT, Lin YH, Twu YC. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression. Immunobiology 2019;224:649-58. [PMID: 31421859 DOI: 10.1016/j.imbio.2019.07.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
690 Ahn J, Kong E, Choe K, Song E, Hwang Y, Seo H, Park I, Kim P. In vivo longitudinal depth-wise visualization of tumorigenesis by needle-shaped side-view confocal endomicroscopy. Biomed Opt Express 2019;10:2719-29. [PMID: 31259046 DOI: 10.1364/BOE.10.002719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
691 Taddei ML, Pietrovito L, Leo A, Chiarugi P. Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. Cells 2020;9:E510. [PMID: 32102348 DOI: 10.3390/cells9020510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
692 Crotti S, Piccoli M, Rizzolio F, Giordano A, Nitti D, Agostini M. Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? J Cell Physiol. 2017;232:967-975. [PMID: 27775168 DOI: 10.1002/jcp.25658] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 10.8] [Reference Citation Analysis]
693 Tijhuis AE, Johnson SC, McClelland SE. The emerging links between chromosomal instability (CIN), metastasis, inflammation and tumour immunity. Mol Cytogenet 2019;12:17. [PMID: 31114634 DOI: 10.1186/s13039-019-0429-1] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
694 Li A, Song NJ, Riesenberg BP, Li Z. The Emerging Roles of Endoplasmic Reticulum Stress in Balancing Immunity and Tolerance in Health and Diseases: Mechanisms and Opportunities. Front Immunol 2019;10:3154. [PMID: 32117210 DOI: 10.3389/fimmu.2019.03154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
695 Shou Y, Yang L, Yang Y, Zhu X, Li F, Xu J. Identification of Signatures of Prognosis Prediction for Melanoma Using a Hypoxia Score. Front Genet 2020;11:570530. [PMID: 33133157 DOI: 10.3389/fgene.2020.570530] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
696 Vaughan HJ, Green JJ, Tzeng SY. Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery. Adv Mater 2020;32:1901081. [DOI: 10.1002/adma.201901081] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
697 Chou MY, Yang MH. Interplay of Immunometabolism and Epithelial-Mesenchymal Transition in the Tumor Microenvironment. Int J Mol Sci 2021;22:9878. [PMID: 34576042 DOI: 10.3390/ijms22189878] [Reference Citation Analysis]
698 Kitano H, Kitadai Y, Teishima J, Yuge R, Shinmei S, Goto K, Inoue S, Hayashi T, Sentani K, Yasui W, Matsubara A. Combination therapy using molecular-targeted drugs modulates tumor microenvironment and impairs tumor growth in renal cell carcinoma. Cancer Med 2017;6:2308-20. [PMID: 28834289 DOI: 10.1002/cam4.1124] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
699 Ray M, Ruffalo MM, Bar‐joseph Z. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer. Genes Chromosomes Cancer 2019;58:34-42. [DOI: 10.1002/gcc.22688] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
700 Nazari A, Ahmadi Z, Hassanshahi G, Abbasifard M, Taghipour Z, Falahati-Pour SK, Khorramdelazad H. Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review. Oman Med J 2020;35:e103. [PMID: 32181005 DOI: 10.5001/omj.2020.21] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
701 Yao H, Xu K, Zhou J, Zhou L, Wei S. A Tumor Microenvironment Destroyer for Efficient Cancer Suppression. ACS Biomater Sci Eng 2020;6:450-62. [DOI: 10.1021/acsbiomaterials.9b01544] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
702 Egilmez NK, Kilinc MO. Tumor-resident CD8+ T-cell: the critical catalyst in IL-12-mediated reversal of tumor immune suppression. Arch Immunol Ther Exp (Warsz) 2010;58:399-405. [PMID: 20872283 DOI: 10.1007/s00005-010-0097-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
703 Menon N, Dang HX, Datla US, Moarefian M, Lawrence CB, Maher CA, Jones CN. Heparin-based hydrogel scaffolding alters the transcriptomic profile and increases the chemoresistance of MDA-MB-231 triple-negative breast cancer cells. Biomater Sci 2020;8:2786-96. [PMID: 32091043 DOI: 10.1039/c9bm01481k] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
704 Allen CT, Judd NP, Bui JD, Uppaluri R. The clinical implications of antitumor immunity in head and neck cancer. The Laryngoscope 2012;122:144-57. [DOI: 10.1002/lary.21913] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.4] [Reference Citation Analysis]
705 Zhao H, Yang L, Baddour J, Achreja A, Bernard V, Moss T, Marini JC, Tudawe T, Seviour EG, San Lucas FA, Alvarez H, Gupta S, Maiti SN, Cooper L, Peehl D, Ram PT, Maitra A, Nagrath D. Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism. Elife. 2016;5:e10250. [PMID: 26920219 DOI: 10.7554/elife.10250] [Cited by in Crossref: 395] [Cited by in F6Publishing: 294] [Article Influence: 65.8] [Reference Citation Analysis]
706 Kumar A, Kant S, Singh SM. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Toxicol Appl Pharmacol. 2013;273:196-208. [PMID: 24051182 DOI: 10.1016/j.taap.2013.09.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
707 Brown S, Whalen M. Tributyltin alters secretion of interleukin 1 beta from human immune cells. J Appl Toxicol 2015;35:895-908. [PMID: 25382723 DOI: 10.1002/jat.3087] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
708 Meškytė EM, Keskas S, Ciribilli Y. MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis. Int J Mol Sci 2020;21:E7710. [PMID: 33081056 DOI: 10.3390/ijms21207710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
709 Cui W, Zhou J, Dehne N, Brüne B. Hypoxia induces calpain activity and degrades SMAD2 to attenuate TGFβ signaling in macrophages. Cell Biosci 2015;5:36. [PMID: 26146544 DOI: 10.1186/s13578-015-0026-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
710 Wang Z, Xu H, Zhu L, He T, Lv W, Wu Z. Establishment and Evaluation of a 6-Gene Survival Risk Assessment Model Related to Lung Adenocarcinoma Microenvironment. Biomed Res Int 2020;2020:6472153. [PMID: 32337264 DOI: 10.1155/2020/6472153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
711 Bottomley MJ, Thomson J, Harwood C, Leigh I. The Role of the Immune System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E2009. [PMID: 31022866 DOI: 10.3390/ijms20082009] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31